Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
J Alzheimers Dis
    July 2024
  1. BUTTERFIELD DA
    Activation of the Neuronal Cell Cycle in Brains in Amnestic Mild Cognitive Impairment: Early Involvement in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240615.
    >> Share

  2. MANDAL PK, Maroon JC, Samkaria A, Arora Y, et al
    Iron Chelators and Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240605.
    >> Share

  3. AMARAL-CARVALHO V, Bento Lima-Silva T, Inacio Mariano L, Cruz de Souza L, et al
    Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240554.
    >> Share

  4. WANG RT, Sun Z, Tan CC, Tan L, et al
    Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240292.
    >> Share

  5. BOCTI C
    Is Simpler Always Better? The Case for Going Beyond the Amyloid Hypothesis in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 9. doi: 10.3233/JAD-240488.
    >> Share

  6. ELMAN JA, Schork NJ, Rangan AV
    Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes.
    J Alzheimers Dis. 2024 Jul 8. doi: 10.3233/JAD-231252.
    >> Share

  7. REIVE BS, Lau V, Sanchez-Lafuente CL, Henri-Bhargava A, et al
    The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 5. doi: 10.3233/JAD-240088.
    >> Share

  8. PORTAL B, Sodergren M, Pares I Borrell T, Giraud R, et al
    Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 4. doi: 10.3233/JAD-231461.
    >> Share


  9. Erratum to: Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2024 Jul 2. doi: 10.3233/JAD-249014.
    >> Share

    June 2024
  10. JIN H, Yang Q, Chen G, Zhang W, et al
    Effects of Hepatorenal Function on Urinary Alzheimer-Associated Neuronal Thread Protein: A Laboratory-Based Cross-Sectional Study Among the Older Chinese Population.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-240148.
    >> Share

  11. ZHANG YH, Zhao P, Gao HL, Zhong ML, et al
    Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-231389.
    >> Share


  12. Erratum to: Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-249011.
    >> Share

  13. GARCIA-MARTINEZ M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, et al
    LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-240067.
    >> Share

  14. ZHUANG X, Cordes D, Bender AR, Nandy R, et al
    Classifying Alzheimer's Disease Neuropathology Using Clinical and MRI Measurements.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-231321.
    >> Share

  15. PUZZO D
    Beyond Amyloid-beta: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 27. doi: 10.3233/JAD-240406.
    >> Share

  16. COIMBRA JRM, Resende R, Custodio JBA, Salvador JAR, et al
    BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.
    J Alzheimers Dis. 2024 Jun 22. doi: 10.3233/JAD-240146.
    >> Share

  17. SAKHAROVA T, Mao S, Osadchuk M
    Updated Models of Alzheimer's Disease with Deep Neural Networks.
    J Alzheimers Dis. 2024 Jun 21. doi: 10.3233/JAD-240183.
    >> Share

  18. PERRY G, Castellani R
    Alzheimer's Disease: Are We There Yet?
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-249012.
    >> Share

  19. LOBUE C, McClintock SM, Chiang HS, Helphrey J, et al
    A Critical Review of Noninvasive Brain Stimulation Technologies in Alzheimer's Dementia and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240230.
    >> Share

  20. HU Y, Wang X, Zhao Z, Liu M, et al
    The Downregulation of ITGAX Exacerbates Amyloid-beta Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia.
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240118.
    >> Share

  21. GARERI P, Cotroneo AM, Montella R, Gaglianone M, et al
    Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 15. doi: 10.3233/JAD-240497.
    >> Share

  22. DESAI S, Chen IY, Hom C, Doran E, et al
    Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
    >> Share

  23. CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
    Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
    >> Share

  24. CHEN X, Walton K, Brodaty H, Chalton K, et al
    Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
    >> Share

  25. CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
    The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
    >> Share

  26. SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
    Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
    >> Share

  27. CHANDLER JM, Ye W, Mi X, Doty EG, et al
    Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
    >> Share

  28. LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
    Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
    >> Share

  29. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
    >> Share

  30. LI D, Xie Q, Xie J, Ni M, et al
    Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
    >> Share

  31. LI JG, Mutreja Y, Servili M, Leone A, et al
    The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
    >> Share


  32. Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.
    >> Share

  33. SUN CK, Guo F, Ou YN, Zhang MZ, et al
    Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
    >> Share

  34. LIANG X, Wang Y, Li S, Fan J, et al
    Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
    >> Share

  35. FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
    A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
    >> Share

    May 2024
  36. TAYLOR J, Jaros M, Chen C, Harrison J, et al
    Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
    >> Share

  37. CANTERO-FORTIZ Y, Cano A, Boada M
    Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
    >> Share

  38. ZHAO A, Balcer LJ, Himali JJ, O'Donnell A, et al
    Association of Loneliness with Functional Connectivity MRI, Amyloid-beta PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 28. doi: 10.3233/JAD-231425.
    >> Share

  39. ILBOUDO Y, Yoshiji S, Lu T, Butler-Laporte G, et al
    Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies.
    J Alzheimers Dis. 2024 May 27. doi: 10.3233/JAD-221223.
    >> Share

  40. DUCHESNE S, Rousseau LS, Belzile-Marsolais F, Welch LA, et al
    A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-230772.
    >> Share

  41. GENG Z, Wu Y, Liu J, Zhan Y, et al
    A Study on the Effect of Executive Control Network Functional Connection on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-231449.
    >> Share

  42. AGUILAR BJ, Jasuja GK, Li X, Shishova E, et al
    Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-240027.
    >> Share

  43. HERMES S, Cady J, Armentrout S, O'Connor J, et al
    Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-230236.
    >> Share

  44. STARMANS NLP, Kappelle LJ, Muller M, Staals J, et al
    Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-240119.
    >> Share

  45. CHAI YL, Strohm L, Zhu Y, Chia RSL, et al
    Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-230572.
    >> Share

  46. NING M, An L, Dong L, Zhu R, et al
    Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study.
    J Alzheimers Dis. 2024 May 20. doi: 10.3233/JAD-240082.
    >> Share

  47. PRZYBYSZEWSKI AW, Chudzik A
    How to Cure Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-240231.
    >> Share

  48. GAMM S, Ummel D, Vasil N, Grenier S, et al
    Getting Insight to the Lived Emotional Experience of People with Alzheimer's Disease Shortly After Diagnosis: A Phenomenological Approach.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-231403.
    >> Share

  49. ZENG B, Tang C, Wang J, Yang Q, et al
    Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
    >> Share

  50. PLUTA R, Bogucka-Kocka A, Bogucki J, Kocki J, et al
    Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
    >> Share

  51. COSTANTINI E, Carrarini C, Calisi D, De Rosa M, et al
    Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
    >> Share

  52. KURIHARA M, Kondo S, Ohse K, Nojima H, et al
    Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
    >> Share

  53. WEGNER P, Balabin H, Ay MC, Bauermeister S, et al
    Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
    >> Share

  54. NAKAYA M, Sato N, Matsuda H, Maikusa N, et al
    Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
    >> Share

  55. STAM CJ, de Haan W
    Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
    >> Share

  56. MCINTIRE LB
    Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
    J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
    >> Share

  57. IRFAN B, Ankouni G, Reader J, Seraji-Bozorgzad N, et al
    Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for Culturally Sensitive Care.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
    >> Share

  58. ZAKRZEWSKI JJ, Davis JD, Gemelli ZT, Korthauer LE, et al
    Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
    >> Share

  59. SATO K, Niimi Y, Ihara R, Suzuki K, et al
    Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
    >> Share

  60. CHONG JSX, Tan YJ, Koh AJ, Ting SKS, et al
    Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
    >> Share

  61. GUO ZX, Liu F, Wang FY, Ou YN, et al
    CAIDE Score, Alzheimer's Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240005.
    >> Share

  62. MCLAREN AMR, Kawaja MD
    Olfactory Dysfunction and Alzheimer's Disease: A Review.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-231377.
    >> Share

  63. WU C, Ruan T, Yuan Y, Xu C, et al
    Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
    >> Share

  64. ZUPANIC E, Emersic A, Wimo A, Winblad B, et al
    Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240190.
    >> Share

  65. XIE L, Raj Y, Varathan P, He B, et al
    Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240098.
    >> Share

  66. ZHU M, Liu Y, Chen C, Chen H, et al
    TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-240012.
    >> Share

  67. GIRALDO-BERRIO D, Jimenez-Del-Rio M, Velez-Pardo C
    Sildenafil Reverses the Neuropathological Alzheimer's Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation.
    J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-231169.
    >> Share

    April 2024
  68. XU J, Chen Y, Shi Y, Sun A, et al
    Associations Between Neuroinflammation-Related Conditions and Alzheimer's Disease: A Study of US Insurance Claims Data.
    J Alzheimers Dis. 2024 Apr 30. doi: 10.3233/JAD-231286.
    >> Share

  69. WU B, Chen M, Meng L, Tian Q, et al
    Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-240096.
    >> Share

  70. LI Y, Yang Z, Zhang Y, Liu F, et al
    Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-231361.
    >> Share

  71. GALE SA
    Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-240195.
    >> Share

  72. OHNO M
    A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231451.
    >> Share

  73. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231026.
    >> Share


  74. Erratum to: Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-249008.
    >> Share

  75. UM YH, Wang SM, Kang DW, Kim S, et al
    Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240065.
    >> Share

  76. ELGHANAM Y, Purja S, Kim EY
    Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240008.
    >> Share

  77. DURAN T, Gaussoin SA, Latham LA, Rundle MM, et al
    Examining a Preclinical Alzheimer's Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231435.
    >> Share

  78. GARCIA-CARLOS CA, Basurto-Islas G, Perry G, Mondragon-Rodriguez S, et al
    Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-beta and Phosphorylated Tau Proteins.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231365.
    >> Share

  79. MEMON A, Moore JA, Kang C, Ismail Z, et al
    Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231084.
    >> Share

  80. LIU M, Ma N, Yang X, Sun M, et al
    The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 25. doi: 10.3233/JAD-240001.
    >> Share

  81. NGO S, Jackson AJ, Manivannan M, Young JC, et al
    Real World Financial Mismanagement in Alzheimer's Disease, Frontotemporal Dementia, and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Apr 24. doi: 10.3233/JAD-231021.
    >> Share

  82. HUANG Z
    Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-240042.
    >> Share

  83. DUFF K, Hammers DB, Koppelmans V, King JB, et al
    Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231392.
    >> Share

  84. CHU Y, Xie Q, Meng R, Leng B, et al
    Evaluation of the Quality and Readability of Online Information about Alzheimer's Disease in China.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231339.
    >> Share

  85. CETINSOY O, Anyanwu I, Krishnanand H, Natarajan G, et al
    Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-231383.
    >> Share

  86. KIM D, Jamrasi P, Li X, Ahn S, et al
    Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-230946.
    >> Share

  87. BUTLER T, Wang X, Chiang G, Xi K, et al
    Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231312.
    >> Share

  88. KIM M, Song YS, Han K, Bae YJ, et al
    Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231131.
    >> Share

  89. CAI J, Xie D, Kong F, Zhai Z, et al
    Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231249.
    >> Share

  90. SIGHINOLFI G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, et al
    Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231192.
    >> Share

  91. CHANDRASEKARAN G, Xie SX
    Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231047.
    >> Share

  92. DAS S
    Omics Approaches in Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-240272.
    >> Share

  93. TAHAMI MONFARED AA, Khachatryan A, Hummel N, Kopiec A, et al
    Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231259.
    >> Share

  94. CHOI YY, Lee JJ, Te Nijenhuis J, Choi KY, et al
    Multi-Ethnic Norms for Volumes of Subcortical and Lobar Brain Structures Measured by Neuro I: Ethnicity May Improve the Diagnosis of Alzheimer's Disease1.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231182.
    >> Share

  95. YOO HS, Kim HK, Lee JH, Chun JH, et al
    Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-230975.
    >> Share

  96. KHALED M, Al-Jamal H, Tajer L, El-Mir R, et al
    Alzheimer's Disease in Lebanon: Exploring Genetic and Environmental Risk Factors-A Comprehensive Review.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231432.
    >> Share

  97. ETEKOCHAY MO, Amaravadhi AR, Gonzalez GV, Atanasov AG, et al
    Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231135.
    >> Share

  98. DORADO-MARTINEZ C, Montiel-Flores E, Ordonez-Librado JL, Gutierrez-Valdez AL, et al
    Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-230818.
    >> Share

  99. BINI J
    The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231463.
    >> Share

  100. BECKERS E, Riphagen JM, Van Egroo M, Bennett DA, et al
    Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231328.
    >> Share

  101. SACHDEVA P, Narayanan KB, Sinha JK, Gupta S, et al
    Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 6. doi: 10.3233/JAD-231181.
    >> Share

  102. WIDJAYA MA, Lee SD, Cheng WC, Wu BT, et al
    Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Apr 5. doi: 10.3233/JAD-230803.
    >> Share

  103. ACQUARONE E, Argyrousi EK, Arancio O, Watterson DM, et al
    The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-240063.
    >> Share

  104. AREA-GOMEZ E, Schon EA
    Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231318.
    >> Share

  105. DAUAR MT, Picard C, Labonte A, Breitner J, et al
    Contactin 5 and Apolipoproteins Interplay in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231003.
    >> Share

    March 2024
  106. BRAGAZZI NL, Boulares A, Garbarino S
    Could the Historical Transition from Segmented to Monophasic Sleep Explain the Modern Insurgence of Alzheimer's Disease and Related Dementias?
    J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-240154.
    >> Share

  107. MORENO-RODRIGUEZ M, Perez SE, Martinez-Gardeazabal J, Manuel I, et al
    Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-231485.
    >> Share

  108. MUELLER SG
    Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life.
    J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231183.
    >> Share

  109. MATTSSON P, Cselenyi Z, Forsberg Moren A, Freund-Levi Y, et al
    High Contrast PET Imaging of Subcortical and Allocortical Amyloid-beta in Early Alzheimer's Disease Using [11C]AZD2184.
    J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231013.
    >> Share

  110. ROBINSON AC, Bin Rizwan T, Davidson YS, Minshull J, et al
    Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231429.
    >> Share

  111. VIJAYAN M, Reddy PH
    Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231281.
    >> Share

  112. GELFO F, Petrosini L, Mandolesi L, Landolfo E, et al
    Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231279.
    >> Share

  113. LOVE RWB
    Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-beta Plaques in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231247.
    >> Share

  114. LI Y, Xu X, Wang P, Chen X, et al
    Association of Cancer History with Lifetime Risk of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231223.
    >> Share

  115. MATTKE S, Jun H, Chu S, Hanson M, et al
    Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231134.
    >> Share

  116. ZHANG M, Qu Y, Li Q, Gu C, et al
    Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
    J Alzheimers Dis. 2024 Mar 21. doi: 10.3233/JAD-230648.
    >> Share

  117. CUMMINGS J
    "Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-240145.
    >> Share

  118. SHUI L, Shibata D, Chan KCG, Zhang W, et al
    Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-231149.
    >> Share

  119. POLIS B, Samson AO
    Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.
    J Alzheimers Dis. 2024 Mar 19. doi: 10.3233/JAD-240058.
    >> Share

  120. ZHONG P, Cao Q, Yan Z
    Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
    >> Share

  121. SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
    FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
    >> Share

  122. ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
    Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
    >> Share

  123. ZHANG X, Gomez L, Below JE, Naj AC, et al
    An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
    >> Share

  124. SHEN Z, Yang X, Lan Y, Chen G, et al
    The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
    >> Share

  125. RAMADAN FA, Arani G, Jafri A, Thompson T, et al
    Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
    >> Share

  126. BROOKS WH
    Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
    >> Share

  127. CAO J, Tang Y, Chen S, Yu S, et al
    The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
    >> Share

  128. TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
    Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
    >> Share

  129. ZHAI M, Zhang Y, Yan D, Wang Y, et al
    Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
    >> Share

  130. CESANA BM, Bergh S, Ciccone A, Cognat E, et al
    Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
    >> Share

  131. CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
    Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
    J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
    >> Share

  132. TERAO I, Kodama W
    Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Networ
    J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
    >> Share

  133. MANDAL PK
    Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
    >> Share


  134. Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-239016.
    >> Share

  135. GOHEL D, Zhang P, Gupta AK, Li Y, et al
    Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-231391.
    >> Share

  136. YANG J, Liu X, Oveisgharan S, Zammit AR, et al
    Inferring Alzheimer's Disease Pathologic Traits from Clinical Measures in Living Adults.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-230639.
    >> Share

    February 2024
  137. WANG CS, Chen PS, Tsai TY, Hou NT, et al
    Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-240002.
    >> Share

  138. LI S, Lan X, Liu Y, Zhou J, et al
    Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-231031.
    >> Share

  139. LU TV, Grill JD, Gillen DL
    Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231283.
    >> Share

  140. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231238.
    >> Share

  141. GARCIA-ALBERCA JM, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, et al
    An Insertion Within SIRPbeta1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231150.
    >> Share

  142. CHI HC, Ma LZ, Wang ZB, Sheng ZH, et al
    Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231111.
    >> Share

  143. ROSSI E, Marrosu F, Saba L
    Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230852.
    >> Share

  144. NJOMBORO P, Lekhutlile T
    The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230426.
    >> Share

  145. VERWAERDE P, Estrella C, Burlet S, Barrier M, et al
    First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-220883.
    >> Share

  146. KUMARI S, Kaur P, Singh AK, Ashar MS, et al
    Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-231445.
    >> Share

  147. KAVOOSI S, Shahraki A, Sheervalilou R
    Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230966.
    >> Share

  148. SABBIR MG
    Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230883.
    >> Share

  149. CULIBRK RA, Ebbert KA, Yeisley DJ, Chen R, et al
    Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230600.
    >> Share

  150. KAMEYAMA H, Tagai K, Takasaki E, Kashibayashi T, et al
    Examining Frontal Lobe Asymmetry and Its Potential Role in Aggressive Behaviors in Early Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-231306.
    >> Share

  151. VAISHNAV N, Gonzalez R, Karunungan K, Tyler A, et al
    Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-230067.
    >> Share

  152. ADAMS JA, Uryash A, Lopez JR
    Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-231010.
    >> Share

  153. RAPOS PEREIRA F, George N, Dalla Barba G, Dubois B, et al
    The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-230921.
    >> Share

  154. COGRAM P, Garduno BM, Ren B, Xu X, et al
    First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-249004.
    >> Share

  155. ACHARYA NK, Grossman HC, Clifford PM, Levin EC, et al
    A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-231028.
    >> Share

  156. CZUCZWAR SAJ, Kocki J, Miziak B, Bogucki J, et al
    Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231333.
    >> Share

  157. RAJABLI F, Seixas AA, Akgun B, Adams LD, et al
    African Ancestry Individuals with Higher Educational Attainment are Resilient to Alzheimer's Disease Measured by pTau181.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231116.
    >> Share

  158. SUN H, Li P, Gao L, Yang J, et al
    Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230928.
    >> Share

  159. NELSON D, Thompson KJ, Wang L, Wang Z, et al
    Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230907.
    >> Share

  160. GILLS JL, Bubu OM
    Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-231385.
    >> Share

  161. KIM SA, Maeda M, Murata F, Fujii T, et al
    Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study.
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806.
    >> Share

  162. JU IG, Lee S, Kim SH, Im H, et al
    Trichosanthis Semen Exerts Neuroprotective Effects in Alzheimer's Disease Models by Inhibiting Amyloid-beta Accumulation and Regulating the Akt and ERK Signaling Pathways.
    J Alzheimers Dis. 2024 Feb 13. doi: 10.3233/JAD-231124.
    >> Share

  163. LI Z, Fan Z, Zhang Q
    The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Feb 7. doi: 10.3233/JAD-230799.
    >> Share

  164. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
    Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
    >> Share

  165. DE LA MONTE SM, Tong M
    Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
    >> Share

  166. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
    Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
    >> Share

    January 2024
  167. MONE P, De Luca A, Kansakar U, Santulli G, et al
    Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
    >> Share

  168. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
    Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
    >> Share

  169. SIBLE IJ, Nation DA
    Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
    >> Share

  170. NOORI A, Jayakumar R, Moturi V, Li Z, et al
    Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
    >> Share

  171. WHEELER KV, Irimia A, Braskie MN
    Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
    >> Share

  172. JIAO L, Jing Z, Zhang W, Su X, et al
    Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
    >> Share

  173. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
    >> Share

  174. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
    Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
    >> Share

  175. BELKHELFA M, Bekrar S, Rezaig L, Beder N, et al
    Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230910.
    >> Share

  176. WEI G, Tian X, Yang H, Luo Y, et al
    Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230822.
    >> Share

  177. TAKASE H, Hamanaka G, Hoshino T, Ohtomo R, et al
    Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-231049.
    >> Share

  178. OKINAKA Y, Shinagawa Y, Claussen C, Gul S, et al
    RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230874.
    >> Share

  179. SAEED A, Alharazi T, Alshaghdali K, Rezgui R, et al
    Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230821.
    >> Share

  180. VILLEMAGNE VL, Dore V, Chong L, Kassiou M, et al
    Brain 11beta-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
    J Alzheimers Dis. 2024 Jan 19. doi: 10.3233/JAD-220542.
    >> Share

  181. ZHOU J, Zhao M, Yang Z, Chen L, et al
    Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 18. doi: 10.3233/JAD-230733.
    >> Share

  182. GORHAM IK, Reid DM, Sun J, Zhou Z, et al
    Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.
    J Alzheimers Dis. 2024 Jan 16. doi: 10.3233/JAD-230880.
    >> Share

  183. KURANO M, Saito Y, Yatomi Y
    Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 13. doi: 10.3233/JAD-230942.
    >> Share

  184. CHEN M, Wang F, Lei H, Yang Z, et al
    In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
    >> Share

  185. FORT-AZNAR L, Molina-Porcel L, Ramos-Campoy O, Esteller D, et al
    Misfolded alpha-Synuclein in Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230919.
    >> Share

  186. SMITH HS, Robinson JO, Levchenko A, Pereira S, et al
    Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230609.
    >> Share

  187. HAN Y, Huang C, Pan Y, Gu X, et al
    Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
    >> Share

  188. WU LY, Chong JR, Chong JPC, Hilal S, et al
    Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
    >> Share

  189. ZHANG C, Lei X, Ma W, Long J, et al
    Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
    >> Share

  190. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
    The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
    >> Share

  191. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
    The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
    >> Share

  192. FAN X, Cai Y, Zhao L, Liu W, et al
    Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
    >> Share

  193. VALENTIN-ESCALERA J, Leclerc M, Calon F
    High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
    >> Share

  194. SELLES MC, Oliveira MM
    The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
    >> Share

  195. LI J, Yang M, Wei R, Cao Y, et al
    The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
    >> Share

  196. NADEAU PA, Jobin B, Boller B
    Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;97:521.
    >> Share


  197. The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
    J Alzheimers Dis. 2024;97:1.
    >> Share

  198. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
    Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
    J Alzheimers Dis. 2024;97:309-325.
    >> Share

  199. ZENG Y, Cao S, Pang K, Tang J, et al
    Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2024;97:229-237.
    >> Share

  200. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
    The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
    J Alzheimers Dis. 2024;97:507-519.
    >> Share

  201. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
    Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
    J Alzheimers Dis. 2024;97:219-228.
    >> Share

  202. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
    Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
    J Alzheimers Dis. 2024;97:345-358.
    >> Share

  203. GUO Y, Sun Y, Li M, Qi WY, et al
    Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
    J Alzheimers Dis. 2024;97:471-484.
    >> Share

  204. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
    Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:171-178.
    >> Share

  205. MARTIN J, Reid N, Ward DD, King S, et al
    Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
    J Alzheimers Dis. 2024;97:101-119.
    >> Share

  206. YANG M, Gan J, Liu S, Yang Y, et al
    Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
    J Alzheimers Dis. 2024;97:409-419.
    >> Share

  207. KIM REY, Lee M, Kang DW, Wang SM, et al
    Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    J Alzheimers Dis. 2024;97:259-271.
    >> Share

  208. NA S, Lee C, Ho S, Hong YJ, et al
    A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
    J Alzheimers Dis. 2024;97:193-204.
    >> Share

  209. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
    The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
    J Alzheimers Dis. 2024;97:179-191.
    >> Share

  210. BRUNO JL, Shaw JS, Hosseini SMH
    Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
    J Alzheimers Dis. 2024;97:327-343.
    >> Share

  211. DE LA PERRELLE L
    Health Care Is Not Enough to Prevent Dementia.
    J Alzheimers Dis. 2024;97:951-952.
    >> Share

  212. DIGMA LA, Winer JR, Greicius MD
    Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
    J Alzheimers Dis. 2024;97:567-572.
    >> Share

  213. FRENTZ I, van Arendonk J, Leeuwis AE, Vernooij MW, et al
    Interaction Between Arteriosclerosis and Amyloid-beta on Cognitive Function.
    J Alzheimers Dis. 2024;97:953-961.
    >> Share

  214. MATERS J, van der Steen JT, de Vugt ME, Bakker C, et al
    Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.
    J Alzheimers Dis. 2024;97:573-586.
    >> Share

  215. SCHRODER VE, Skrozic A, Erz D, Kaysen A, et al
    Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
    J Alzheimers Dis. 2024;97:791-804.
    >> Share

  216. DINGLE SE, Milte CM, Daly RM, Torres SJ, et al
    Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study.
    J Alzheimers Dis. 2024;97:939-949.
    >> Share

  217. KOSEL F, Hartley MR, Franklin TB
    Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli.
    J Alzheimers Dis. 2024;97:659-677.
    >> Share

  218. REHMAN H, Ang TFA, Tao Q, Espenilla AL, et al
    Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.
    J Alzheimers Dis. 2024;97:621-633.
    >> Share

  219. REN J, Yu Y, Wang Y, Dong Y, et al
    Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.
    J Alzheimers Dis. 2024;97:609-620.
    >> Share

  220. MAZZOLA P, Zanetti M, Ferraguzzi G, Villa ML, et al
    Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2.
    J Alzheimers Dis. 2024;97:741-752.
    >> Share

  221. BRITZ J, Ojo E, Haque N, Dhukhwa A, et al
    Sex-Dependent Effects of Chronic Circadian Disruption in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2024;97:855-870.
    >> Share

  222. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
    Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
    J Alzheimers Dis. 2024;97:1111-1123.
    >> Share

  223. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
    The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
    J Alzheimers Dis. 2024;97:1353-1363.
    >> Share

  224. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
    The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
    J Alzheimers Dis. 2024;97:1007-1031.
    >> Share

  225. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
    Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    J Alzheimers Dis. 2024;97:1161-1171.
    >> Share

  226. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
    The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
    J Alzheimers Dis. 2024;97:1083-1090.
    >> Share

  227. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
    Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2024;97:1249-1260.
    >> Share

  228. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
    Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
    J Alzheimers Dis. 2024;97:1435-1448.
    >> Share

  229. DU P, Zhang X, Lian X, Holscher C, et al
    O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    J Alzheimers Dis. 2024;97:1051-1068.
    >> Share

  230. SHANG L, Dong L, Huang X, Chu S, et al
    Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
    J Alzheimers Dis. 2024;97:1313-1322.
    >> Share

  231. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
    FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
    J Alzheimers Dis. 2024;97:1173-1187.
    >> Share

  232. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
    Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1341-1351.
    >> Share

  233. TSENG YT, Chang YL, Chiu YS
    Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
    J Alzheimers Dis. 2024;97:1189-1209.
    >> Share

  234. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
    Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
    J Alzheimers Dis. 2024;97:1223-1233.
    >> Share

  235. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
    Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1235-1247.
    >> Share

  236. FERINI-STRAMBI L
    Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?
    J Alzheimers Dis. 2024;97:1641-1643.
    >> Share

  237. KANG J, Park M, Kim T
    Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024;97:1939-1950.
    >> Share

  238. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
    Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
    J Alzheimers Dis. 2024;97:1901-1911.
    >> Share

  239. BACHAND AM, Dell LD
    Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
    J Alzheimers Dis. 2024;97:1931-1937.
    >> Share

  240. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
    Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
    J Alzheimers Dis. 2024;97:1829-1840.
    >> Share

  241. HARRIS JL, Wang X, Christian SK, Novikova L, et al
    Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
    J Alzheimers Dis. 2024;97:1793-1806.
    >> Share

  242. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
    APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
    J Alzheimers Dis. 2024;97:1629-1639.
    >> Share

  243. ZHANG S, Ai H, Wang J, Liu T, et al
    Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:1737-1749.
    >> Share

  244. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
    Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    J Alzheimers Dis. 2024;97:1807-1827.
    >> Share

  245. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
    Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
    J Alzheimers Dis. 2024;97:1765-1776.
    >> Share

  246. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
    Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
    J Alzheimers Dis. 2024;97:1841-1850.
    >> Share

  247. ARMSTRONG MJ, Barnes LL
    Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
    J Alzheimers Dis. 2024;97:1571-1580.
    >> Share

  248. CUI X, Wang J, Wu B, Zhao Q, et al
    Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
    J Alzheimers Dis. 2024;97:1519-1531.
    >> Share

  249. FINCH CE, Burstein SM
    Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
    J Alzheimers Dis. 2024;97:1581-1588.
    >> Share

  250. SIAFARIKAS N
    Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
    J Alzheimers Dis. 2024;98:75-78.
    >> Share

  251. MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
    Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study.
    J Alzheimers Dis. 2024;98:275-285.
    >> Share

  252. NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
    Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:231-246.
    >> Share

  253. PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
    Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.
    J Alzheimers Dis. 2024;98:83-94.
    >> Share

  254. ROSS JP, Post SG, Scheinfeld L
    Lucidity in the Deeply Forgetful: A Scoping Review.
    J Alzheimers Dis. 2024;98:3-11.
    >> Share

  255. PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
    Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study.
    J Alzheimers Dis. 2024;98:145-150.
    >> Share

  256. BALLENGER J, George DR, Whitehouse PJ
    Digging Deeper: What Can We Really Learn about Dementia from History?
    J Alzheimers Dis. 2024;98:417-419.
    >> Share

  257. ORR ME
    A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain.
    J Alzheimers Dis. 2024;98:411-415.
    >> Share

  258. SHIMADA H, Doi T, Tsutsumimoto K, Makino K, et al
    Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.
    J Alzheimers Dis. 2024;98:659-669.
    >> Share

  259. ZHANG XX, Wang HR, Meng-Wei, Hu YZ, et al
    Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.
    J Alzheimers Dis. 2024;98:373-385.
    >> Share

  260. WANG J, Leong IT, Johnson MK, Pei Y, et al
    What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives.
    J Alzheimers Dis. 2024;98:519-538.
    >> Share

  261. VERA R, Hong N, Jiang B, Liang G, et al
    Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
    J Alzheimers Dis. 2024;98:549-562.
    >> Share

  262. GREENBLATT CL, Lathe R
    Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.
    J Alzheimers Dis. 2024;98:361-372.
    >> Share

  263. WANG Y, Wang S, Wu J, Liu X, et al
    Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
    J Alzheimers Dis. 2024;98:505-517.
    >> Share

  264. PARKER DC, Whitson HE, Smith PJ, Kraus VB, et al
    Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-beta Accumulation.
    J Alzheimers Dis. 2024;98:593-600.
    >> Share

  265. HAN SL, Ou YN, Han BL, Guo HH, et al
    Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline.
    J Alzheimers Dis. 2024;98:1133-1143.
    >> Share

  266. COGUT V, McNeely TL, Bussian TJ, Graves SI, et al
    Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
    J Alzheimers Dis. 2024;98:925-940.
    >> Share

  267. TSENG WI, Hsu YC, Huang LK, Hong CT, et al
    Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:1095-1106.
    >> Share

  268. MARTINEZ-DUBARBIE F, Lopez-Garcia S, Lage C, Di Molfetta G, et al
    Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
    J Alzheimers Dis. 2024;98:1029-1042.
    >> Share

  269. O'SHEA DM, Camacho S, Ezzeddine R, Besser L, et al
    The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.
    J Alzheimers Dis. 2024;98:1017-1027.
    >> Share

  270. PODGER L, Stewart WF, Serrano D, Lipton RB, et al
    Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.
    J Alzheimers Dis. 2024;98:1079-1094.
    >> Share

  271. CEYZERIAT K, Jaques E, Gloria Y, Badina A, et al
    Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.
    J Alzheimers Dis. 2024;98:1001-1016.
    >> Share

  272. PAPADIMITRIOU A, Dawson AZ, Thorgerson A, Bhandari S, et al
    Understanding the Relationship Between Wealth and Cognitive Function by Race/Ethnicity Among Older United States Adults with Diabetes.
    J Alzheimers Dis. 2024;98:1145-1155.
    >> Share

  273. SANCHEZ-SOBLECHERO A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al
    Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?
    J Alzheimers Dis. 2024;98:957-967.
    >> Share

  274. BERGAMINO M, Keeling E, McElvogue M, Schaefer SY, et al
    White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI.
    J Alzheimers Dis. 2024;98:863-884.
    >> Share


  275. Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2024;98:1543-1546.
    >> Share

  276. JANBEK J, Laursen TM, Frimodt-Moller N, Magyari M, et al
    Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases.
    J Alzheimers Dis. 2024;98:1503-1514.
    >> Share

  277. CHEN Y, Su Y, Wu J, Chen K, et al
    Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.
    J Alzheimers Dis. 2024;98:1415-1426.
    >> Share

  278. GALANKIN TL, Bespalov AY, Moebius HY
    Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.
    J Alzheimers Dis. 2024;98:1483-1491.
    >> Share

  279. HOJJATI SH, Chiang GC, Butler TA, de Leon M, et al
    Remote Associations Between Tau and Cortical Amyloid-beta Are Stage-Dependent.
    J Alzheimers Dis. 2024;98:1467-1482.
    >> Share

  280. CALDERON-GARCIDUENAS L, Ayala A, Mukherjee PS
    2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?
    J Alzheimers Dis. 2024;98:1277-1282.
    >> Share

  281. SYED RA, Hayat M, Qaiser H, Uzair M, et al
    Aging-Related Protein Alterations in the Brain.
    J Alzheimers Dis. 2024;99.
    >> Share

  282. ALROUJI M, Yasmin S, Furkan M, Alhumaydhi FA, et al
    Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics.
    J Alzheimers Dis. 2024;99:333-343.
    >> Share

  283. MORROW CB, Pontone GM
    Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
    J Alzheimers Dis. 2024;99:101-103.
    >> Share

  284. CRESSOT C, Vrillon A, Lilamand M, Francisque H, et al
    Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
    J Alzheimers Dis. 2024;99:85-99.
    >> Share

  285. ESPAY AJ, Herrup K, Imbimbo BP, Kepp KP, et al
    Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-beta42.
    J Alzheimers Dis. 2024;99:877-881.
    >> Share

  286. TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
    The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed.
    J Alzheimers Dis. 2024;99:1159-1171.
    >> Share

  287. SUGANUMA T, Hatori S, Chen CK, Hori S, et al
    Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-beta Plaque Burden.
    J Alzheimers Dis. 2024;99:1285-1301.
    >> Share

  288. WANG T, Zhang W, Maclin JMA, Xu H, et al
    Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
    J Alzheimers Dis. 2024;99:1385-1396.
    >> Share

  289. XIONG R, Li B, Yu H, Fan T, et al
    Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1 Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
    J Alzheimers Dis. 2024;99:1303-1316.
    >> Share

  290. LEE CS, Ferguson AN, Gibbons LE, Walker R, et al
    Eye Adult Changes in Thought (Eye ACT) Study: Design and Report on the Inaugural Cohort.
    J Alzheimers Dis. 2024;100:309-320.
    >> Share

  291. MENG H, Lv X, Zhang R, Feng Y, et al
    Occurrence and Risk Factors for Cognitive Decline Shared by Couples: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;100:29-40.
    >> Share

  292. GIBBONS LE, Mobley T, Mayeda ER, Lee CS, et al
    How Generalizable Are Findings from a Community-Based Prospective Cohort Study? Extending Estimates from the Adult Changes in Thought Study to Its Source Population.
    J Alzheimers Dis. 2024;100:163-174.
    >> Share

  293. SHI Q, Liu WS, Liu F, Zeng YX, et al
    The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.
    J Alzheimers Dis. 2024;100:77-85.
    >> Share

  294. SANNEMANN L, Bartels C, Brosseron F, Buerger K, et al
    Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
    J Alzheimers Dis. 2024;100:193-205.
    >> Share

  295. ZUKOWSKI LA, Brinkerhoff SA, Levin I, Herter TM, et al
    Amyloid-beta Deposition Predicts Grocery Shopping Performance in Older Adults Without Cognitive Impairment.
    J Alzheimers Dis. 2024;100:53-75.
    >> Share


  296. Robert Rissman, PhD, is the recipient of the 2024 Alzheimer Award.
    J Alzheimers Dis. 2024;100:377-378.
    >> Share

  297. KRIZANOVIC N, Jokisch M, Jockel KH, Schmidt B, et al
    Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
    J Alzheimers Dis. 2024;100:495-507.
    >> Share

  298. HOWARD E, Moody JN, Prieto S, Hayes JP, et al
    Higher Cerebrospinal Fluid Levels of Amyloid-beta40 Following Traumatic Brain Injury Relate to Confrontation Naming Performance.
    J Alzheimers Dis. 2024;100:539-550.
    >> Share

  299. HE Q, Wang W, Xiong Y, Tao C, et al
    Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia.
    J Alzheimers Dis. 2024;100:603-611.
    >> Share

  300. LOEFFLER DA
    Approaches for Increasing Cerebral Efflux of Amyloid-beta in Experimental Systems.
    J Alzheimers Dis. 2024;100:379-411.
    >> Share

    December 2023
  301. AHMED T, Zhang P, Kumar K
    Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
    J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
    >> Share

  302. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
    Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
    >> Share

  303. ALMKVIST O, Larsson M, Graff C
    Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
    >> Share

  304. ZHANG E, Dai F
    Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
    J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
    >> Share

  305. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
    Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
    >> Share

  306. FAN X, Li H, Liu L, Zhang K, et al
    Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
    >> Share

  307. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
    Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
    >> Share

  308. MORIN P, Aguilar BJ, Li X, Chen J, et al
    Alzheimer's Disease Stage Transitions Among United States Veterans.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230850.
    >> Share

  309. MAHZARNIA A, Lutz MW, Badea A
    A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
    >> Share

  310. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
    Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
    >> Share

  311. ROBINSON CG, Coleman T, Buciuc M, Singh NA, et al
    Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-230652.
    >> Share

  312. EL HAFFAF LM, Ronat L, Cannizzaro A, Hanganu A, et al
    Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-220857.
    >> Share

  313. LI KY, Lin BT, Hsu ST, Chien CF, et al
    Quetiapine Oral Solution in Alzheimer's Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study.
    J Alzheimers Dis. 2023 Dec 20. doi: 10.3233/JAD-231007.
    >> Share

  314. LOJO-RAMIREZ JA, Guerra-Gomez M, Marin-Cabanas AM, Fernandez-Rodriguez P, et al
    Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 19. doi: 10.3233/JAD-230744.
    >> Share

  315. KEIZER HG, Brands R, Oosting RS, Seinen W, et al
    The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230991.
    >> Share

  316. PARK YS, Joo HJ, Jang YS, Jeon H, et al
    Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230715.
    >> Share

  317. BAPAT R, Ma D, Duong TQ
    Predicting Four-Year's Alzheimer's Disease Onset Using Longitudinal Neurocognitive Tests and MRI Data Using Explainable Deep Convolutional Neural Networks.
    J Alzheimers Dis. 2023 Dec 16. doi: 10.3233/JAD-230893.
    >> Share

  318. JANG YJ, Choi MG, Yoo BJ, Lee KJ, et al
    Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230927.
    >> Share

  319. MALOTAUX V, Colmant L, Quenon L, Huyghe L, et al
    Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230696.
    >> Share

  320. UKRAINTSEVA S, Duan H, Holmes R, Bagley O, et al
    Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-220998.
    >> Share

  321. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-231034.
    >> Share

  322. DA X, Hempel E, Ou Y, Rowe OE, et al
    Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-230506.
    >> Share

  323. NGUYEN SA, Oughli HA, Lavretsky H
    Use of Complementary and Integrative Medicine for Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-230710.
    >> Share

  324. SCHMUED L, Maloney B, Schmued C, Lahiri DK, et al
    Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-221285.
    >> Share

    November 2023
  325. HAO N, Bai X, Hu A, Zhao G, et al
    Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer's Disease and Other Dementias Between 1990 and 2019.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230827.
    >> Share

  326. LI Y, Chen X, Zhou M, Feng S, et al
    Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230273.
    >> Share

  327. CARPI M, Fernandes M, Mercuri NB, Liguori C, et al
    Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.
    J Alzheimers Dis. 2023 Nov 29. doi: 10.3233/JAD-230933.
    >> Share

  328. WANG Y, Jiang R, Li M, Wang Z, et al
    Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Nov 27. doi: 10.3233/JAD-230784.
    >> Share

  329. ZHANG X, Wu P, Zhao Y
    COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-231151.
    >> Share

  330. CHU C, Low YLC, Ma L, Wang Y, et al
    How Can We Use Mathematical Modeling of Amyloid-beta in Alzheimer's Disease Research and Clinical Practices?
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-230938.
    >> Share

  331. KAWARABAYASHI T, Nakamura T, Miyashita K, Segawa T, et al
    Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
    J Alzheimers Dis. 2023 Nov 23. doi: 10.3233/JAD-230419.
    >> Share

  332. MELENDEZ JC, Satorres E, Pitarque A, Escudero J, et al
    Transcranial Direct Current Stimulation Intervention in Alzheimer's Disease and Its Follow-Up.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230826.
    >> Share

  333. WANG X, Huang R, Huang B, Li X, et al
    S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230533.
    >> Share

  334. JOHNSON CE, Duncan MJ, Murphy MP
    Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230527.
    >> Share

  335. SPAMPINATO MV, Ulber JL, Fayyaz H, Sullivan A, et al
    Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-220835.
    >> Share

  336. WHITE JP, Schembri A, Prenn-Gologranc C, Ondrus M, et al
    Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 21. doi: 10.3233/JAD-230352.
    >> Share

  337. LEWIS JE, McDaniel HR, Woolger JM, Khan SA, et al
    The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230659.
    >> Share

  338. MONLLOR P, Kumar P, Lloret MA, Ftara A, et al
    Multifactorial Causation of Alzheimer's Disease Due to COVID-19.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230396.
    >> Share

  339. EL KADIRI W, Perrignon-Sommet M, Delpont B, Graber M, et al
    Changes in Taste Perception in Patients with Minor and Major Cognitive Impairment Linked to Alzheimer's Disease Recorded by Gustatory Evoked Potentials.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230270.
    >> Share

  340. TETZLOFF KA, Duffy JR, Clark HM, Pham NTT, et al
    Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230912.
    >> Share

  341. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230755.
    >> Share

  342. DING P, Gurney M, Perry G, Xu R, et al
    Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230632.
    >> Share

  343. GIUNTI E, Collu R, Daley S, Querfurth H, et al
    Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230551.
    >> Share

  344. LIU YB, Wang XJ, Tan L, Tan CC, et al
    PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230516.
    >> Share

  345. LAI D, Zhang M, Li R, Zhang C, et al
    Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230510.
    >> Share

  346. BOZKURT AS, Yilmaz SG
    Ferroptotic Potency of ISM1 Expression in the Drug-Induced Alzheimer's Disease-Like Phenotype Under the Influence of Betulin.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230940.
    >> Share

  347. LI JQ, Zhong XL, Song JH, Chi S, et al
    Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230936.
    >> Share

  348. LOPES BOSCHETTI JC, Soares KL, Carvalho GR, Filho ACV, et al
    CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230843.
    >> Share

  349. YANG Z, Banks SJ, Ritter AR, Cummings JL, et al
    Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230631.
    >> Share

  350. WU W, Shen A, Lee I, Miranda-Morales EG, et al
    Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230412.
    >> Share

  351. ZENG XX, Zeng JB
    Systems Medicine as a Strategy to Deal with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230739.
    >> Share

  352. TAO S, Fan W, Liu J, Wang T, et al
    NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230567.
    >> Share

  353. CERNOTOVA D, Hruzova K, Levcik D, Svoboda J, et al
    Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230333.
    >> Share

  354. SNYTNIKOVA O, Telegina D, Savina E, Tsentalovich Y, et al
    Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230706.
    >> Share

  355. FERNANDO MG, Silva R, Fernando WMADB, de Silva HA, et al
    Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230670.
    >> Share

  356. MATSUMOTO H, Tagai K, Endo H, Matsuoka K, et al
    Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230581.
    >> Share

  357. FREDERIKSEN KS, Lanctot KL, Weidner W, Hahn-Pedersen JH, et al
    A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230487.
    >> Share

  358. SHINAGAWA H, Ohuchi K, Goto Y, Hashimoto K, et al
    Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230686.
    >> Share

  359. AZAMI H, Daftarifard E, Humeau-Heurtier A, Fernandez A, et al
    Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230544.
    >> Share

  360. LY M, Yu GZ, Chwa WJ, Raji CA, et al
    Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230738.
    >> Share

  361. LI K, Rashid T, Li J, Honnorat N, et al
    Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230389.
    >> Share

  362. MANI S, Dubey R, Lai IC, Babu MA, et al
    Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
    >> Share

  363. PERRON J, Scramstad C, Hyun Ko J
    Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
    J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
    >> Share

    October 2023
  364. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
    Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
    >> Share

  365. YANG J, Shi X, Wang Y, Ma M, et al
    Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
    >> Share

  366. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
    How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
    >> Share

  367. GRANT WB, Blake SM
    Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.
    J Alzheimers Dis. 2023 Oct 28. doi: 10.3233/JAD-230418.
    >> Share

  368. DONG Y, Hou T, Li Y, Liu R, et al
    Plasma Amyloid-beta, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230932.
    >> Share

  369. ALROUJI M, Majrashi TA, Alhumaydhi FA, Zari A, et al
    Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230828.
    >> Share

  370. INGANNATO A, Bessi V, Chiari A, Salvatori D, et al
    GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.
    J Alzheimers Dis. 2023 Oct 21. doi: 10.3233/JAD-230689.
    >> Share

  371. BEN KHEDHER MR, Haddad M, Fulop T, Laurin D, et al
    Implication of Circulating Extracellular Vesicles-Bound Amyloid-beta42 Oligomers in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230823.
    >> Share

  372. HOANG MT, Kareholt I, Schon P, von Koch L, et al
    The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer's Disease and Other Dementias: A Swedish Nationwide Study.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230388.
    >> Share

  373. TZENG IS
    Examination of Matching Methods, Sparse Effects, and Limitations in a Nationwide Database Study on Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230701.
    >> Share

  374. LEE A, Shan D, Castle D, Rajji TK, et al
    Landscape of Phase II Trials in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230660.
    >> Share

  375. BUCHMAN AS, Leurgans SE, Kim N, Agrawal S, et al
    Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230223.
    >> Share

  376. JIANG J, Hong Y, Li W, Wang A, et al
    Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230577.
    >> Share

  377. XUE W, He W, Yan M, Zhao H, et al
    Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230559.
    >> Share

  378. XIA S, Chen H, Tang T
    Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230554.
    >> Share

  379. LI A, Du J, Cai Y, Chen X, et al
    Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230446.
    >> Share

  380. BIAN Z, Hu X, Liu X, Yu H, et al
    Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230413.
    >> Share

  381. ROACH JC, Rapozo MK, Hara J, Glusman G, et al
    A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230403.
    >> Share

  382. KIM M, Yi D, Byun MS, Ahn H, et al
    Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
    >> Share

  383. AKUSHEVICH I, Yashkin A, Ukraintseva S, Yashin AI, et al
    The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-221292.
    >> Share

  384. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
    Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
    >> Share

  385. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
    Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
    >> Share

  386. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
    Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
    >> Share

  387. LIU CC, Wang QH, Xin JY, Liu YH, et al
    Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
    >> Share

    September 2023
  388. BARBA L, Otto M, Abu-Rumeileh S
    The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
    >> Share

  389. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
    Toward Prevention and Reduction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
    >> Share

  390. LIU Y, Shen Y
    Applications of Nanoparticles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
    >> Share

  391. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
    Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
    >> Share

  392. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
    Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
    >> Share

  393. POLIN C, Gelle T, Auditeau E, Adou C, et al
    Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
    >> Share

  394. DALY T
    Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
    >> Share

  395. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
    Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
    >> Share

  396. ROGERS JT, Cahill CM
    Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
    >> Share

  397. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
    Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230458.
    >> Share

  398. CHOW TE, Veziris CR, Mundada N, Martinez-Arroyo AI, et al
    Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230367.
    >> Share

  399. QEADAN F, McCunn A, Tingey B, Price R, et al
    Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
    J Alzheimers Dis. 2023 Sep 21. doi: 10.3233/JAD-230714.
    >> Share

  400. DINNERSTEIN E
    Erratum to: The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-239010.
    >> Share

  401. SUN Y, Moghekar A, Soldan A, Pettigrew C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-230807.
    >> Share

  402. ALKON DL, Sun MK, Tuchman AJ, Thompson RE, et al
    Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230868.
    >> Share

  403. LEIBY AC, Scambray KA, Nguyen HL, Basith F, et al
    Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230238.
    >> Share

  404. LARDELLI M, Baer L, Hin N, Allen A, et al
    The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer's Disease and Other Inherited Neurodegenerative Conditions.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230522.
    >> Share

  405. ZHANG Y, Xue Y, Wang L, Han Z, et al
    rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230327.
    >> Share

  406. MERLO S, Costa L, Chiechio S, Busceti CL, et al
    Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230148.
    >> Share

  407. BLUSZTAJN JK, Aytan N, Rajendiran T, Mellott TJ, et al
    Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230543.
    >> Share

  408. PARRENO TORRES A, Roncero-Parra C, Borja AL, Mateo-Sotos J, et al
    Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via Classical Machine Learning Algorithms.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230525.
    >> Share

  409. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230441.
    >> Share

  410. NIK AKHTAR S, Lu Q
    RhoA-LIMK Signaling Axis Reveals Rostral-Caudal Plane and Spatial Dysregulation in the Brain of Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230408.
    >> Share

  411. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
    Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230317.
    >> Share

  412. YANG Y, Li M, Leng B, Yao R, et al
    Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-221288.
    >> Share

  413. TANG H, Sun Y, Fachim HA, Cheung TKD, et al
    Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230616.
    >> Share

  414. WITUCKI L, Borowczyk K, Suszynska-Zajczyk J, Warzych E, et al
    Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230578.
    >> Share

  415. GUIEYSSE T, Lamothe R, Houot M, Razafimahatratra S, et al
    Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230552.
    >> Share

  416. FERNANDES C, Montalvo G, Caligiuri M, Pertsinakis M, et al
    Handwriting Changes in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230438.
    >> Share

  417. XU X, Wang H, Zhang QY, Meng XY, et al
    Dissecting Mitochondrial Mechanisms of Alzheimer's Disease Using Gene Dependency Network and Its Implications for Discovering Nutrients Combatting the Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230366.
    >> Share

  418. LARDELLI M
    An Alternative View of Familial Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230313.
    >> Share

  419. DE LA MONTE SM
    Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230555.
    >> Share

  420. FORTEL I, Zhan L, Ajilore O, Wu Y, et al
    Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230035.
    >> Share

  421. DAVIDSON S, Allenback G, Decourt B, Sabbagh MN, et al
    Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230489.
    >> Share

  422. FUKUDA H, Kanzaki H, Murata F, Maeda M, et al
    Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230471.
    >> Share

  423. ZIYAD SR, Altulyan M, Alharbi M
    SHMAD: A Smart Health Care System to Monitor Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230402.
    >> Share

  424. NAKAMURA Y, Narita K, Kim R, Nishiyama K, et al
    Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230386.
    >> Share

  425. VERDE F, Aiello EN, Adobbati L, Poletti B, et al
    Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
    J Alzheimers Dis. 2023 Sep 7. doi: 10.3233/JAD-230562.
    >> Share

  426. DU Y, Chen X, Zhang B, Jin X, et al
    Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230565.
    >> Share

  427. LEHMANN DJ, Elshorbagy A, Hurley MJ
    Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230295.
    >> Share

  428. KOPPELMANS V, Ruitenberg MFL, Schaefer SY, King JB, et al
    Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221297.
    >> Share

  429. ADEWALE BA, Coker MM, Ogunniyi A, Kalaria RN, et al
    Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221030.
    >> Share

  430. MAKRI M, Gkioka M, Moraitou D, Fidani L, et al
    Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.
    J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954.
    >> Share

    August 2023
  431. LI Z, Wu H, Ji Y, Shi Z, et al
    Toward Reagent-Free Discrimination of Alzheimer's Disease Using Blood Plasma Spectral Digital Biomarkers and Machine Learning.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230248.
    >> Share

  432. GEZEN-AK D, Dursun E
    Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230214.
    >> Share

  433. ZHANG J, Liu Q, Zhang H, Dai M, et al
    Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230027.
    >> Share

  434. FAZLOLLAHI A, Lee S, Coleman F, McCann E, et al
    Increased Resolution of Structural MRI at 3T Improves Estimation of Regional Cortical Degeneration in Individual Dementia Patients Using Surface Thickness Maps.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230030.
    >> Share

  435. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
    Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
    >> Share

  436. WU Y, Eisel ULM
    Microglia-Astrocyte Communication in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
    >> Share

  437. SCHORK NJ, Elman JA
    Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230548.
    >> Share

  438. BEI J, Miranda-Morales EG, Gan Q, Qiu Y, et al
    Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230347.
    >> Share

  439. SATTAROV R, Toresson H, Orbjorn C, Mattsson-Carlgren N, et al
    Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230119.
    >> Share

  440. HEIDARZADEH N, Ratte S
    'Eye-Tracking' with Words for Alzheimer's Disease Detection: Time Alignment of Words Enunciation with Image Regions During Image Description Tasks.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-220711.
    >> Share

  441. LI J, Mountz EJ, Mizuno A, Shah AM, et al
    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
    >> Share

  442. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
    Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
    >> Share

  443. JIANG J, Wang A, Liu Y, Yao Z, et al
    Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
    >> Share

  444. KIM DY, Kim JS, Seo YS, Park WY, et al
    Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
    >> Share

  445. ABYADEH M, Yadav VK, Kaya A
    Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
    J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
    >> Share

  446. JANN K, Boudreau J, Albrecht D, Cen SY, et al
    FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 18. doi: 10.3233/JAD-220851.
    >> Share

  447. MAMELAK M
    The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
    J Alzheimers Dis. 2023 Aug 14. doi: 10.3233/JAD-230415.
    >> Share

  448. KATISKO K, Kruger J, Soppela H, Hartikainen P, et al
    Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 12. doi: 10.3233/JAD-230494.
    >> Share

  449. KOBRO-FLATMOEN A, Hormann TM, Gouras G
    Intracellular Amyloid-beta in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 10. doi: 10.3233/JAD-230349.
    >> Share

  450. YANG H, Wang W, Jia L, Qin W, et al
    Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
    J Alzheimers Dis. 2023 Aug 8. doi: 10.3233/JAD-239007.
    >> Share

  451. WANG X, Sundermann EE, Buckley RF, Reas ET, et al
    Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230466.
    >> Share

  452. KENKPEN AK, Storey JJ, Olson ER, Guden TE, et al
    Developing Connections Between LINC00298 RNA and Alzheimer's Disease Through Mapping Its Interactome and Through Biochemical Characterization.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230057.
    >> Share

  453. HARRIS K, Ling Y, Bukhbinder AS, Chen L, et al
    The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-221231.
    >> Share

  454. CONTI E, Grana D, Angiulli F, Karantzoulis A, et al
    TSPO Modulates Oligomeric Amyloid-beta-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 5. doi: 10.3233/JAD-230239.
    >> Share

  455. CAI HY, Yang D, Qiao J, Yang JT, et al
    Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 2. doi: 10.3233/JAD-239006.
    >> Share

  456. QAISER H, Uzair M, Al-Regaiey K, Rafiq S, et al
    Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230394.
    >> Share

  457. MENDEZ MF
    Can Speaking More Than One Language Help Prevent Alzheimer's Disease?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230285.
    >> Share

  458. SONG S, Asken B, Armstrong MJ, Yang Y, et al
    Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230208.
    >> Share

  459. BACHMAN SL, Blankenship JM, Busa M, Serviente C, et al
    Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230152.
    >> Share

  460. BAUMARD J
    Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230731.
    >> Share

    July 2023
  461. LA BARBERA L, D'Amelio M
    Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model.
    J Alzheimers Dis. 2023 Jul 28. doi: 10.3233/JAD-230681.
    >> Share

  462. LIN Y, Hu T, Cheng L, Chen Y, et al
    Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jul 26. doi: 10.3233/JAD-230159.
    >> Share

  463. LEITAO ADG, Spencer B, Sarsoza F, Ngolab J, et al
    Hippocampal Reduction of alpha-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230232.
    >> Share

  464. VICENTE MC, Paneghini JL, Stabile AM, Amorim M, et al
    Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230151.
    >> Share

  465. NADEAU PA, Jobin B, Boller B
    Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-220991.
    >> Share

  466. VOSSEL K
    Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230613.
    >> Share

  467. WHITE LR, Corrada MM, Kawas CH, Cholerton BA, et al
    Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230331.
    >> Share

  468. NOWRANGI MA, Outen JD, Kim J, Avramopoulos D, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-221247.
    >> Share


  469. Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD, are the recipients of the 2023 Alzheimer Award.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-239005.
    >> Share

  470. LI J, Zeng Q, Luo X, Li K, et al
    Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Continuum.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230503.
    >> Share

  471. LOPEZ-MARTOS D, Brugulat-Serrat A, Canas-Martinez A, Canals-Gispert L, et al
    Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230290.
    >> Share

  472. KILPATRICK LA, Siddarth P, Krause-Sorio B, Milillo MM, et al
    Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-221159.
    >> Share

  473. STALLARD E, Kociolek A, Jin Z, Ryu H, et al
    Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-220811.
    >> Share

  474. YU Y, Xia X, Meng X, Li D, et al
    Plasma Phosphorylated Tau181 and Amyloid-beta42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2023 Jul 18. doi: 10.3233/JAD-230085.
    >> Share

  475. HARTLEY SL, Fleming V, Schworer EK, Peven J, et al
    Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
    J Alzheimers Dis. 2023 Jul 17. doi: 10.3233/JAD-230200.
    >> Share

  476. PUENTES-DIAZ N, Chaparro D, Reyes-Marquez V, Morales-Morales D, et al
    Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-230542.
    >> Share

  477. OLMOS-VILLASENOR R, Sepulveda-Silva C, Julio-Ramos T, Fuentes-Lopez E, et al
    Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-221272.
    >> Share

  478. CHENG C, Yang C, Jia C, Wang Q, et al
    The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230381.
    >> Share

  479. CHUM PP, Bishara MA, Solis SR, Behringer EJ, et al
    Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230300.
    >> Share

  480. CHEN R, Morris BJ, Donlon TA, Ross GW, et al
    Incidence of Alzheimer's Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230350.
    >> Share

  481. XU Y, Vasiljevic E, Deming YK, Jonaitis EM, et al
    Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230097.
    >> Share

  482. TIO ES, Hohman TJ, Milic M, Bennett DA, et al
    Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230434.
    >> Share

  483. KUDO S, Funayama M, Kurose S, Shimizu Y, et al
    Shadowing Behavior May Be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230257.
    >> Share

  484. MIGUEL L, Gervais J, Nicolas G, Lecourtois M, et al
    SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants.
    J Alzheimers Dis. 2023 Jul 8. doi: 10.3233/JAD-230211.
    >> Share

  485. YANG Y, Lv J, Bai H, Ren L, et al
    Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 7. doi: 10.3233/JAD-230291.
    >> Share

  486. XIA ZD, Ma RX, Wen JF, Zhai YF, et al
    Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230326.
    >> Share

  487. MAO M, Wang C, Hou T, Han X, et al
    Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230056.
    >> Share

  488. ZHANG HQ, Chau ACM, Shea YF, Chiu PK, et al
    Disrupted Structural White Matter Network in Alzheimer's Disease Continuum, Vascular Dementia, and Mixed Dementia: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023 Jul 3. doi: 10.3233/JAD-230341.
    >> Share

    June 2023
  489. CAI HY, Hou SJ, Wen R, Feng QF, et al
    Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230128.
    >> Share

  490. AKADA K, Koyama N, Miura Y, Takahashi K, et al
    Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230106.
    >> Share

  491. HANSEN SB
    Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-230538.
    >> Share

  492. MOBASHERI K, Zaefizadeh M, Ghobeh M, Eidi A, et al
    Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-221095.
    >> Share

  493. MERTEN N, Pinto AA, Paulsen AJ, Chen Y, et al
    Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2023 Jun 28. doi: 10.3233/JAD-221287.
    >> Share

  494. SCHAFER HACKENHAAR F, Josefsson M, Nordin Adolfsson A, Landfors M, et al
    Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-230039.
    >> Share

  495. CHHIMPA N, Singh N, Puri N, Kayath HP, et al
    The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-220514.
    >> Share

  496. KANG JM, Shin JH, Kim WR, Seo S, et al
    Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230339.
    >> Share

  497. SORRENTINO F, Fenoglio C, Sacchi L, Serpente M, et al
    Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230322.
    >> Share

  498. ALVES SS, de Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, et al
    Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230153.
    >> Share

  499. ZHANG J, Gao S, Liu W
    Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230177.
    >> Share

  500. AUDRONYTE E, Pakulaite-Kazliene G, Sutnikiene V, Kaubrys G, et al
    Odor Discrimination as a Marker of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230077.
    >> Share

  501. KULMINSKI AM, Feng F, Loiko E, Nazarian A, et al
    Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230397.
    >> Share

  502. JEONG SH, Cha J, Jung JH, Yun M, et al
    Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230187.
    >> Share

  503. HAUTECLOQUE-RAYSZ G, Sellal F, Bousiges O, Phillipi N, et al
    Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-221197.
    >> Share

  504. BELAN AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, et al
    Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230250.
    >> Share

  505. CHEN W, Lin C, Su F, Fang Y, et al
    Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230182.
    >> Share

  506. FU XX, Wei B, Cao HM, Duan R, et al
    Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-230133.
    >> Share

  507. ORTI-CASAN N, Wajant H, Kuiperij HB, Hooijsma A, et al
    Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-221230.
    >> Share

  508. BOLLINGER RM, Gabel M, Coble DW, Chen SW, et al
    Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.
    J Alzheimers Dis. 2023 Jun 18. doi: 10.3233/JAD-230079.
    >> Share

  509. NAKAMURA Y, Omori T, Kim R, Nishiyama K, et al
    Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study.
    J Alzheimers Dis. 2023 Jun 14. doi: 10.3233/JAD-230387.
    >> Share

  510. YAN R, Wang W, Yang W, Huang M, et al
    Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230314.
    >> Share

  511. JIANG WR, Wu W, Yang LJ, Yang W, et al
    Alteration of Cognitive Function in Aging and Alzheimer's Disease Mice Is Related to Dysfunction of the Neuroimmune System.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230292.
    >> Share

  512. MANSOR NI, Ling KH, Rosli R, Hassan Z, et al
    Centella asiatica (L.) Urban. Attenuates Cell Damage in Hydrogen Peroxide-Induced Oxidative Stress in Transgenic Murine Embryonic Stem Cell Line-Derived Neural-Like Cells: A Preliminary Study for Potential Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-221233.
    >> Share

  513. XU GY, Liu YH, Zeng XQ, Chen DW, et al
    The Diagnostic Potential of Circulating Autoantibodies to Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230252.
    >> Share

  514. QAISAR R, Karim A, Iqbal MS, Alkahtani SA, et al
    ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230201.
    >> Share

  515. PATEL S, Wei J, Shi Z, Rifkin AS, et al
    Refining Risk for Alzheimer's Disease Among Heterozygous APOEvarepsilon4 Carriers.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230156.
    >> Share

  516. PEAVY GM
    Can't Have One Without the Other: Study Partner Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230455.
    >> Share

  517. VANNINEN A, Lukkarinen H, Kokkola T, Koivisto AM, et al
    Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230144.
    >> Share

  518. MILANO C, Hoxhaj D, Del Chicca M, Pascazio A, et al
    Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.
    J Alzheimers Dis. 2023 Jun 9. doi: 10.3233/JAD-230170.
    >> Share

  519. HU D, Dong X, Wang Q, Liu M, et al
    PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-beta Protein Precursor Processing.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230192.
    >> Share

  520. ZHANG X, Liu Y, Huang M, Gunewardena S, et al
    Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230316.
    >> Share

  521. RUDGE JD
    The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 3. doi: 10.3233/JAD-221175.
    >> Share

    May 2023
  522. SUN L, Ye KX, Wong HLK, Wang L, et al
    The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
    >> Share

  523. HAZAN J, Liu K, Fox N, Howard R, et al
    Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
    >> Share

  524. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
    Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
    >> Share

  525. LI D, Yu YY, Hu N, Zhang M, et al
    Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221227.
    >> Share

  526. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
    The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
    >> Share

  527. LIU M, Li M, He J, He Y, et al
    Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
    >> Share

  528. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
    Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
    >> Share

  529. LIU J, Xie Y, Lu Y, Zhao Z, et al
    APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
    >> Share

  530. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
    Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
    >> Share

  531. MI Z, Abrahamson EE, Ryu AY, Malek-Ahmadi M, et al
    Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 19. doi: 10.3233/JAD-221063.
    >> Share

  532. PUOYAN-MAJD S, Parnow A, Rashno M, Heidarimoghadam R, et al
    The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230096.
    >> Share

  533. MORI H, Yoshino Y, Iga JI, Ochi S, et al
    Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230078.
    >> Share

  534. HUI HYH, Ran AR, Dai JJ, Cheung CY, et al
    Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230055.
    >> Share

  535. ELZAYAT EM, Shahien SA, El-Sherif AA, Hosney M, et al
    miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221298.
    >> Share

  536. QUERRY M, Blanc F, Bousiges O, Philippi N, et al
    Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221243.
    >> Share

  537. GONZALEZ C, Mimmack KJ, Amariglio RE, Becker JA, et al
    Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-220885.
    >> Share

  538. VOLLOCH V, Rits-Volloch S
    Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-230164.
    >> Share

  539. ORTNER M, Lanz K, Goldhardt O, Muller-Sarnowski F, et al
    Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-221187.
    >> Share

  540. WHEELERA CJ
    Evolutionary Selection of APOEvarepsilon4 Encourages Increased Focus on Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230390.
    >> Share

  541. DINNERSETIN E
    The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230254.
    >> Share

  542. HIROTA Y, Sakakibara Y, Takei K, Nishijima R, et al
    Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230121.
    >> Share

  543. WHITE LR
    If Midlife Brain Injury Is a Risk Factor for Alzheimer's Disease and Related Dementias, What Is the Neuropathologic Mechanism?
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230332.
    >> Share

  544. TOPPING M, Kim J, Fletcher J
    Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth.
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230086.
    >> Share

  545. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
    Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
    >> Share

  546. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
    Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
    >> Share

  547. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
    Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
    >> Share

  548. LIN H, Pan T, Wang M, Ge J, et al
    Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
    >> Share

  549. YAN Y, Wu Y, Xiao G, Wang L, et al
    White Matter Changes as an Independent Predictor of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
    >> Share

  550. CHENG J, Zheng H, Liu C, Jin J, et al
    Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
    >> Share

  551. LI Y, Chang J, Chen X, Liu J, et al
    Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
    >> Share

  552. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
    Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
    >> Share

  553. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
    Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
    >> Share

  554. BLUSZTAJN JK, Slack BE
    Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
    >> Share

  555. ABBATE C
    The Adult Neurogenesis Theory of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
    >> Share

  556. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
    Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
    >> Share

  557. MOYAERT P, Beun S, Achten E, Clement P, et al
    Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
    >> Share

  558. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
    Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
    >> Share

    April 2023
  559. HSIAO WW, Angela S, Le TN, Ku CC, et al
    Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays.
    J Alzheimers Dis. 2023 Apr 28. doi: 10.3233/JAD-221202.
    >> Share

  560. PRESS DZ, Musaeus CS, Zhao L, Breton J, et al
    Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI.
    J Alzheimers Dis. 2023 Apr 26. doi: 10.3233/JAD-220614.
    >> Share

  561. ZHANG K, Du X, Gao Y, Liu S, et al
    Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221253.
    >> Share

  562. LIU R, Zhang L, You H
    Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221147.
    >> Share

  563. LIEW Y, Retinasamy T, Arulsamy A, Ali I, et al
    Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-230059.
    >> Share

  564. LIANG J, LeFleur B, Hussainy S, Perry G, et al
    Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-221241.
    >> Share

  565. OTOKI Y, Yu D, Shen Q, Sahlas DJ, et al
    Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-220795.
    >> Share

  566. SINGH M, Jindal D, Kumar R, Pancham P, et al
    Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221222.
    >> Share

  567. WILLIAMS E, Mutlu-Smith M, Alex A, Chin XW, et al
    Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221185.
    >> Share

  568. STARK J, Hiersche KJ, Yu JC, Hasselbach AN, et al
    Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221084.
    >> Share

  569. HENDRIE HC
    Screening and Assessment for Alzheimer's Disease in the Days of Biological Biomarkers.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230215.
    >> Share

  570. TIAN J, Stucky C, Wang T, Muma NA, et al
    Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230072.
    >> Share

  571. ZHAO Z, Wang J, Wang Y, Liu X, et al
    18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-221251.
    >> Share

  572. EITHZ N, Sorensen J, Sopina L
    Healthcare Costs in the Year Before and After Alzheimer's Disease Diagnosis: A Danish Register-Based Matched Cohort Study.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-220821.
    >> Share

  573. JIA J, Zhang Y, Shi Y, Yina X, et al
    Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
    >> Share

  574. MAO C, You H, Hou B, Chu S, et al
    Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
    >> Share

  575. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
    Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
    >> Share

  576. QIAN L, Bian W, Wang D, Ming Z, et al
    Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
    >> Share

  577. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
    Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
    >> Share

    March 2023
  578. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-230068.
    >> Share

  579. RAHMANI F, Ghezzi L, Tosti V, Liu J, et al
    Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-221007.
    >> Share

  580. ZIYAD SR, Alharbi M, Altulyan M
    Artificial Intelligence Model for Alzheimer's Disease Detection with Convolution Neural Network for Magnetic Resonance Images.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221250.
    >> Share

  581. SUN Y, Hu HY, Hu H, Huang LY, et al
    Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221207.
    >> Share

  582. FORTEA J, Garcia-Arcelay E, Terrancle A, Galvez B, et al
    Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221160.
    >> Share

  583. WIDJAYA MA, Cheng YJ, Kuo YM, Liu CH, et al
    Transcriptomic Analyses of Exercise Training in Alzheimer's Disease Cerebral Cortex.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221139.
    >> Share

  584. NAKAMURA T, Kawarabayashi T, Ueda T, Shimomura S, et al
    Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta 40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-220996.
    >> Share

  585. HOOK G, Kindy M, Hook V
    Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-beta in hAbetaPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    J Alzheimers Dis. 2023 Mar 21. doi: 10.3233/JAD-221005.
    >> Share

  586. FILLENBAUM GG, Mohs R
    CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-230026.
    >> Share

  587. BAYAT S, Roe CM, Schindler S, Murphy SA, et al
    Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268.
    >> Share

  588. DOLCET-NEGRE MM, Imaz Aguayo L, de Eulate RG, Marti-Andres G, et al
    Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221002.
    >> Share

  589. MOON SW, Byun MS, Yi D, Kim MJ, et al
    Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-220911.
    >> Share

  590. MAN S, Chen B, Zhang Y, Xu H, et al
    The Associations Between Cataracts and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221137.
    >> Share

  591. GOLAS AC, Salwierz P, Rajji TK, Bowie CR, et al
    Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221097.
    >> Share

  592. HE Y, Li J, Yi L, Li X, et al
    Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer's Disease Models.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221115.
    >> Share

  593. HOLLENBENDERS Y, Pobiruchin M, Reichenbach A
    Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221061.
    >> Share

  594. BONOMI CG, Assogna M, Di Donna MG, Bernocchi F, et al
    Cerebrospinal Fluid sTREM-2, GFAP, and beta-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221010.
    >> Share

  595. XU S, Xie L, Zhang Y, Wu X, et al
    Inferior Frontal Sulcal Hyperintensity on FLAIR Is Associated with Small Vessel Disease but not Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-220843.
    >> Share

  596. XU Y, Zheng F, Zhong Q, Zhu Y, et al
    Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
    >> Share

  597. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
    NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
    >> Share

  598. SHAH J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, et al
    Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
    J Alzheimers Dis. 2023 Mar 3. doi: 10.3233/JAD-221261.
    >> Share

  599. LIU H, Reynolds GP, Wei X
    The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 2. doi: 10.3233/JAD-221226.
    >> Share

    February 2023
  600. LOUGHMAN A, Adler C, Macpherson H
    Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?
    J Alzheimers Dis. 2023 Feb 27. doi: 10.3233/JAD-220760.
    >> Share

  601. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M, et al
    Neuroprotective Effect of Combined Treatment with Epigallocatechin 3-Gallate and Melatonin on Familial Alzheimer's Disease PSEN1 E280A Cerebral Spheroids Derived from Menstrual Mesenchymal Stromal Cells.
    J Alzheimers Dis. 2023 Feb 24. doi: 10.3233/JAD-220903.
    >> Share

  602. ATWOOD CS, Perry G
    Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke?
    J Alzheimers Dis. 2023 Feb 22. doi: 10.3233/JAD-230040.
    >> Share

  603. WALKER JM, Gonzales MM, Goette W, Farrell K, et al
    Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-230022.
    >> Share

  604. DEMARSHALL CA, Viviano J, Emrani S, Thayasivam U, et al
    Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-221091.
    >> Share

  605. ACOSTA-BAENA N, Lopera-Gomez CM, Jaramillo-Elorza MC, Velilla-Jimenez L, et al
    Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221294.
    >> Share

  606. YIN W, Wan K, Zhu W, Zhou X, et al
    Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221174.
    >> Share

  607. DING P, Gorenflo MP, Zhu X, Xu R, et al
    Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-220787.
    >> Share

  608. WANG Z, Tan L, Zong Y, Ma YH, et al
    sTREM2 and GFAP Mediated the Association of IGF-1 Signaling Biomarkers with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2023 Feb 16. doi: 10.3233/JAD-220725.
    >> Share

  609. STITES SD, Coe NB
    Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research.
    J Alzheimers Dis. 2023 Feb 16. doi: 10.3233/JAD-220507.
    >> Share

  610. ERSOEZLUE E, Perneczky R, Tato M, Utecht J, et al
    A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Feb 15. doi: 10.3233/JAD-220464.
    >> Share

  611. HAO SW, Li TR, Han C, Han Y, et al
    Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2023 Feb 14. doi: 10.3233/JAD-221211.
    >> Share

  612. MARCISZ A, Polanska J
    Can T1-Weighted Magnetic Resonance Imaging Significantly Improve Mini-Mental State Examination-Based Distinguishing Between Mild Cognitive Impairment and Early-Stage Alzheimer's Disease?
    J Alzheimers Dis. 2023 Feb 14. doi: 10.3233/JAD-220806.
    >> Share

  613. SHIR D, Mielke MM, Hofrenning EI, Lesnick TG, et al
    Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
    J Alzheimers Dis. 2023 Feb 13. doi: 10.3233/JAD-221015.
    >> Share

  614. SWERDLOW RH
    The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview.
    J Alzheimers Dis. 2023 Feb 11. doi: 10.3233/JAD-221286.
    >> Share

  615. AGGER MP, Danielsen ER, Carstensen MS, Nguyen NM, et al
    Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-221238.
    >> Share

  616. WANG Z, Zeng S, Jing Y, Mao W, et al
    Sarm1 Regulates Circadian Rhythm Disorder in Alzheimer's Disease in Mice.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-221027.
    >> Share

  617. CHATTERJEE P, Dore V, Pedrini S, Krishnadas N, et al
    Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-220908.
    >> Share

  618. PETTI U, Baker S, Korhonen A, Robin J, et al
    The Generalizability of Longitudinal Changes in Speech Before Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-220847.
    >> Share

  619. REN JR, Wang Z, Cheng Y, He CY, et al
    Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-beta Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia Study.
    J Alzheimers Dis. 2023 Feb 7. doi: 10.3233/JAD-221107.
    >> Share

  620. KHEZRI MR, Ghasemnejad-Berenji M, Moloodsouri D
    The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-221157.
    >> Share

  621. ZHAO YL, Ou YN, Ma YH, Tan L, et al
    Characteristics of Subjective Cognitive Decline Associated with Alzheimer's Disease Amyloid Pathology: Findings from The CABLE Study.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-221154.
    >> Share

  622. ZHU CW, Gu Y, Kociolek AJ, Fernandez KK, et al
    Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-221021.
    >> Share

  623. VAN DEN BERG E, Nilsson J, Kersten I, Brinkmalm G, et al
    Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-220977.
    >> Share

  624. STOCKS J, Heywood A, Popuri K, Beg MF, et al
    Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-220975.
    >> Share

  625. TANDON R, Levey AI, Lah JJ, Seyfried NT, et al
    Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-220683.
    >> Share

  626. ZHOU M, Jiao Q, Wu Z, Li W, et al
    Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks.
    J Alzheimers Dis. 2023 Feb 2. doi: 10.3233/JAD-220727.
    >> Share

  627. PANYARD DJ, Deming YK, Darst BF, Van Hulle CA, et al
    Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2023 Feb 2. doi: 10.3233/JAD-220599.
    >> Share

  628. HIGHET B, Wiseman JA, Mein H, Parker R, et al
    PSA-NCAM Regulatory Gene Expression Changes in the Alzheimer's Disease Entorhinal Cortex Revealed with Multiplexed in situ Hybridization.
    J Alzheimers Dis. 2023 Feb 1. doi: 10.3233/JAD-220986.
    >> Share

    January 2023
  629. LILEK J, Ajroud K, Feldman AZ, Krishnamachari S, et al
    Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 30. doi: 10.3233/JAD-220848.
    >> Share

  630. NEWTON P, Tchounguen J, Pettigrew C, Lim C, et al
    Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Jan 28. doi: 10.3233/JAD-220846.
    >> Share

  631. VOSS T, Kost J, Mercer SP, Furtek C, et al
    Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
    J Alzheimers Dis. 2023 Jan 28. doi: 10.3233/JAD-220836.
    >> Share

  632. WU C, Ma YH, Hu H, Zhao B, et al
    Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.
    J Alzheimers Dis. 2023 Jan 28. doi: 10.3233/JAD-220731.
    >> Share

  633. WAN K, Yin W, Tang Y, Zhu W, et al
    Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study.
    J Alzheimers Dis. 2023 Jan 25. doi: 10.3233/JAD-221100.
    >> Share

  634. TAO X, Zhang R, Wang L, Li X, et al
    Luteolin and Exercise Combination Therapy Ameliorates Amyloid-beta1-42 Oligomers-Induced Cognitive Impairment in Alzheimer's Disease Mice by Mediating Neuroinflammation and Autophagy.
    J Alzheimers Dis. 2023 Jan 25. doi: 10.3233/JAD-220904.
    >> Share

  635. DENG L, Wang Y
    Fully Connected Multi-Kernel Convolutional Neural Network Based on Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2023 Jan 25. doi: 10.3233/JAD-220519.
    >> Share

  636. SALEM H, Suchting R, Gonzales MM, Seshadri S, et al
    Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.
    J Alzheimers Dis. 2023 Jan 24. doi: 10.3233/JAD-220826.
    >> Share


  637. Erratum to: Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-229019.
    >> Share

  638. PERRY G
    Alzheimer's Disease: Not Just for the Aged?
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-230016.
    >> Share

  639. WINSTON CN, Langford O, Levin N, Raman R, et al
    Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-221118.
    >> Share

  640. SAMUDRA N, Ranasinghe K, Kirsch H, Rankin K, et al
    Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps.
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-220983.
    >> Share

  641. SAGARO GG, Traini E, Amenta F
    Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jan 20. doi: 10.3233/JAD-221189.
    >> Share

  642. BASHA SC, Ramaiah MJ, Kosagisharaf JR
    Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 20. doi: 10.3233/JAD-221070.
    >> Share

  643. HUANG W, Xia Q, Zheng F, Zhao X, et al
    Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221064.
    >> Share

  644. ISHABIYI FO, Ogidi J, Olukade BA, Amorha CC, et al
    Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221020.
    >> Share

  645. GUO X, Zhang G, Peng Q, Huang L, et al
    Emerging Roles of Meningeal Lymphatic Vessels in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221016.
    >> Share

  646. DALY T, Henry V, Bourdenx M
    From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221004.
    >> Share

  647. CORRIGAN RR, Labrador L, Grizzanti J, Mey M, et al
    Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 13. doi: 10.3233/JAD-221057.
    >> Share

  648. AZAMI H, Moguilner S, Penagos H, Sarkis RA, et al
    EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 12. doi: 10.3233/JAD-221152.
    >> Share

  649. WANG X, Zhou X, Lee J, Furdui CM, et al
    In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 11. doi: 10.3233/JAD-221044.
    >> Share

  650. GARCIA-ALBERCA JM, Gris E, de la Guia P, Mendoza S, et al
    Efficacy of Souvenaid(R) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 11. doi: 10.3233/JAD-221003.
    >> Share

  651. FISCHER MHF, Zibrandtsen IC, Hogh P, Musaeus CS, et al
    Systematic Review of EEG Coherence in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 9. doi: 10.3233/JAD-220508.
    >> Share


  652. Erratum to: Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.
    J Alzheimers Dis. 2023 Jan 7. doi: 10.3233/JAD-229020.
    >> Share

  653. NICOLAZZO J, Cavuoto M, Rowsthorn E, Cribb L, et al
    Insomnia Symptoms and Biomarkers of Alzheimer's Disease in the Community.
    J Alzheimers Dis. 2023 Jan 7. doi: 10.3233/JAD-220924.
    >> Share

  654. RAHKONEN A, Taipale H, Koponen M, Hartikainen S, et al
    The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer's Disease: A Nationwide Case-Control Study.
    J Alzheimers Dis. 2023 Jan 7. doi: 10.3233/JAD-220409.
    >> Share

  655. ZHU M, Tang M, Du Y
    Identification of TAC1 Associated with Alzheimer's Disease Using a Robust Rank Aggregation Approach.
    J Alzheimers Dis. 2023 Jan 6. doi: 10.3233/JAD-220950.
    >> Share

  656. EISER AR, Fulop T
    Alzheimer's Disease is a Multi-Organ Disorder: It May Already Be Preventable.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-221078.
    >> Share

  657. LIMA M, Tabuas-Pereira M, Duraes J, Vieira D, et al
    Neuropsychological Assessment in the Distinction Between Biomarker Defined Frontal-Variant of Alzheimer's Disease and Behavioral-Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-220897.
    >> Share

  658. SHARMA N, Banerjee R, Davis RL
    Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-220884.
    >> Share

  659. HUIE EZ, Escudero A, Saito N, Harvey D, et al
    TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-220558.
    >> Share

  660. RADESTIG MA, Skoog J, Zetterberg H, Skillback T, et al
    Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
    J Alzheimers Dis. 2023;91:291-303.
    >> Share

  661. HU LT, Xie XY, Zhou GF, Wen QX, et al
    HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24.
    J Alzheimers Dis. 2023;91:407-426.
    >> Share

  662. KATABATHULA S, Davis PB, Xu R
    Sex-Specific Heterogeneity of Mild Cognitive Impairment Identified Based on Multi-Modal Data Analysis.
    J Alzheimers Dis. 2023;91:233-243.
    >> Share

  663. NOGUCHI-SHINOHARA M, Hamaguchi T, Sakai K, Komatsu J, et al
    Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial.
    J Alzheimers Dis. 2023;91:805-814.
    >> Share

  664. LIU Y, Zeng Z, Huang S, Shang P, et al
    Brain Activation During Working Memory Task in Amnestic Mild Cognitive Impairment Patients and Its Association with Memory and Attention.
    J Alzheimers Dis. 2023;91:863-875.
    >> Share

  665. CHANDLER J, Kubisiak J
    Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-beta Status: A 5-Year Retrospective Claims Study of GERAS-US Patients.
    J Alzheimers Dis. 2023;91:753-765.
    >> Share

  666. FENECH RK, Hamstra SI, Finch MS, Ryan CR, et al
    Low-Dose Lithium Supplementation Influences GSK3beta Activity in a Brain Region Specific Manner in C57BL6 Male Mice.
    J Alzheimers Dis. 2023;91:615-626.
    >> Share

  667. WU J, Su Y, Zhu W, Jalili Mallak N, et al
    Improved Prediction of Amyloid-beta and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.
    J Alzheimers Dis. 2023;91:637-651.
    >> Share

  668. SAKAI K, Noguchi-Shinohara M, Tanaka H, Ikeda T, et al
    Cerebrospinal Fluid Biomarkers and Amyloid-beta Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
    J Alzheimers Dis. 2023;91:1173-1183.
    >> Share

  669. SCHAFER S, Mallick E, Schwed L, Konig A, et al
    Screening for Mild Cognitive Impairment Using a Machine Learning Classifier and the Remote Speech Biomarker for Cognition: Evidence from Two Clinically Relevant Cohorts.
    J Alzheimers Dis. 2023;91:1165-1171.
    >> Share

  670. MEYSAMI S, Raji CA, Glatt RM, Popa ES, et al
    Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden.
    J Alzheimers Dis. 2023;91:999-1006.
    >> Share

  671. CASELLI RJ, Chen Y, Chen K, Bauer RJ, et al
    Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study.
    J Alzheimers Dis. 2023;91:1049-1058.
    >> Share

  672. MASCARENHAS FONSECA L, Sage Chaytor N, Olufadi Y, Buchwald D, et al
    Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
    J Alzheimers Dis. 2023;91:1395-1407.
    >> Share

  673. SACRIPANTE R, Girtler N, Doglione E, Nobili F, et al
    Forgetting Rates of Prose Memory in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;91:1385-1394.
    >> Share

  674. HAYS WEEKS CC, Zlatar ZZ, Meloy MJ, Shin DD, et al
    APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance.
    J Alzheimers Dis. 2023;91:1371-1383.
    >> Share

  675. JANSE A, van de Rest O, de Groot LCPGM, Witkamp RF, et al
    The Association of Vitamin D Status with Mild Cognitive Impairment and Dementia Subtypes: A Cross-Sectional Analysis in Dutch Geriatric Outpatients.
    J Alzheimers Dis. 2023;91:1359-1369.
    >> Share

  676. MARIN-MARIN L, Miro-Padilla A, Costumero V
    Structural But Not Functional Connectivity Differences within Default Mode Network Indicate Conversion to Dementia.
    J Alzheimers Dis. 2023;91:1483-1494.
    >> Share

  677. LIU C, Lee SH, Loewenstein DA, Galvin JE, et al
    Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.
    J Alzheimers Dis. 2023;91:1313-1322.
    >> Share

  678. HUQUE H, Eramudugolla R, Chidiac B, Ee N, et al
    Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;91:1231-1241.
    >> Share

  679. BOUGES S, Fischer BL, Norton DL, Wyman MF, et al
    Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.
    J Alzheimers Dis. 2023;92:285-294.
    >> Share

  680. YOSHIDA M, Uemura T, Mizoi M, Waragai M, et al
    Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
    J Alzheimers Dis. 2023;92:361-369.
    >> Share

  681. BAEZ S, Trujillo-Llano C, de Souza LC, Lillo P, et al
    Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.
    J Alzheimers Dis. 2023;92:153-169.
    >> Share

  682. HUANG Z
    A Function of Amyloid-beta in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
    J Alzheimers Dis. 2023;92:29-57.
    >> Share

  683. GRASSET L, Power MC, Crivello F, Tzourio C, et al
    How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.
    J Alzheimers Dis. 2023;92:183-193.
    >> Share

  684. CORRERO II AN, Gauthreaux K, Perales-Puchalt J, Chen YC, et al
    Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.
    J Alzheimers Dis. 2023;92:109-128.
    >> Share

  685. MOEBIUS HJ, Church KJ
    The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
    J Alzheimers Dis. 2023;92:1-12.
    >> Share

  686. YANG M, Qi R, Liu Y, Shen X, et al
    Casein Kinase 1delta Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
    J Alzheimers Dis. 2023;91:1527-1539.
    >> Share

  687. ONO R, Sakurai T, Sugimoto T, Uchida K, et al
    Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
    J Alzheimers Dis. 2023;92:487-498.
    >> Share

  688. GABRIELLI AP, Weidling I, Ranjan A, Wang X, et al
    Mitochondria Profoundly Influence Apolipoprotein E Biology.
    J Alzheimers Dis. 2023;92:591-604.
    >> Share

  689. TAN YJ, Siow I, Saffari SE, Ting SKS, et al
    Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
    J Alzheimers Dis. 2023;92:573-580.
    >> Share

  690. ROYALL DR, Palmer RF
    Multiple Adipokines Predict Dementia Severity as Measured by delta: Replication Across Biofluids and Cohorts.
    J Alzheimers Dis. 2023;92:639-652.
    >> Share

  691. MANN FD, Clouston SAP, Cuevas A, Waszczuk MA, et al
    Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders.
    J Alzheimers Dis. 2023;92:701-712.
    >> Share

  692. TANG M, Su N, Zhang D, Dai Y, et al
    The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations.
    J Alzheimers Dis. 2023;92:691-700.
    >> Share

  693. GYLLENHAMMAR M, Rennie A, Padilla DF, Wallert J, et al
    The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.
    J Alzheimers Dis. 2023;92:605-614.
    >> Share

  694. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
    Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
    J Alzheimers Dis. 2023;92:1027-1035.
    >> Share

  695. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
    Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
    J Alzheimers Dis. 2023;92:1093-1109.
    >> Share

  696. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
    The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
    J Alzheimers Dis. 2023;92:769-789.
    >> Share

  697. LI QY, Li XM, Hu HY, Ma YH, et al
    Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2023;92:853-873.
    >> Share

  698. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
    Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
    J Alzheimers Dis. 2023;92:959-974.
    >> Share

  699. KIM BS, Jun S, Kim H
    Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;92:803-814.
    >> Share

  700. ZHANG F, Niu L, Zhong R, Li S, et al
    Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AbetaPP/PS1 AD Mice and Their Wild-Type Littermates.
    J Alzheimers Dis. 2023;92:1341-1355.
    >> Share

  701. BUKHBINDER AS, Hinojosa M, Harris K, Li X, et al
    Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
    J Alzheimers Dis. 2023;92:1323-1339.
    >> Share

  702. KAWAKATSU S, Kobayashi R
    Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
    J Alzheimers Dis. 2023;93:389-392.
    >> Share

  703. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
    Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    J Alzheimers Dis. 2023;93:247-262.
    >> Share

  704. GAO Y, Liu Y, Zhang Y, Wang Y, et al
    Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
    J Alzheimers Dis. 2023;93:169-178.
    >> Share

  705. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
    Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
    J Alzheimers Dis. 2023;93:365-378.
    >> Share

  706. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
    Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
    J Alzheimers Dis. 2023;93:151-167.
    >> Share

  707. LV X, Chu M, Liu Y, Jing D, et al
    Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023;93:295-305.
    >> Share

  708. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
    The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
    J Alzheimers Dis. 2023;93:307-319.
    >> Share

  709. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
    Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
    J Alzheimers Dis. 2023;93:211-224.
    >> Share

  710. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
    The Future of Cognitive Screening in Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;93:47-59.
    >> Share

  711. KREBS C, Brill E, Minkova L, Federspiel A, et al
    Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;93:107-124.
    >> Share

  712. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
    Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
    J Alzheimers Dis. 2023;93:61-74.
    >> Share

  713. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
    Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;93:75-86.
    >> Share

  714. FLETCHER E
    Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
    J Alzheimers Dis. 2023;93:815-819.
    >> Share

  715. CASTELLANI RJ, Shanes ED, McCord M, Reish NJ, et al
    Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report.
    J Alzheimers Dis. 2023;93:803-813.
    >> Share

  716. XIAO Y, Liao L, Huang K, Yao S, et al
    Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
    J Alzheimers Dis. 2023;93:791-801.
    >> Share

  717. HICKEY M, Hueg TK, Priskorn L, Uldbjerg CS, et al
    Depression in Mid- and Later-Life and Risk of Dementia in Women: A Prospective Study within the Danish Nurses Cohort.
    J Alzheimers Dis. 2023;93:779-789.
    >> Share

  718. CHEN CD, Ponisio MR, Lang JA, Flores S, et al
    Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.
    J Alzheimers Dis. 2023;93:765-777.
    >> Share

  719. HATTORI Y, Saito S, Nakaoku Y, Ogata S, et al
    Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
    J Alzheimers Dis. 2023;93:743-754.
    >> Share

  720. ZHANG LY, Wang DZ, Wang J, Guo L, et al
    Associations of Serum Antimicrobial Peptide LL-37 with Longitudinal Cognitive Decline and Neurodegeneration Among Older Adults with Memory Complaints.
    J Alzheimers Dis. 2023;93:595-603.
    >> Share

  721. AGUILAR-BARBERA M, Soler-Girabau P, Tabuenca-Martin AI, Prieto-Del Val L, et al
    Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
    J Alzheimers Dis. 2023;93:621-631.
    >> Share

  722. SIBLE IJ, Nation DA
    Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;93:533-543.
    >> Share

  723. BISWAS R, Kawas C, Montine TJ, Bukhari SA, et al
    Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
    J Alzheimers Dis. 2023;93:561-575.
    >> Share

  724. BROOK ES, D'Alonzo ZJ, Lam V, Chan DC, et al
    Plasma Amyloid-beta Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.
    J Alzheimers Dis. 2023;93:653-664.
    >> Share

  725. RHYU JM, Park J, Shin BS, Kim YE, et al
    A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia.
    J Alzheimers Dis. 2023;93:403-409.
    >> Share

  726. DUFF K, Wan L, Embree L, Hoffman JM, et al
    Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.
    J Alzheimers Dis. 2023;93:449-457.
    >> Share

  727. ZHANG J, Zhang T, Wang Y, Yao L, et al
    Galpha13-Mediated Signaling Cascade Is Related to the Tau Pathology Caused by Anesthesia and Surgery in 5XFAD Transgenic Mice.
    J Alzheimers Dis. 2023;93:545-560.
    >> Share

  728. IMAI A, Matsuoka T, Narumoto J
    Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.
    J Alzheimers Dis. 2023;93:521-532.
    >> Share

  729. ZHENG YB, Sun J, Shi L, Su SZ, et al
    Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023;93:483-493.
    >> Share

  730. NOBLE JM, Papapanou PN
    With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease.
    J Alzheimers Dis. 2023;93:991-994.
    >> Share

  731. GOLLOP C, Zingel R, Jacob L, Smith L, et al
    Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study.
    J Alzheimers Dis. 2023;93:1033-1040.
    >> Share

  732. FAN J, Zhu Z, Chen Y, Yang C, et al
    SORL1 rs1699102 Moderates the Effect of Sex on Language Network.
    J Alzheimers Dis. 2023;93:1051-1063.
    >> Share

  733. WU J, Su Y, Chen Y, Zhu W, et al
    A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry.
    J Alzheimers Dis. 2023;93:1153-1168.
    >> Share

  734. JIANG C, Wang Y, Dong Y, Liu R, et al
    Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
    J Alzheimers Dis. 2023;93:1111-1124.
    >> Share

  735. MARSHALL AJ, Gaubert A, Kapoor A, Tan A, et al
    Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?
    J Alzheimers Dis. 2023;93:1041-1050.
    >> Share

  736. NIJSKENS C, Henstra M, Rhodius-Meester H, Yasar S, et al
    Cardiovascular Risk Management in Persons with Dementia.
    J Alzheimers Dis. 2023;93:879-889.
    >> Share

  737. GIBBONS LE, Power MC, Walker RL, Kumar RG, et al
    Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.
    J Alzheimers Dis. 2023;93:949-961.
    >> Share

  738. SMITH CJ, Ashford JW
    Apolipoprotein varepsilon4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations.
    J Alzheimers Dis. 2023;93:907-918.
    >> Share

  739. BAUERNSCHMIDT D, Hirt J, Langer G, Meyer G, et al
    Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;93:891-906.
    >> Share

  740. PILONIETA G, Pisu M, Martin RC, Shan L, et al
    Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.
    J Alzheimers Dis. 2023;93:927-937.
    >> Share

  741. XIANG Q, Andersen SL, Sweigart B, Gunn S, et al
    Signatures of Neuropsychological Test Results in the Long Life Family Study: A Cluster Analysis.
    J Alzheimers Dis. 2023;93:1457-1469.
    >> Share

  742. BEST MN, Lim Y, Ferenc NN, Kim N, et al
    Extracellular Tau Oligomers Damage the Axon Initial Segment.
    J Alzheimers Dis. 2023;93:1425-1441.
    >> Share

  743. XU S, Ren Y, Liu R, Li Y, et al
    Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023;93:1355-1368.
    >> Share

  744. YANG F, Yang L, Fang X, Deng Y, et al
    Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    J Alzheimers Dis. 2023;93:1341-1354.
    >> Share

  745. NALLAPU BT, Petersen KK, Lipton RB, Grober E, et al
    Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
    J Alzheimers Dis. 2023;93:1381-1393.
    >> Share

  746. ANDERSSON MJ, Stone J
    Best Medicine for Dementia: The Life-Long Defense of the Brain.
    J Alzheimers Dis. 2023;94:51-66.
    >> Share

  747. DI J, Nelson RS, Jicha GA, Moga DC, et al
    Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
    J Alzheimers Dis. 2023;94:333-346.
    >> Share

  748. MEDURI G, Guillemeau K, Daguinot C, Dounane O, et al
    Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    J Alzheimers Dis. 2023;94:313-331.
    >> Share

  749. SINHA N, Fausto BA, Mander B, Gluck MA, et al
    High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans.
    J Alzheimers Dis. 2023;94:281-290.
    >> Share

  750. BUAWANGPONG N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, et al
    Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
    J Alzheimers Dis. 2023;94:163-175.
    >> Share

  751. DE ANDA-DURAN I, Kolachalama VB, Carmichael OT, Hwang PH, et al
    Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.
    J Alzheimers Dis. 2023;94:101-113.
    >> Share

  752. LOUGHREY DG, Leroi I
    Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy.
    J Alzheimers Dis. 2023;94:597-599.
    >> Share

  753. OLIVEIRA FF
    Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;94:777-780.
    >> Share

  754. CURTIS ME, Smith T, Nenov M, Blass BE, et al
    Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome.
    J Alzheimers Dis. 2023;94:513-518.
    >> Share

  755. LI B, Shi K, Ren C, Kong M, et al
    Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features.
    J Alzheimers Dis. 2023;94:627-640.
    >> Share

  756. TOCCACELI BLASI M, Valletta M, Trebbastoni A, D'Antonio F, et al
    Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
    J Alzheimers Dis. 2023;94:601-610.
    >> Share

  757. WANG J, Wang M, Ren S, Huang L, et al
    The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
    J Alzheimers Dis. 2023;94:763-775.
    >> Share

  758. FARINA FR, Booi L, Occhipinti JA, Quoidbach V, et al
    Young Adult Brain Capital: A New Opportunity for Dementia Prevention.
    J Alzheimers Dis. 2023;94:415-423.
    >> Share

  759. MAURER A, Himmel G, Lange C, Mathies F, et al
    Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients.
    J Alzheimers Dis. 2023;94:559-584.
    >> Share

  760. EDWARDS L, Thomas KR, Weigand AJ, Edmonds EC, et al
    White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;94:695-707.
    >> Share

  761. CHOU OHI, Zhou J, Li L, Chan JSK, et al
    The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
    J Alzheimers Dis. 2023;94:547-557.
    >> Share

  762. LI T, Pappas C, Klinedinst B, Pollpeter A, et al
    Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults.
    J Alzheimers Dis. 2023;94.
    >> Share

  763. KOSTEV K
    Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk.
    J Alzheimers Dis. 2023;94:961-962.
    >> Share

  764. CASTELBLANCO-TORO SM, Jurado-Delgado J, Meneses-Bernal JF, Santacruz-Escudero JM, et al
    Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population.
    J Alzheimers Dis. 2023;94:1197-1207.
    >> Share

  765. CUBERO-PLAZAS L, Sancho-Cantus D, de la Rubia Orti JE, Prieto-Contreras L, et al
    Impact of Family Function on the Quality of Life and Health Perception of Non-Institutionalized Dementia Patients.
    J Alzheimers Dis. 2023;94:963-975.
    >> Share

  766. PANZA F, Solfrizzi V, Sardone R, Dibello V, et al
    Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
    J Alzheimers Dis. 2023;94:879-898.
    >> Share

  767. BAYRAM E, Holden SK, Fullard M, Armstrong MJ, et al
    Race and Ethnicity in Lewy Body Dementia: A Narrative Review.
    J Alzheimers Dis. 2023;94:861-878.
    >> Share

  768. WANG G, Li DY, Vance DE, Li W, et al
    Alcohol Use Disorder as a Risk Factor for Cognitive Impairment.
    J Alzheimers Dis. 2023;94:899-907.
    >> Share

  769. CAILLAUD M, Maltezos S, Hudon C, Mellah S, et al
    Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    J Alzheimers Dis. 2023;94:1047-1056.
    >> Share

  770. CHWA WJ, Lopez OL, Longstreth WT, Dai W, et al
    Longitudinal Patterns of Brain Changes in a Community Sample in Relation to Aging and Cognitive Status.
    J Alzheimers Dis. 2023;94:1035-1045.
    >> Share

  771. SANDISON H, Callan NGL, Rao RV, Phipps J, et al
    Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.
    J Alzheimers Dis. 2023;94:993-1004.
    >> Share

  772. LI D, Yang H, Lyu M, Wang J, et al
    Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.
    J Alzheimers Dis. 2023;94.
    >> Share

  773. GOTTSCHALK WK, Mahon S, Hodgson D, Barrera J, et al
    The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
    J Alzheimers Dis. 2023;94:1563-1576.
    >> Share

  774. SUSAC J, Vukojevic J, Debogovic S, Bajic Z, et al
    Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
    J Alzheimers Dis. 2023;94:1417-1430.
    >> Share

  775. BAYER TA, Jiang L, Erqou S, Kunicki ZJ, et al
    Incidence of New Dementia Diagnosis in Veterans Admitted to Nursing Homes After Heart Failure Hospitalization.
    J Alzheimers Dis. 2023;94:1397-1404.
    >> Share

  776. LANSDELL TA, Xu H, Galligan JJ, Dorrance AM, et al
    Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.
    J Alzheimers Dis. 2023;94:1361-1375.
    >> Share

  777. YABUUCHI K, Kimura N, Masuda T, Matsubara E, et al
    Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
    J Alzheimers Dis. 2023;95:299-306.
    >> Share

  778. HUANG L, Li Y, Wu J, Chen N, et al
    Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.
    J Alzheimers Dis. 2023;95:227-236.
    >> Share

  779. CASTILLO C, Bravo-Arrepol G, Wendt A, Saez-Orellana F, et al
    Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity.
    J Alzheimers Dis. 2023;94.
    >> Share

  780. NORRIS CM
    Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
    J Alzheimers Dis. 2023;95:599-602.
    >> Share

  781. PANIKKAR D, Vivek S, Crimmins E, Faul J, et al
    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
    J Alzheimers Dis. 2023;95:735-748.
    >> Share

  782. PASSMORE SR, Longhurst C, Gerbitz A, Green-Harris G, et al
    "I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.
    J Alzheimers Dis. 2023;95:663-675.
    >> Share

  783. ROSALES-LAGARDE A, Cubero-Rego L, Menendez-Conde F, Rodriguez-Torres EE, et al
    Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study.
    J Alzheimers Dis. 2023;95:477-491.
    >> Share

  784. VOLGMAN AS, Engelstein E, Aggarwal NT
    Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men?
    J Alzheimers Dis. 2023;95:407-409.
    >> Share

  785. MIYAWAKI CE, McClellan A, Bouldin ED, Brohard C, et al
    Feasibility and Efficacy of Life Review Delivered by Virtually-Trained Family Caregivers.
    J Alzheimers Dis. 2023;95:573-583.
    >> Share

  786. MACYCZKO JR, Wang N, Lu W, Jeevaratnam S, et al
    Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
    J Alzheimers Dis. 2023;95:399-405.
    >> Share

  787. BOGDAN A, Fabre R, Desmidt T, Golebiowski J, et al
    Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
    J Alzheimers Dis. 2023;95:415-426.
    >> Share

  788. GUEVARA JE, Kurniadi NE, Duff K
    Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.
    J Alzheimers Dis. 2023;95:509-521.
    >> Share

  789. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
    J Alzheimers Dis. 2023;95:493-507.
    >> Share

  790. LOPES DAS NEVES P, Duraes J, Silva-Spinola A, Lima M, et al
    Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
    J Alzheimers Dis. 2023;95:391-397.
    >> Share

  791. DALY T
    JAD: A Forum for Philosophy in Science.
    J Alzheimers Dis. 2023;95:411-413.
    >> Share

  792. HUA S, Peters BA, Lee S, Fitzgerald K, et al
    Gut Microbiota and Cognitive Function Among Women Living with HIV.
    J Alzheimers Dis. 2023;95:1147-1161.
    >> Share

  793. COSTA T, Premi E, Liloia D, Cauda F, et al
    Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
    J Alzheimers Dis. 2023;95:1059-1065.
    >> Share

  794. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
    Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;95:829-845.
    >> Share

  795. AL-LAHHAM R, Mendez N
    Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
    J Alzheimers Dis. 2023;95:1041-1058.
    >> Share

  796. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
    Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
    J Alzheimers Dis. 2023;95:931-940.
    >> Share

  797. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
    Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
    J Alzheimers Dis. 2023;95:1067-1075.
    >> Share

  798. FLEISCHMAN DA, Arfanakis K, Zhang S, Leurgans SE, et al
    Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023;95:1585-1595.
    >> Share

  799. WANG S, Liu S, Ke S, Zhou W, et al
    APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;95:1509-1518.
    >> Share

  800. WATTS A, Haneline S, Welsh-Bohmer KA, Wu J, et al
    TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEvarepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;95:1697-1707.
    >> Share

  801. AMOFA-HO PA, Stickel AM, Chen R, Kobayashi LC, et al
    The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition.
    J Alzheimers Dis. 2023;95:1405-1416.
    >> Share

  802. MARCOLINI S, Rojczyk P, Seitz-Holland J, Koerte IK, et al
    Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
    J Alzheimers Dis. 2023;95:1427-1448.
    >> Share

  803. WANG R, Kuang C, Guo C, Chen Y, et al
    Automatic Detection of Putative Mild Cognitive Impairment from Speech Acoustic Features in Mandarin-Speaking Elders.
    J Alzheimers Dis. 2023;95:901-914.
    >> Share

  804. DAAMEN M, Scheef L, Li S, Grothe MJ, et al
    Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;95:1013-1028.
    >> Share

  805. CODY SL, Miller GH, Fazeli PL, Wang G, et al
    Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.
    J Alzheimers Dis. 2023;95:753-768.
    >> Share

  806. KEPP KP, Sensi SL, Johnsen KB, Barrio JR, et al
    The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
    J Alzheimers Dis. 2023;94:497-507.
    >> Share

  807. SAJI N, Ishihara Y, Murotani K, Uchiyama A, et al
    Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.
    J Alzheimers Dis. 2023;96:369-380.
    >> Share

  808. DATLOW LY, King J, Leventhal M, Wallace TC, et al
    Association of Pork Intake with Cognitive Performance in Older Adults Enrolled in the National Health and Nutrition Examination Survey (NHANES), 2011-2014 Data Cycles.
    J Alzheimers Dis. 2023;96:351-358.
    >> Share

  809. PACHECO PACHADO M, Casas AI, Elbatreek MH, Nogales C, et al
    Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
    J Alzheimers Dis. 2023;96:47-56.
    >> Share

  810. CHEN S, Huang W, He T, Zhang M, et al
    Exploring the Causality Between Plasma Brain-Derived Neurotrophic Factor and Neurological Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023;96:135-148.
    >> Share

  811. UTZ J, Olm P, Jablonowski J, Siegmann EM, et al
    Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.
    J Alzheimers Dis. 2023;96:265-275.
    >> Share

  812. HAMMERS DB, Lin JH, Polsinelli AJ, Logan PE, et al
    Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.
    J Alzheimers Dis. 2023;96:197-214.
    >> Share

  813. DING H, Mandapati A, Hamel AP, Karjadi C, et al
    Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
    J Alzheimers Dis. 2023;96:277-286.
    >> Share

  814. LINDH-RENGIFO M, Jonasson SB, Ullen S, Palmqvist S, et al
    Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;96:161-171.
    >> Share

  815. CAVUOTO MG, Robinson SR, O'Donoghue FJ, Barnes M, et al
    Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
    J Alzheimers Dis. 2023;96:149-159.
    >> Share

  816. SMITH GS, Kuwabara H, Yan H, Nassery N, et al
    Serotonin Degeneration and Amyloid-beta Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
    J Alzheimers Dis. 2023;96:215-227.
    >> Share


  817. Erratum to: Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023;96:859-860.
    >> Share

  818. BAHRANI AA, Abner EL, DeCarli CS, Barber JM, et al
    Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
    J Alzheimers Dis. 2023;96:683-693.
    >> Share

  819. KARJADI C, Xue C, Cordella C, Kiran S, et al
    Fusion of Low-Level Descriptors of Digital Voice Recordings for Dementia Assessment.
    J Alzheimers Dis. 2023;96:507-514.
    >> Share

  820. LI J, Weiss J, Rajadhyaksha A, Acosta D, et al
    Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
    J Alzheimers Dis. 2023;96:801-811.
    >> Share

  821. MICHOPOULOU S, Prosser A, Dickson J, Guy M, et al
    Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1317-1327.
    >> Share

  822. ZHOU J, Wang ZB, Sun Y, Fu Y, et al
    Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly.
    J Alzheimers Dis. 2023;96:1071-1081.
    >> Share

  823. CHWA WJ, Raji CA, Toups K, Hathaway A, et al
    Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1051-1058.
    >> Share

  824. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
    J Alzheimers Dis. 2023;96:1329-1338.
    >> Share

  825. BROSENS N, Samouil D, Stolker S, Katsika EV, et al
    Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1097-1113.
    >> Share

  826. ZHU Y, Olchanski N, Cohen JT, Freund KM, et al
    Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.
    J Alzheimers Dis. 2023;96:1183-1193.
    >> Share

  827. BERNARDES C, Lima M, Duro D, Silva-Spinola A, et al
    Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
    J Alzheimers Dis. 2023;96:1173-1182.
    >> Share

  828. NAISMITH SL, Michaelian JC, Santos C, Mehrani I, et al
    Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.
    J Alzheimers Dis. 2023;96:913-925.
    >> Share

  829. KOULOUSAKIS P, Willems E, Schepers M, Rombaut B, et al
    Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1207-1219.
    >> Share

  830. HEALY E
    Impact of the MIND Diet on Cognition in Individuals with Dementia.
    J Alzheimers Dis. 2023;96:967-977.
    >> Share

  831. ZHAO B, Ou YN, Zhang XY, Fu Y, et al
    Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.
    J Alzheimers Dis. 2023;96:1813-1825.
    >> Share

  832. ROBINSON MJ, Newbury S, Singh K, Leonenko Z, et al
    The Interplay Between Cholesterol and Amyloid-beta on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling.
    J Alzheimers Dis. 2023;96:1663-1683.
    >> Share

  833. TIAN J, Du E, Jia K, Wang T, et al
    Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-beta Knockin Mice During Aging.
    J Alzheimers Dis. 2023;96:1579-1592.
    >> Share

  834. SLUGGETT JK, Air T, Cations M, Caughey GE, et al
    Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services.
    J Alzheimers Dis. 2023;96:1747-1758.
    >> Share

  835. GAO Y, Duan X, Li W, Zhang X, et al
    Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
    J Alzheimers Dis. 2023;96:1739-1746.
    >> Share

  836. YOON J, Sasaki K, Tateoka K, Arai T, et al
    Evaluation of Cognitive and Physical Function Among Older Adults by Their Physical Activity: A Cross-Sectional Kasama Study, Japan.
    J Alzheimers Dis. 2023;96:1801-1812.
    >> Share

  837. SOLIS-URRA P, Rodriguez-Ayllon M, Alvarez-Ortega M, Molina-Hidalgo C, et al
    Physical Performance and Amyloid-beta in Humans: A Systematic Review and Meta-Analysis of Observational Studies.
    J Alzheimers Dis. 2023;96:1427-1439.
    >> Share

  838. GARCIA-ALBERCA JM, de la Rosa MD, Solo de Zaldivar P, Ledesma M, et al
    Effect of Nordic Sensi(R) Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.
    J Alzheimers Dis. 2023;96:1609-1622.
    >> Share

  839. SHORT MI, Fohner AE, Skjellegrind HK, Beiser A, et al
    Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
    J Alzheimers Dis. 2023;96:1767-1780.
    >> Share

  840. BRICENO EM, Dhakal U, Sharma U, Adhikari N, et al
    Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.
    J Alzheimers Dis. 2023;96:1339-1352.
    >> Share

  841. AXELSSON ANDREN E, Kettunen P, Bjerke M, Rolstad S, et al
    Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-beta Protein Precursor beta in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2023;96:1515-1528.
    >> Share

  842. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
    Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2023;95:1417-1425.
    >> Share

    December 2022
  843. ITZHAKI RF
    COVID-19 and Alzheimer's Disease: What Is the Connection?
    J Alzheimers Dis. 2022 Dec 26. doi: 10.3233/JAD-220955.
    >> Share

  844. BIAN Z, Yu H, Hu X, Bian Y, et al
    Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-beta-Induced NOX2 Activation in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Dec 22. doi: 10.3233/JAD-220761.
    >> Share

  845. CHEN Y, Zhang Y, Chen Q, Liu Y, et al
    Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    J Alzheimers Dis. 2022 Dec 20. doi: 10.3233/JAD-221058.
    >> Share

  846. ERUYSAL E, Ravdin L, Zhang C, Kamel H, et al
    Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 20. doi: 10.3233/JAD-220686.
    >> Share

  847. JIA J, Zhang Y, Shi Y, Yin X, et al
    A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-221065.
    >> Share

  848. PARKER DC, Kraus WE, Whitson HE, Kraus VB, et al
    Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan St
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220906.
    >> Share

  849. FLEMING V, Helsel BC, Ptomey LT, Rosas HD, et al
    Weight Loss and Alzheimer's Disease in Down Syndrome.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220865.
    >> Share

  850. CHAI YL, Liang NHP, Chong JR, Venketasubramanian N, et al
    Serum Cathepsin D Is a Potential Biomarker for Alzheimer's Disease Dementia and Cognitive Decline.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220852.
    >> Share

  851. MORYS F, Potvin O, Zeighami Y, Vogel J, et al
    Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220535.
    >> Share

  852. CANARIO NS, Jorge LP, Santana IJ, Castelo-Branco MS, et al
    Hemispheric Patterns of Recruitment of Object Processing Regions in Early Alzheimer's Disease: A Study Along the Entire Ventral Stream.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220055.
    >> Share

  853. DAI WZ, Liu L, Zhu MZ, Lu J, et al
    Morphological and Structural Network Analysis of Sporadic Alzheimer's Disease Brains Based on the APOE4 Gene.
    J Alzheimers Dis. 2022 Dec 14. doi: 10.3233/JAD-220877.
    >> Share

  854. CAO K, Bay AA, Hajjar I, Wharton W, et al
    Rationale and Design of the PARTNER Trial: Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 14. doi: 10.3233/JAD-220783.
    >> Share

  855. CHEN Q, Abrigo J, Deng M, Shi L, et al
    Diffusion Changes in Hippocampal Cingulum in Early Biologically Defined Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 14. doi: 10.3233/JAD-220671.
    >> Share

  856. LI H, Liu H, Lutz MW, Luo S, et al
    Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 13. doi: 10.3233/JAD-220680.
    >> Share

  857. MATHEW S, WuDunn D, Mackay DD, Vosmeier A, et al
    Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 8. doi: 10.3233/JAD-210533.
    >> Share

  858. IBAN-ARIAS R, Trageser KJ, Yang EJ, Griggs E, et al
    Exposure to World Trade Center Dust Exacerbates Cognitive Impairment and Evokes a Central and Peripheral Pro-Inflammatory Transcriptional Profile in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-221046.
    >> Share

  859. KLEIMAN MJ, Ariko T, Galvin JE
    Hierarchical Two-Stage Cost-Sensitive Clinical Decision Support System for Screening Prodromal Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-220891.
    >> Share

  860. CHENG ZZ, Gao F, Lv XY, Wang Q, et al
    Features of Cerebral Small Vessel Disease Contributes to the Differential Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-220872.
    >> Share

  861. XU LZ, Li BQ, Li FY, Li Y, et al
    NMDA Receptor GluN2B Subunit Is Involved in Excitotoxicity Mediated by Death-Associated Protein Kinase 1 in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-220747.
    >> Share

  862. DELGADO-ALVAREZ A, Diez-Cirarda M, Delgado-Alonso C, Hernandez-Lorenzo L, et al
    Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
    J Alzheimers Dis. 2022 Dec 5. doi: 10.3233/JAD-220907.
    >> Share

  863. GORENFLO MP, Davis PB, Kendall EK, Olaker VR, et al
    Association of Aspirin Use with Reduced Risk of Developing Alzheimer's Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study.
    J Alzheimers Dis. 2022 Dec 5. doi: 10.3233/JAD-220901.
    >> Share

  864. HENEGHAN A, Deng F, Wells K, Ritchie K, et al
    Modifiable Lifestyle Activities Affect Cognition in Cognitively Healthy Middle-Aged Individuals at Risk for Late-Life Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 5. doi: 10.3233/JAD-220267.
    >> Share

  865. RAJAH KUMARAN K, Yunusa S, Perimal E, Wahab H, et al
    Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.
    J Alzheimers Dis. 2022 Dec 3. doi: 10.3233/JAD-220666.
    >> Share

    November 2022
  866. GREEN ZD, Vidoni ED, Swerdlow RH, Burns JM, et al
    Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 29. doi: 10.3233/JAD-210326.
    >> Share

  867. ZHANG R, Song Y, Su X
    Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities.
    J Alzheimers Dis. 2022 Nov 28. doi: 10.3233/JAD-220809.
    >> Share

  868. SURYA K, Manickam N, Jayachandran KS, Kandasamy M, et al
    Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 28. doi: 10.3233/JAD-220559.
    >> Share

  869. FULLGRABE C
    Auditory Biases in Cognitive Assessment: Insights from a Hearing-Loss Simulation for the Screening of Dementia due to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 28. doi: 10.3233/JAD-215695.
    >> Share

  870. YEAP YJ, Kandiah N, Nizetic D, Lim KL, et al
    BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 26. doi: 10.3233/JAD-220867.
    >> Share

  871. ZHOU Y, Dong J, Song J, Lvy C, et al
    Efficacy of Glucose Metabolism-Related Indexes on the Risk and Severity of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2022 Nov 26. doi: 10.3233/JAD-220751.
    >> Share

  872. PETRELLA JR, Michael AM, Qian M, Nwosu A, et al
    Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.
    J Alzheimers Dis. 2022 Nov 25. doi: 10.3233/JAD-220946.
    >> Share

  873. COSTA T, Manuello J, Cauda F, Liloia D, et al
    Retrospective Bayesian Evidence of Null Effect in Two Decades of Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2022 Nov 25. doi: 10.3233/JAD-220942.
    >> Share

  874. DANIEL EV, Kleiman MJ, Galvin JE
    Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.
    J Alzheimers Dis. 2022 Nov 24. doi: 10.3233/JAD-220959.
    >> Share

  875. QUINTANA-HERNANDEZ DJ, Rojas-Hernandez J, Santana-Del Pino A, Cespedes Suarez C, et al
    Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2022 Nov 24. doi: 10.3233/JAD-220889.
    >> Share

  876. LI JG, Blass BE, Pratico D
    Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype.
    J Alzheimers Dis. 2022 Nov 24. doi: 10.3233/JAD-220869.
    >> Share

  877. WISEMAN AL, Briggs CA, Peritt A, Kapecki N, et al
    Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 Nov 23. doi: 10.3233/JAD-220758.
    >> Share

  878. PREMA A, Justin Thenmozhi A, Manivasagam T, Mohamed Essa M, et al
    Erratum to: Fenugreek Seed Powder Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress, and Inflammation in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-229017.
    >> Share

  879. ABBATE C, Trimarchi PD, Fumagalli GG, Gallucci A, et al
    Diencephalic versus Hippocampal Amnesia in Alzheimer's Disease: The Possible Confabulation-Misidentification Phenotype.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220919.
    >> Share

  880. KHEZRI MR, Ghasemnejad-Berenji M
    The Role of Caspases in Alzheimer's Disease: Pathophysiology Implications and Pharmacologic Modulation.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220873.
    >> Share

  881. WU BS, Zhang YR, Yang L, Zhang W, et al
    Polygenic Liability to Alzheimer's Disease Is Associated with a Wide Range of Chronic Diseases: A Cohort Study of 312,305 Participants.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220740.
    >> Share

  882. GROBLER C, van Tongeren M, Gettemans J, Kell DB, et al
    Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220720.
    >> Share

  883. GARCIA MJ, Leadley R, Lang S, Ross J, et al
    Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 18. doi: 10.3233/JAD-220471.
    >> Share

  884. SWERDLOW NR, Joshi YB, Sprock J, Talledo J, et al
    Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 17. doi: 10.3233/JAD-220769.
    >> Share

  885. WHITEHOUSE PJ, George DR
    Dignity for All: How the Challenges of Alzheimer's Disease Need Rethinking and Revaluing.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-221066.
    >> Share

  886. KIM J, Jang H, Park YH, Youn J, et al
    Motor Symptoms in Early- versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-220745.
    >> Share

  887. LUKKARINEN H, Vanninen A, Tesseur I, Pemberton D, et al
    Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-220652.
    >> Share

  888. LIU S, Dashper SG, Zhao R
    Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Nov 14. doi: 10.3233/JAD-220627.
    >> Share

  889. CHEN L, Xue J, Zhao Q, Liang X, et al
    A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 11. pii: JAD220866. doi: 10.3233/JAD-220866.
    >> Share

  890. LIU Z, Zhang H, Liu S, Hou Y, et al
    The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 11. pii: JAD220698. doi: 10.3233/JAD-220698.
    >> Share

  891. DOVER M, Moseley T, Biskaduros A, Paulchakrabarti M, et al
    Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 8. pii: JAD220764. doi: 10.3233/JAD-220764.
    >> Share

  892. JOHNSON AL, Seep E, Norton DL, Mundt MP, et al
    Wisconsin Healthcare Utilization Cost Among American Indians/Alaska Natives with and without Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2022 Nov 8. pii: JAD220393. doi: 10.3233/JAD-220393.
    >> Share

  893. GAUBERT F, Borg C, Chainay H
    Decision-Making in Alzheimer's Disease: The Role of Working Memory and Executive Functions in the Iowa Gambling Task and in Tasks Inspired by Everyday Situations.
    J Alzheimers Dis. 2022 Nov 3. pii: JAD220581. doi: 10.3233/JAD-220581.
    >> Share

  894. WALKER JM, Dehkordi SK, Schaffert J, Goette W, et al
    The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.
    J Alzheimers Dis. 2022 Nov 3. doi: 10.3233/JAD-220898.
    >> Share

  895. CHEN X, Jiang S, Wang R, Bao X, et al
    Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects.
    J Alzheimers Dis. 2022 Nov 2. pii: JAD220721. doi: 10.3233/JAD-220721.
    >> Share


  896. Erratum to: A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD229016. doi: 10.3233/JAD-229016.
    >> Share

  897. KRISHNA G, Santhoshkumar R, Sivakumar PT, Alladi S, et al
    Pathological (Dis)Similarities in Neuronal Exosome-Derived Synaptic and Organellar Marker Levels Between Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD220829. doi: 10.3233/JAD-220829.
    >> Share

  898. HUANG L, Lu Z, Zhang H, Wen H, et al
    A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-beta on Gut Flora.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD220651. doi: 10.3233/JAD-220651.
    >> Share

    October 2022
  899. KLEIMAN MJ, Chang LC, Galvin JE
    The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2022 Oct 31. pii: JAD220927. doi: 10.3233/JAD-220927.
    >> Share

  900. GIRALDO DL, Smith RE, Struyfs H, Niemantsverdriet E, et al
    Investigating Tissue-Specific Abnormalities in Alzheimer's Disease with Multi-Shell Diffusion MRI.
    J Alzheimers Dis. 2022 Oct 31. pii: JAD220551. doi: 10.3233/JAD-220551.
    >> Share

  901. LATON J, Van Schependom J, Goossens J, Wiels W, et al
    Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.
    J Alzheimers Dis. 2022 Oct 29. pii: JAD220693. doi: 10.3233/JAD-220693.
    >> Share

  902. MUSAEUS CS, Waldemar G, Andersen BB, Hogh P, et al
    Long-Term EEG Monitoring in Patients with Alzheimer's Disease Using Ear-EEG: A Feasibility Study.
    J Alzheimers Dis. 2022 Oct 29. pii: JAD220491. doi: 10.3233/JAD-220491.
    >> Share

  903. SCHAFFERT J, Bue CL, Hynan LS, Hart J, et al
    Erratum to: Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD229015. doi: 10.3233/JAD-229015.
    >> Share

  904. GOLZARI-SORKHEH M, Weaver DF, Reed MA
    COVID-19 as a Risk Factor for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220800. doi: 10.3233/JAD-220800.
    >> Share

  905. GAO F, Zhang PF, Gao J, Song J, et al
    The CCL2 rs4586 SNP Is Associated with Slower Amyloid-beta Deposition and Faster Tau Accumulation of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220716. doi: 10.3233/JAD-220716.
    >> Share

  906. MA Y, Li W, Fan C, Wang Y, et al
    Comprehensive Analysis of Long Non-Coding RNAs N4-Acetylcytidine in Alzheimer's Disease Mice Model Using High-Throughput Sequencing.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220564. doi: 10.3233/JAD-220564.
    >> Share

  907. DISSANAYAKE AS, Tan YB, Bowie CR, Butters MA, et al
    Sex Modifies the Associations of APOEvarepsilon4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 25. pii: JAD220586. doi: 10.3233/JAD-220586.
    >> Share

  908. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Hypothalamic Functional Connectivity and Apathy in People with Alzheimer's Disease and Cognitively Normal Healthy Controls.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220708. doi: 10.3233/JAD-220708.
    >> Share

  909. GAITAN JM, Asthana S, Carlsson CM, Engelman CD, et al
    Circulating Klotho Is Higher in Cerebrospinal Fluid than Serum and Elevated Among KLOTHO Heterozygotes in a Cohort with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220571. doi: 10.3233/JAD-220571.
    >> Share

  910. JACOBS N, Theunissen B
    It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?
    J Alzheimers Dis. 2022 Oct 21. pii: JAD220569. doi: 10.3233/JAD-220569.
    >> Share

  911. PONTRELLO CG, McWhirt JM, Glabe CG, Brewer GJ, et al
    Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-beta Accumulation and Plaque Deposition in a Transgenic Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220824. doi: 10.3233/JAD-220824.
    >> Share

  912. WANG YR, Wang MT, Zeng XQ, Liu YH, et al
    Associations of Naturally Occurring Antibodies to Presenilin-1 with Brain Amyloid-beta Load and Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220775. doi: 10.3233/JAD-220775.
    >> Share

  913. EHLEN JC, Forman CM, Ostrowski D, Ostrowski TD, et al
    Autonomic Dysfunction Impairs Baroreflex Function in an Alzheimer's Disease Animal Model.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220496. doi: 10.3233/JAD-220496.
    >> Share

  914. HILUND-CARLSEN PF, Revheim ME, Alavi A, Satyamurthy N, et al
    Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials.
    J Alzheimers Dis. 2022 Oct 17. pii: JAD220841. doi: 10.3233/JAD-220841.
    >> Share

  915. SEGURA-URIBE JJ, Garcia-de la Torre P, Castillo-Mendieta T, Bribiesca-Cruz I, et al
    Tibolone Improves Memory and Decreases the Content of Amyloid-beta Peptides and Tau Protein in the Hippocampus of a Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 17. pii: JAD220434. doi: 10.3233/JAD-220434.
    >> Share

  916. ROVETA F, Cermelli A, Boschi S, Ferrandes F, et al
    Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Oct 15. pii: JAD220515. doi: 10.3233/JAD-220515.
    >> Share

  917. XIA X, Qin Q, Peng Y, Wang M, et al
    Retinal Examinations Provides Early Warning of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 14. pii: JAD220596. doi: 10.3233/JAD-220596.
    >> Share

  918. RITCHIE M, Witbracht M, Nuno MM, Hoang D, et al
    Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials.
    J Alzheimers Dis. 2022 Oct 12. pii: JAD220801. doi: 10.3233/JAD-220801.
    >> Share

  919. LI TR, Lyu DY, Liu FQ
    Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    J Alzheimers Dis. 2022 Oct 6. pii: JAD220598. doi: 10.3233/JAD-220598.
    >> Share

  920. WELLER AE, Ferraro TN, Doyle GA, Reiner BC, et al
    Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220391. doi: 10.3233/JAD-220391.
    >> Share

  921. HUANG Y, Driedonks TAP, Cheng L, Rajapaksha H, et al
    Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220322. doi: 10.3233/JAD-220322.
    >> Share

  922. FUKUDA H, Maeda M, Murata F, Murata Y, et al
    Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer's Disease Patients in Japan: LIFE Study.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220200. doi: 10.3233/JAD-220200.
    >> Share

    September 2022
  923. LIN J, Yang S, Wang C, Yu E, et al
    Prediction of Alzheimer's Disease Using Patterns of Methylation Levels in Key Immunologic-Related Genes.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220701. doi: 10.3233/JAD-220701.
    >> Share

  924. VALVERDE A, Mitrofanis J
    Photobiomodulation for Hypertension and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220632. doi: 10.3233/JAD-220632.
    >> Share

  925. GUO Q, Cai Q, Huang F, Wei Z, et al
    The Therapeutic Effects of Seven Lycophyte Compounds on Cell Models of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 29. pii: JAD220704. doi: 10.3233/JAD-220704.
    >> Share

  926. WU X, Peng C, Nelson PT, Cheng Q, et al
    Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 27. pii: JAD220590. doi: 10.3233/JAD-220590.
    >> Share

  927. SHEN WB, Elahi M, Wang B, Zhan M, et al
    Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Sep 26. pii: JAD215687. doi: 10.3233/JAD-215687.
    >> Share

  928. VILLAREJO-GALENDE A, Garcia-Arcelay E, Pinol-Ripoll G, Del Olmo-Rodriguez A, et al
    Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 23. pii: JAD220696. doi: 10.3233/JAD-220696.
    >> Share

  929. SABBIR MG, Speth RC, Albensi BC
    Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220766. doi: 10.3233/JAD-220766.
    >> Share

  930. ALVAREZ XA, Winston CN, Barlow JW, Sarsoza FM, et al
    Modulation of Amyloid-beta and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin(R) and Donepezil.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220575. doi: 10.3233/JAD-220575.
    >> Share

  931. YAMADA Y, Kobayashi M, Shinkawa K, Nemoto M, et al
    Characteristics of Drawing Process Differentiate Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Sep 20. pii: JAD220546. doi: 10.3233/JAD-220546.
    >> Share

  932. XU C, Zhao L, Dong C
    A Review of Application of Abeta42/40 Ratio in Diagnosis and Prognosis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220673. doi: 10.3233/JAD-220673.
    >> Share

  933. KHEZRI MR, Esmaeili A, Ghasemnejad-Berenji M
    Platelet Activation and Alzheimer's Disease: The Probable Role of PI3K/AKT Pathway.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220663. doi: 10.3233/JAD-220663.
    >> Share

  934. DOWNEY J, Lam JCK, Li VOK, Gozes I, et al
    Somatic Mutations and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220643. doi: 10.3233/JAD-220643.
    >> Share

  935. ZARBOCK KR, Han JH, Singh AP, Thomas SP, et al
    Trimethylamine N-Oxide Reduces Neurite Density and Plaque Intensity in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220413. doi: 10.3233/JAD-220413.
    >> Share

  936. DENTONI G, Naia L, Portal B, Leal NS, et al
    Mitochondrial Alterations in Neurons Derived from the Murine AppNL-F Knock-In Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220383. doi: 10.3233/JAD-220383.
    >> Share

  937. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220359. doi: 10.3233/JAD-220359.
    >> Share

  938. TRUMBORE CN, Raghunandan A
    An Alzheimer's Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220622. doi: 10.3233/JAD-220622.
    >> Share

  939. MORROW A, Panyard DJ, Deming YK, Jonaitis E, et al
    Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220349. doi: 10.3233/JAD-220349.
    >> Share

  940. STURCHIO A, Dwivedi AK, Malm T, Wood MJA, et al
    High Soluble Amyloid-beta42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220808. doi: 10.3233/JAD-220808.
    >> Share

  941. BALDEIRAS I, Silva-Spinola A, Lima M, Leitao MJ, et al
    Alzheimer's Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220587. doi: 10.3233/JAD-220587.
    >> Share

  942. TARIOT PN, Braeckman R, Oh C
    Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220530. doi: 10.3233/JAD-220530.
    >> Share

  943. OTA M, Sato N, Nakaya M, Shigemoto Y, et al
    Relationships Between the Deposition of Amyloid-beta and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
    J Alzheimers Dis. 2022 Sep 15. pii: JAD220534. doi: 10.3233/JAD-220534.
    >> Share

  944. YEH WC, Hsu CY, Li KY, Chien CF, et al
    Association between Subclinical Epileptiform Discharge and the Severity of Cognitive Decline in Alzheimer's Disease: A Longitudinal Cohort Study.
    J Alzheimers Dis. 2022 Sep 12. pii: JAD220567. doi: 10.3233/JAD-220567.
    >> Share

  945. NOLAN JM, Power R, Howard AN, Bergin P, et al
    Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220556. doi: 10.3233/JAD-220556.
    >> Share

  946. DU XL, Song L, Schulz PE, Xu H, et al
    Associations Between Vascular Diseases and Alzheimer's Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220548. doi: 10.3233/JAD-220548.
    >> Share

  947. LATGE-TOVAR S, Bertrand E, Cosentino S, Dourado MCN, et al
    Self- and Other-Evaluation in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220453. doi: 10.3233/JAD-220453.
    >> Share

  948. WANG G, Estrella A, Hakim O, Milazzo P, et al
    Mini-Mental State Examination and Montreal Cognitive Assessment as Tools for Following Cognitive Changes in Alzheimer's Disease Neuroimaging Initiative Participants.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220397. doi: 10.3233/JAD-220397.
    >> Share

  949. MIGLIORATI M, Manrique C, Rahrah M, Escoffier G, et al
    The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220281. doi: 10.3233/JAD-220281.
    >> Share

  950. AHULLO-FUSTER MA, Ortiz T, Varela-Donoso E, Nacher J, et al
    The Parietal Lobe in Alzheimer's Disease and Blindness.
    J Alzheimers Dis. 2022 Sep 8. pii: JAD220498. doi: 10.3233/JAD-220498.
    >> Share

  951. SAGUES-SESE E, Rioja J, Garzon-Maldonado FJ, Narvaez M, et al
    Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220688. doi: 10.3233/JAD-220688.
    >> Share

  952. CEJUDO JC, Samaniego M, Almeria M, Castrillo S, et al
    Ikos Test: New Tool for the Assessment of Semantic Knowledge in Early Alzheimer Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220516. doi: 10.3233/JAD-220516.
    >> Share

  953. WANG X, Wang Y, Liu H, Zhu X, et al
    Macular Microvascular Density as a Diagnostic Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220482. doi: 10.3233/JAD-220482.
    >> Share

  954. CAMARGO MVZA, Pais MV, Bellan AFR, Tahira AC, et al
    Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220385. doi: 10.3233/JAD-220385.
    >> Share

  955. SHELTON MG, Kerns KA, Castora FJ, Coleman RA, et al
    Incorporating Mitochondrial Gene Expression Changes Within a Testable Mathematical Model for Alzheimer's Disease: Stress Response Modulation Predicts Potential Therapeutic Targets.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220163. doi: 10.3233/JAD-220163.
    >> Share

  956. CASTORA FJ, Kerns KA, Pflanzer HK, Hitefield NL, et al
    Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220161. doi: 10.3233/JAD-220161.
    >> Share

  957. BEHESHTI I, Geddert N, Perron J, Gupta V, et al
    Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.
    J Alzheimers Dis. 2022 Sep 2. pii: JAD220585. doi: 10.3233/JAD-220585.
    >> Share

  958. WRIGHT JR, Deen QFE, Stevenson A, Telford-Cooke L, et al
    Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220642. doi: 10.3233/JAD-220642.
    >> Share

  959. COMON M, Rouch I, Edjolo A, Padovan C, et al
    Impaired Facial Emotion Recognition and Gaze Direction Detection in Mild Alzheimer's Disease: Results from the PACO Study.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220401. doi: 10.3233/JAD-220401.
    >> Share

  960. SPINELLI G, Bakardjian H, Schwartz D, Potier MC, et al
    Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220204. doi: 10.3233/JAD-220204.
    >> Share

    August 2022
  961. BARDENHEIER BH, Resnik LJ, Jutkowitz E, Gravenstein S, et al
    Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer's Disease and Related Dementias: A Cluster Analysis.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220573. doi: 10.3233/JAD-220573.
    >> Share

  962. LI S, Liu B, Li QH, Zhang Y, et al
    Evaluating the Bidirectional Causal Association Between Daytime Napping and Alzheimer's Disease Using Mendelian Randomization.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220497. doi: 10.3233/JAD-220497.
    >> Share

  963. WAWRZICZNY E, Picard S, Buquet A, Traversac E, et al
    Hypnosis Intervention for Couples Confronted with Alzheimer's Disease: Promising Results of a First Exploratory Study.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220430. doi: 10.3233/JAD-220430.
    >> Share

  964. KURASZ AM, De Wit L, Smith GE, Armstrong MJ, et al
    Neuropathological and Clinical Correlates of Lewy Body Disease Survival by Race and Ethnicity in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Aug 22. pii: JAD220297. doi: 10.3233/JAD-220297.
    >> Share

  965. YANG J, Oveisgharan S, Liu X, Wilson RS, et al
    Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 17. pii: JAD220446. doi: 10.3233/JAD-220446.
    >> Share

  966. DOREY CK, Gierhart D, Fitch KA, Crandell I, et al
    Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Gray and White Matter of Brains with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220460. doi: 10.3233/JAD-220460.
    >> Share

  967. YOSHIDA K, Seo M, Luo Y, Sahker E, et al
    Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220263. doi: 10.3233/JAD-220263.
    >> Share

  968. ALA T, Bakir D, Goel S, Feller N, et al
    A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Aug 12. pii: JAD220392. doi: 10.3233/JAD-220392.
    >> Share

  969. OU YN, Zhao B, Fu Y, Sheng ZH, et al
    The Association of Serum Uric Acid Level, Gout, and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Aug 11. pii: JAD220649. doi: 10.3233/JAD-220649.
    >> Share

  970. FINGERHUT H, Gozdas E, Hosseini SMH
    Quantitative MRI Evidence for Cognitive Reserve in Healthy Elders and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 11. pii: JAD220197. doi: 10.3233/JAD-220197.
    >> Share

  971. ROSENDE-ROCA M, Canabate P, Moreno M, Preckler S, et al
    Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer's Disease Dementia: A Latent Class Analysis.
    J Alzheimers Dis. 2022 Aug 9. pii: JAD215648. doi: 10.3233/JAD-215648.
    >> Share

  972. FREBERG E, Taglialatela G
    Exercise as a Potential Therapeutic Strategy to Target the Clinical Link Between Depression and Alzheimer's Disease: A Narrative Review.
    J Alzheimers Dis. 2022 Aug 9. pii: JAD210632. doi: 10.3233/JAD-210632.
    >> Share

  973. BU K, Patel D, Morris R, Han W, et al
    Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2022 Aug 6. pii: JAD220583. doi: 10.3233/JAD-220583.
    >> Share

  974. SERRA L, Giancaterino G, Giulietti G, Petrosini L, et al
    Cognitive Reserve Modulates Brain Structure and Cortical Architecture in the Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 6. pii: JAD220377. doi: 10.3233/JAD-220377.
    >> Share

  975. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD220407. doi: 10.3233/JAD-220407.
    >> Share

  976. PEREZ SD, Phillips JS, Norise C, Kinney NG, et al
    Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215728. doi: 10.3233/JAD-215728.
    >> Share

  977. CANARIO E, Chen D, Han Y, Niu H, et al
    Global Network Analysis of Alzheimer's Disease with Minimum Spanning Trees.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215573. doi: 10.3233/JAD-215573.
    >> Share

    July 2022
  978. TAHAMI MONFARED AA, Stern Y, Doogan S, Irizarry M, et al
    Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media Conversations.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220422. doi: 10.3233/JAD-220422.
    >> Share

  979. HOFFMANN CM, Nianogo RA, Yaffe K, Rosenwohl-Mack A, et al
    Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220278. doi: 10.3233/JAD-220278.
    >> Share

  980. WANG L, Davis PB, Volkow ND, Berger NA, et al
    Association of COVID-19 with New-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 29. pii: JAD220717. doi: 10.3233/JAD-220717.
    >> Share

  981. CONTINI C, Serrao S, Manconi B, Olianas A, et al
    Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2022 Jul 26. pii: JAD220246. doi: 10.3233/JAD-220246.
    >> Share

  982. CAPRIOGLIO C, Garibotto V, Jessen F, Frolich L, et al
    The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.
    J Alzheimers Dis. 2022 Jul 25. pii: JAD220333. doi: 10.3233/JAD-220333.
    >> Share

  983. ZHONG S, Zhao B, Ma YH, Sun Y, et al
    Associations of Physical Activity with Alzheimer's Disease Pathologies and Cognition: The CABLE Study.
    J Alzheimers Dis. 2022 Jul 22. pii: JAD220389. doi: 10.3233/JAD-220389.
    >> Share

  984. ARIAS JJ, Lin GA, Tyler AM, Douglas MP, et al
    Geriatricians' Perspectives on the Multiple Dimensions of Utility of Genetic Testing for Alzheimer's Disease: A Qualitative Study.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220674. doi: 10.3233/JAD-220674.
    >> Share

  985. ZALLEN DT
    Alzheimer's Disease: Risk Tests and the Medical Record.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220584. doi: 10.3233/JAD-220584.
    >> Share

  986. LUO W, Pryzbyl KJ, Bigio EH, Weintraub S, et al
    Reduced Hippocampal and Anterior Cingulate Expression of Antioxidant Enzymes and Membrane Progesterone Receptors in Alzheimer's Disease with Depression.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220574. doi: 10.3233/JAD-220574.
    >> Share

  987. YAO W, Zhang X, Zhao H, Xu Y, et al
    Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220475. doi: 10.3233/JAD-220475.
    >> Share

  988. OMANA H, Madou E, Hunter SW
    The Effects on Gait of 4-Wheeled Walker Use in People with Alzheimer's Disease Dementia and Gait Impairment: A Pilot Study.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220331. doi: 10.3233/JAD-220331.
    >> Share

  989. CERESETTI R, Rouch I, Laurent B, Getenet JC, et al
    Processing of Facial Expressions of Emotions and Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220236. doi: 10.3233/JAD-220236.
    >> Share

  990. DRENTHEN GS, Backes WH, Freeze WM, Jacobs HIL, et al
    Rich-Club Connectivity of the Structural Covariance Network Relates to Memory Processes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 18. pii: JAD220175. doi: 10.3233/JAD-220175.
    >> Share

  991. SONG C, Li F, Wang LY, Shi YQ, et al
    Incidental Finding: Urine Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP) and Serum Vitamin D25.
    J Alzheimers Dis. 2022 Jul 18. pii: JAD220165. doi: 10.3233/JAD-220165.
    >> Share

  992. TIMSINA J, Gomez-Fonseca D, Wang L, Do A, et al
    Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.
    J Alzheimers Dis. 2022 Jul 16. pii: JAD220399. doi: 10.3233/JAD-220399.
    >> Share


  993. Janina Krell-Roesch, PhD, and Yonas E. Geda, MD recipients of the 2022 Alzheimer Award.
    J Alzheimers Dis. 2022 Jul 15. pii: JAD229009. doi: 10.3233/JAD-229009.
    >> Share

  994. PEZZOLI S, Manca R, Cagnin A, Venneri A, et al
    A Multimodal Neuroimaging and Neuropsychological Study of Visual Hallucinations in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 15. pii: JAD215107. doi: 10.3233/JAD-215107.
    >> Share

  995. XUE F, Gao L, Chen T, Chen H, et al
    Parkinson's Disease rs117896735 Variant Regulates INPP5F Expression in Brain Tissues and Increases Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 13. pii: JAD220086. doi: 10.3233/JAD-220086.
    >> Share

  996. CLARK K, Yee Leung Y, Lee WP, Voight B, et al
    Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
    J Alzheimers Dis. 2022 Jul 12. pii: JAD220025. doi: 10.3233/JAD-220025.
    >> Share

  997. LIU Q, Liu H, Zhang S, Yang Q, et al
    Cerebrospinal Fluid Synaptosomal-Associated Protein 25 Levels in Patients with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2022 Jul 12. pii: JAD215696. doi: 10.3233/JAD-215696.
    >> Share

  998. WONG GC, Chow KH
    DNA Damage Response-Associated Cell Cycle Re-Entry and Neuronal Senescence in Brain Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220203. doi: 10.3233/JAD-220203.
    >> Share

  999. CARNEMOLLA S, Kumfor F, Liang CT, Foxe D, et al
    Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220080. doi: 10.3233/JAD-220080.
    >> Share

  1000. VLEGELS N, Ossenkoppele R, van der Flier WM, Koek HL, et al
    Does Loss of Integrity of the Cingulum Bundle Link Amyloid-beta Accumulation and Neurodegeneration in Alzheimer's Disease?
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220024. doi: 10.3233/JAD-220024.
    >> Share

  1001. XUE C, Tang Y, Wang C, Yang H, et al
    The Effects of Normal Aging, Subjective Cognitive Decline, Mild Cognitive Impairment, or Alzheimer's Disease on Visual Search.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220209. doi: 10.3233/JAD-220209.
    >> Share

  1002. RAMANAN VK, Heckman MG, Przybelski SA, Lesnick TG, et al
    Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220164. doi: 10.3233/JAD-220164.
    >> Share

  1003. NABIROTCHKIN S, Bouaziz J, Glibert F, Mandel J, et al
    Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220120. doi: 10.3233/JAD-220120.
    >> Share

  1004. KRISHNADAS N, Huang K, Schultz SA, Dore V, et al
    Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD215558. doi: 10.3233/JAD-215558.
    >> Share

  1005. MOTAZEDI E, Cheng W, Thomassen JQ, Frei O, et al
    Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220174. doi: 10.3233/JAD-220174.
    >> Share

  1006. BLEAKLEY A, Maloney EK, Harkins K, Nelson MN, et al
    An Elicitation Study to Understand Black, Hispanic, and Male Older Adults' Willingness to Participate in Alzheimer's Disease-Focused Research Registries.
    J Alzheimers Dis. 2022 Jul 5. pii: JAD220196. doi: 10.3233/JAD-220196.
    >> Share

  1007. CHIA SY, Vipin A, Ng KP, Tu H, et al
    Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-beta, and Cerebral Atrophy.
    J Alzheimers Dis. 2022 Jul 5. pii: JAD220116. doi: 10.3233/JAD-220116.
    >> Share

  1008. SUN W, Wu Q, Chen H, Yu L, et al
    A Validation Study of the Hong Kong Brief Cognitive Test for Screening Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 4. pii: JAD220417. doi: 10.3233/JAD-220417.
    >> Share

  1009. TOUPS K, Hathaway A, Gordon D, Chung H, et al
    Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.
    J Alzheimers Dis. 2022 Jul 4. pii: JAD215707. doi: 10.3233/JAD-215707.
    >> Share

    June 2022
  1010. HAN SW, Park YH, Jang ES, Nho K, et al
    Implications of Liver Enzymes in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220343. doi: 10.3233/JAD-220343.
    >> Share

  1011. WOJDALA AL, Chiasserini D, Bellomo G, Paciotti S, et al
    Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220323. doi: 10.3233/JAD-220323.
    >> Share

  1012. ALMULLA AF, Supasitthumrong T, Amrapala A, Tunvirachaisakul C, et al
    The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220295. doi: 10.3233/JAD-220295.
    >> Share

  1013. LUO A, Ning P, Lu H, Huang H, et al
    Association Between Metformin and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Clinical Observational Studies.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220180. doi: 10.3233/JAD-220180.
    >> Share

  1014. BABILONI C
    The Dark Side of Alzheimer's Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level.
    J Alzheimers Dis. 2022 Jun 24. pii: JAD220582. doi: 10.3233/JAD-220582.
    >> Share

  1015. KRANCE SH, Wu CY, Chan ACY, Kwong S, et al
    Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Jun 23. pii: JAD220360. doi: 10.3233/JAD-220360.
    >> Share

  1016. PLANTONE D, Pardini M, Locci S, Nobili F, et al
    B Lymphocytes in Alzheimer's Disease-A Comprehensive Review.
    J Alzheimers Dis. 2022 Jun 23. pii: JAD220261. doi: 10.3233/JAD-220261.
    >> Share

  1017. ALI DG, Bahrani AA, Barber JM, El Khouli RH, et al
    Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220294. doi: 10.3233/JAD-220294.
    >> Share

  1018. CAIRNS DM, Itzhaki RF, Kaplan DL
    Potential Involvement of Varicella Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220287. doi: 10.3233/JAD-220287.
    >> Share

  1019. KHEDR EM, Omeran N, Karam-Allah Ramadan H, Ahmed GK, et al
    Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220176. doi: 10.3233/JAD-220176.
    >> Share

  1020. PAN R, Luo S, Huang Q, Li W, et al
    The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220002. doi: 10.3233/JAD-220002.
    >> Share

  1021. GAN J, Liu S, Chen Z, Yang Y, et al
    Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;1.
    >> Share

  1022. TIAN J, Wang T, Jia K, Guo L, et al
    Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220447. doi: 10.3233/JAD-220447.
    >> Share

  1023. BUKHBINDER AS, Ling Y, Hasan O, Jiang X, et al
    Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220361. doi: 10.3233/JAD-220361.
    >> Share

  1024. WEISSBERGER GH, Samek A, Mosqueda L, Nguyen AL, et al
    Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220187. doi: 10.3233/JAD-220187.
    >> Share

  1025. MIELKE MM, Ransom JE, Mandrekar J, Turcano P, et al
    Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220159. doi: 10.3233/JAD-220159.
    >> Share

  1026. KOBAYASHI M, Yamada Y, Shinkawa K, Nemoto M, et al
    Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215714. doi: 10.3233/JAD-215714.
    >> Share

  1027. LEONHARDI J, Barthel H, Speerforck S, Dietzel J, et al
    Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-beta Imaging?
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215619. doi: 10.3233/JAD-215619.
    >> Share

  1028. JESTER H, Gosrani S, Ding H, Zhou X, et al
    Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215303. doi: 10.3233/JAD-215303.
    >> Share

  1029. ZHU LY, Shi L, Luo Y, Leung J, et al
    Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215189. doi: 10.3233/JAD-215189.
    >> Share

  1030. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 11. pii: JAD220292. doi: 10.3233/JAD-220292.
    >> Share

  1031. BABILONI C, Noce G, Di Bonaventura C, Lizio R, et al
    Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220442. doi: 10.3233/JAD-220442.
    >> Share

  1032. DUAN W, Sehrawat P, Zhou TD, Becker JT, et al
    Pattern of Altered Magnetization Transfer Rate in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220335. doi: 10.3233/JAD-220335.
    >> Share

  1033. MA X, Zhang Y, Gou D, Ma J, et al
    Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 7. pii: JAD220227. doi: 10.3233/JAD-220227.
    >> Share

  1034. GARCIA-ALBERCA JM, Gris E, de la Guia P, Mendoza S, et al
    Effects of Tianeptine Treatment on Depression and Cognitive Function in Patients with Alzheimer's Disease: A 12-Month Retrospective Observational Study.
    J Alzheimers Dis. 2022 Jun 6. pii: JAD215630. doi: 10.3233/JAD-215630.
    >> Share

  1035. WESSELS AM, Belger M, Johnston JA, Yu Y, et al
    Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220303. doi: 10.3233/JAD-220303.
    >> Share

  1036. SUN L, Guo C, Song Y, Sheng J, et al
    Blood BMP6 Associated with Cognitive Performance and Alzheimer's Disease Diagnosis: A Longitudinal Study of Elders.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220279. doi: 10.3233/JAD-220279.
    >> Share

  1037. GOMEZ LR, Albers MW, Baena A, Vila-Castelar C, et al
    Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220075. doi: 10.3233/JAD-220075.
    >> Share

  1038. AGARWAL P, Holland TM, James BD, Cherian LJ, et al
    Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD215600. doi: 10.3233/JAD-215600.
    >> Share

  1039. ARAUJO DC, Veloso AA, Gomes KB, Souza LC, et al
    A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220256. doi: 10.3233/JAD-220256.
    >> Share

  1040. WANG Q, Shi Y, Qi X, Qi L, et al
    Platelet-Derived Amyloid-beta Protein Precursor as a Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220122. doi: 10.3233/JAD-220122.
    >> Share

  1041. HUDA TI, Diaz MJ, Gozlan EC, Chobrutskiy A, et al
    Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220119. doi: 10.3233/JAD-220119.
    >> Share

  1042. HANNONEN S, Andberg S, Karkkainen V, Rusanen M, et al
    Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD215551. doi: 10.3233/JAD-215551.
    >> Share

    May 2022
  1043. SERWER P, Wright ET, Hunter B
    Additions to Alpha-Sheet Based Hypotheses for the Cause of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 30. pii: JAD220311. doi: 10.3233/JAD-220311.
    >> Share

  1044. WANG Y, Li L, Zhao X, Sui S, et al
    Intestinal Microflora Changes in Patients with Mild Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2022 May 30. pii: JAD220076. doi: 10.3233/JAD-220076.
    >> Share

  1045. RIPHAGEN JM, van Hooren RWE, Kenis G, Verhey FRJ, et al
    Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 May 28. pii: JAD215353. doi: 10.3233/JAD-215353.
    >> Share

  1046. MCGRATTAN A, Stewart CJ, Cassidy A, Woodside JV, et al
    Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 23. pii: JAD220205. doi: 10.3233/JAD-220205.
    >> Share

  1047. TSAI YL, Yen CT, Wang YF
    Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD220218. doi: 10.3233/JAD-220218.
    >> Share

  1048. FRAME G, Schuller A, Smith MA, Crish SD, et al
    Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 May 18. pii: JAD220016. doi: 10.3233/JAD-220016.
    >> Share

  1049. HAO J, Guo Y, Guo K, Yang Q, et al
    Peripheral Inflammatory Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD215422. doi: 10.3233/JAD-215422.
    >> Share

  1050. WITTFELD K, Raman MR, Conner SC, Aslam A, et al
    Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.
    J Alzheimers Dis. 2022 May 16. pii: JAD220356. doi: 10.3233/JAD-220356.
    >> Share

  1051. HOILUND-CARLSEN PF, Revheim ME, Alavi A
    Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start.
    J Alzheimers Dis. 2022 May 16. pii: JAD220190. doi: 10.3233/JAD-220190.
    >> Share

  1052. CHENG Y, Jian JM, He CY, Ren JR, et al
    The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-beta and Tau Levels in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 16. pii: JAD220126. doi: 10.3233/JAD-220126.
    >> Share

  1053. TANCHEVA L, Lazarova M, Velkova L, Dolashki A, et al
    Beneficial Effects of Snail Helix aspersa Extract in an Experimental Model of Alzheimer's Type Dementia.
    J Alzheimers Dis. 2022 May 16. pii: JAD215693. doi: 10.3233/JAD-215693.
    >> Share

  1054. HELBOE L, Rosenqvist N, Volbracht C, Pedersen LO, et al
    Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    J Alzheimers Dis. 2022 May 9. pii: JAD220125. doi: 10.3233/JAD-220125.
    >> Share

  1055. WELTY S, Thathiah A, Levine AS
    DNA Damage Increases Secreted Abeta40 and Abeta42 in Neuronal Progenitor Cells: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220030. doi: 10.3233/JAD-220030.
    >> Share

  1056. ZHANG Y, Hu Y, Han Z, Geng Y, et al
    Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220009. doi: 10.3233/JAD-220009.
    >> Share

  1057. FERNANDES M, Chiaravalloti A, Manfredi N, Placidi F, et al
    Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2022 May 9. pii: JAD215734. doi: 10.3233/JAD-215734.
    >> Share

  1058. ZHANG X, Guan Q, Li Y, Zhang J, et al
    Aberrant Cross-Tissue Functional Connectivity in Alzheimer's Disease: Static, Dynamic, and Directional Properties.
    J Alzheimers Dis. 2022 May 9. pii: JAD215649. doi: 10.3233/JAD-215649.
    >> Share

  1059. DAS TK, Blasco-Conesa MP, Korf J, Honarpisheh P, et al
    Bacterial Amyloid Curli Associated Gut Epithelial Neuroendocrine Activation Predominantly Observed in Alzheimer's Disease Mice with Central Amyloid-beta Pathology.
    J Alzheimers Dis. 2022 May 6. pii: JAD220106. doi: 10.3233/JAD-220106.
    >> Share

  1060. DUAN L, Qian X, Wang Q, Huang L, et al
    Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2022 May 6. pii: JAD215720. doi: 10.3233/JAD-215720.
    >> Share

  1061. KALARI M, Abbasi Z, Shasaltaneh MD, Khaleghian A, et al
    A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2022 May 6. pii: JAD215588. doi: 10.3233/JAD-215588.
    >> Share

  1062. NARUKAWA M, Mori Y, Nishida R, Takahashi S, et al
    Expression of Olfactory-Related Genes in the Olfactory Epithelium of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 May 4. pii: JAD220213. doi: 10.3233/JAD-220213.
    >> Share

  1063. MANDAL PK, Dwivedi D, Shukla D, Samkaria A, et al
    Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 4. pii: JAD215729. doi: 10.3233/JAD-215729.
    >> Share

  1064. LIO CT, Kacprowski T, Klaedtke M, Jensen LR, et al
    Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 2. pii: JAD220110. doi: 10.3233/JAD-220110.
    >> Share

    April 2022
  1065. KIM H, Levine A, Cohen D, Gehrman P, et al
    The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    J Alzheimers Dis. 2022 Apr 28. pii: JAD215417. doi: 10.3233/JAD-215417.
    >> Share

  1066. LENG F, Zhan Z, Sun Y, Liu F, et al
    Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220102. doi: 10.3233/JAD-220102.
    >> Share

  1067. DIAS IHK, Shokr H, Shephard F, Chakrabarti L, et al
    Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220083. doi: 10.3233/JAD-220083.
    >> Share

  1068. SALEHIPOUR A, Bagheri M, Sabahi M, Dolatshahi M, et al
    Combination Therapy in Alzheimer's Disease: Is It Time?
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215680. doi: 10.3233/JAD-215680.
    >> Share

  1069. CHEN D, Yi F, Qin Y, Zhang J, et al
    A Stacking Framework for Multi-Classification of Alzheimer's Disease Using Neuroimaging and Clinical Features.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215654. doi: 10.3233/JAD-215654.
    >> Share

  1070. TONGSIRI S, Levkoff S, Gallagher-Thompson D, Teri L, et al
    Cultural Adaptation of the Reducing Disability in Alzheimer's Disease (RDAD) Protocol for an Intervention to Reduce Behavioral and Psychological Symptoms of Dementia in Thailand.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215253. doi: 10.3233/JAD-215253.
    >> Share

  1071. DONG L, Liu C, Sha L, Mao C, et al
    PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220194. doi: 10.3233/JAD-220194.
    >> Share

  1072. BOSE A, Dutta M, Dash NS, Nandi R, et al
    Importance of Task Selection for Connected Speech Analysis in Patients with Alzheimer's Disease from an Ethnically Diverse Sample.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220166. doi: 10.3233/JAD-220166.
    >> Share

  1073. LOBUE C, Kelley BJ, Hart J, Helphrey J, et al
    Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220112. doi: 10.3233/JAD-220112.
    >> Share

  1074. GRAHAM A, Livingston G, Purnell L, Huntley J, et al
    Mild Traumatic Brain Injuries and Future Risk of Developing Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220069. doi: 10.3233/JAD-220069.
    >> Share

  1075. LLAMAS-RODRIGUEZ J, Oltmer J, Greve DN, Williams E, et al
    Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215567. doi: 10.3233/JAD-215567.
    >> Share

  1076. SALAZAR CR, Ritchie M, Gillen DL, Grill JD, et al
    Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215537. doi: 10.3233/JAD-215537.
    >> Share

  1077. KARIKARI TK
    Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.
    J Alzheimers Dis. 2022 Apr 23. pii: JAD215730. doi: 10.3233/JAD-215730.
    >> Share

  1078. CATO S, Ramer S, Hajjar I, Kulshreshtha A, et al
    Alzheimer's Disease Mortality as a Function of Urbanization Level: 1999-2019.
    J Alzheimers Dis. 2022 Apr 22. pii: JAD215586. doi: 10.3233/JAD-215586.
    >> Share

  1079. HUTTEN DR, Bos JHJ, de Vos S, Hak E, et al
    Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.
    J Alzheimers Dis. 2022 Apr 18. pii: JAD215057. doi: 10.3233/JAD-215057.
    >> Share

  1080. RAMSDEN CE, Keyes GS, Calzada E, Horowitz MS, et al
    Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220071. doi: 10.3233/JAD-220071.
    >> Share

  1081. MIRABNAHRAZAM G, Ma D, Lee S, Popuri K, et al
    Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220021. doi: 10.3233/JAD-220021.
    >> Share

  1082. KETCHUM FB, Erickson CM, Chin NA, Gleason CE, et al
    What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215521. doi: 10.3233/JAD-215521.
    >> Share

  1083. WONG HY, Zhong H, Zhong M, Zhou X, et al
    Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215312. doi: 10.3233/JAD-215312.
    >> Share

  1084. DALY T, Mastroleo I
    The First Survivors of Alzheimer's: How Patients Recovered Life and Hope in Their Own Words by Dale Bredesen, Avery, 2021, 272 pp.
    J Alzheimers Dis. 2022 Apr 13. pii: JAD220185. doi: 10.3233/JAD-220185.
    >> Share

  1085. KAWARABAYASHI T, Nakamura T, Sato K, Seino Y, et al
    Lipid Rafts Act as a Common Platform for Amyloid-beta Oligomer-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 Apr 12. pii: JAD215662. doi: 10.3233/JAD-215662.
    >> Share

  1086. MARINELLI L, Trompetto C, Puce L, Monacelli F, et al
    Electromyographic Patterns of Paratonia in Normal Subjects and in Patients with Mild Cognitive Impairment or Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215526. doi: 10.3233/JAD-215526.
    >> Share

  1087. HONE-BLANCHET A, Bhosali A, Krishnamurthy LC, Shahid SS, et al
    Frontal Metabolites and Alzheimer's Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215431. doi: 10.3233/JAD-215431.
    >> Share

  1088. MOZERSKY J, Roberts SJ, Rumbaugh M, Chhatwal J, et al
    Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220113. doi: 10.3233/JAD-220113.
    >> Share

  1089. ISELLA V, Rosazza C, Ferri F, Gazzotti M, et al
    Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220053. doi: 10.3233/JAD-220053.
    >> Share

  1090. GARCIA PRETELT FJ, Suarez Relevo JX, Aguillon D, Lopera F, et al
    Automatic Classification of Subjects of the PSEN1-E280A Family at Risk of Developing Alzheimer's Disease Using Machine Learning and Resting State Electroencephalography.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD210148. doi: 10.3233/JAD-210148.
    >> Share

  1091. GHERARDELLI C, Cisternas P, Vera-Salazar RF, Mendez-Orellana C, et al
    Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 7. pii: JAD215273. doi: 10.3233/JAD-215273.
    >> Share

  1092. GABEL M, Bollinger RM, Coble DW, Grill JD, et al
    Retaining Participants in Longitudinal Studies of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215710. doi: 10.3233/JAD-215710.
    >> Share

  1093. PILOTTO A, Parigi M, Bonzi G, Battaglio B, et al
    Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215646. doi: 10.3233/JAD-215646.
    >> Share

  1094. UENO M, Yoshino Y, Mori H, Funahashi Y, et al
    Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215627. doi: 10.3233/JAD-215627.
    >> Share

  1095. HANYU H, Koyama Y, Horita H, Aoki T, et al
    Characterization of Alzheimer's Disease Subtypes Based on Magnetic Resonance Imaging and Perfusion Single-Photon Emission Computed Tomography.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215674. doi: 10.3233/JAD-215674.
    >> Share

  1096. LAZAROU I, Georgiadis K, Nikolopoulos S, Oikonomou VP, et al
    Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215421. doi: 10.3233/JAD-215421.
    >> Share

    March 2022
  1097. WEI T, Guo Z, Wang Z, Li C, et al
    Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 31. pii: JAD220010. doi: 10.3233/JAD-220010.
    >> Share

  1098. GONZALEZ CORDERO EM, Cuevas-Budhart MA, Perez-Moran D, Trejo Villeda MA, et al
    Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Mar 28. pii: JAD215224. doi: 10.3233/JAD-215224.
    >> Share


  1099. Erratum to: Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2022 Mar 25. pii: JAD229002. doi: 10.3233/JAD-229002.
    >> Share

  1100. KIM CK, Lee YR, Ong L, Gold M, et al
    Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.
    J Alzheimers Dis. 2022 Mar 22. pii: JAD215699. doi: 10.3233/JAD-215699.
    >> Share

  1101. ZHANG PF, Wang ZT, Liu Y, Hu H, et al
    Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD220057. doi: 10.3233/JAD-220057.
    >> Share

  1102. JIAN JM, Fan DY, Cheng Y, Shen YY, et al
    Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215611. doi: 10.3233/JAD-215611.
    >> Share

  1103. MURCHISON CF, Jaeger BC, Szychowski JM, Cutter GR, et al
    Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215553. doi: 10.3233/JAD-215553.
    >> Share

  1104. WANG X, Sun H, Pan S, Bai X, et al
    Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215535. doi: 10.3233/JAD-215535.
    >> Share

  1105. LARGENT EA, Bhardwaj T, Clapp JT, Sykes OS, et al
    You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.
    J Alzheimers Dis. 2022 Mar 18. pii: JAD220061. doi: 10.3233/JAD-220061.
    >> Share

  1106. DOBROMYSLIN VI, Megherbi DB
    Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
    J Alzheimers Dis. 2022 Mar 15. pii: JAD215640. doi: 10.3233/JAD-215640.
    >> Share

  1107. DE OLIVEIRA FF, Bertolucci PHF, Chen ES, Smith MC, et al
    Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215735. doi: 10.3233/JAD-215735.
    >> Share

  1108. DU XL, Song L, Schulz PE, Xu H, et al
    Risk of Developing Alzheimer's Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215657. doi: 10.3233/JAD-215657.
    >> Share

  1109. LUPPI JJ, Schoonhoven DN, van Nifterick AM, Gouw AA, et al
    Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215464. doi: 10.3233/JAD-215464.
    >> Share

  1110. HUANG SY, Yang YX, Zhang YR, Kuo K, et al
    Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220050. doi: 10.3233/JAD-220050.
    >> Share

  1111. TERNAK G, Nemeth M, Rozanovic M, Bogar L, et al
    Alzheimer's Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220018. doi: 10.3233/JAD-220018.
    >> Share

  1112. CAO M, Liu J, Zhang X, Yang T, et al
    ABI3 Is a Novel Early Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215635. doi: 10.3233/JAD-215635.
    >> Share

  1113. KRAUSE-SORIO B, Siddarth P, Kilpatrick L, Milillo MM, et al
    Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215563. doi: 10.3233/JAD-215563.
    >> Share

  1114. NICSANU R, Cervellati C, Benussi L, Squitti R, et al
    Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215542. doi: 10.3233/JAD-215542.
    >> Share

  1115. WOLFSGRUBER S, Kleineidam L, Weyrauch AS, Barkhoff M, et al
    Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215416. doi: 10.3233/JAD-215416.
    >> Share

  1116. CHUNG SJ, Chang Y, Jeon J, Shin JI, et al
    Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Mar 10. pii: JAD220031. doi: 10.3233/JAD-220031.
    >> Share

  1117. SHIM Y, Han HJ, Park KW, Kim BC, et al
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Mode
    J Alzheimers Dis. 2022 Mar 10. pii: JAD215277. doi: 10.3233/JAD-215277.
    >> Share


  1118. Erratum to "Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease".
    J Alzheimers Dis. 2022 Mar 8. pii: JAD229001. doi: 10.3233/JAD-229001.
    >> Share

  1119. ANDROUIN A, Thierry M, Boluda S, Baskaran A, et al
    Alterations of Neuronal Lysosomes in Alzheimer's Disease and in APPxPS1-KI Mice.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215692. doi: 10.3233/JAD-215692.
    >> Share

  1120. CIRSTEA MS, Kliger D, MacLellan AD, Yu AC, et al
    The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215520. doi: 10.3233/JAD-215520.
    >> Share

  1121. WANG X, Li F, Gao Q, Jiang Z, et al
    Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215394. doi: 10.3233/JAD-215394.
    >> Share

  1122. KOK FK, van Leerdam SL, de Lange ECM
    Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD210607. doi: 10.3233/JAD-210607.
    >> Share

  1123. LACORTE E, Ancidoni A, Zaccaria V, Remoli G, et al
    Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD220046. doi: 10.3233/JAD-220046.
    >> Share

  1124. LIU Y, Han PR, Hu H, Wang ZT, et al
    A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD215724. doi: 10.3233/JAD-215724.
    >> Share

  1125. XIAO Y, Gong X, Deng R, Liu W, et al
    Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215705. doi: 10.3233/JAD-215705.
    >> Share

  1126. ARMSTRONG MJ, Song S, Kurasz AM, Li Z, et al
    Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215587. doi: 10.3233/JAD-215587.
    >> Share

  1127. FENG T, Hu X, Fukui Y, Bian Z, et al
    Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215246. doi: 10.3233/JAD-215246.
    >> Share

  1128. BROUSSARD JI, Redell JB, Maynard ME, Zhao J, et al
    Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215023. doi: 10.3233/JAD-215023.
    >> Share

  1129. BABULAL GM, Chen L, Doherty JM, Murphy SA, et al
    Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215708. doi: 10.3233/JAD-215708.
    >> Share

  1130. MEYSAMI S, Raji CA, Mendez MF
    Quantified Brain Magnetic Resonance Imaging Volumes Differentiates Behavioral Variant Frontotemporal Dementia from Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215667. doi: 10.3233/JAD-215667.
    >> Share

  1131. SHI Y, Bao Q, Chen W, Wang L, et al
    Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215666. doi: 10.3233/JAD-215666.
    >> Share

  1132. MI Y, Qin Q, Xing Y, Tang Y, et al
    Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215565. doi: 10.3233/JAD-215565.
    >> Share

  1133. JACUS JP, Voltzenlogel V, Antoine P, Cuervo-Lombard CV, et al
    Apathy Is the Best Dimension to Consider for Awareness Assessment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215550. doi: 10.3233/JAD-215550.
    >> Share

  1134. ESCOBAR YH, O'Piela D, Wold LE, Mackos AR, et al
    Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215290. doi: 10.3233/JAD-215290.
    >> Share

  1135. ALVES SR, da Cruz E Silva C, Martins I, Henriques AG, et al
    A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215059. doi: 10.3233/JAD-215059.
    >> Share

    February 2022
  1136. KRISHNA-K K, Behnisch T, Sajikumar S
    Modulation of the Ubiquitin-Proteasome System Restores Plasticity in Hippocampal Pyramidal Neurons of the APP/PS1 Alzheimer's Disease-Like Mice.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215718. doi: 10.3233/JAD-215718.
    >> Share

  1137. LI W, Yang D, Yan C, Chen M, et al
    Characterizing Network Selectiveness to the Dynamic Spreading of Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215596. doi: 10.3233/JAD-215596.
    >> Share

  1138. KALECKY K, German DC, Montillo AA, Bottiglieri T, et al
    Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215448. doi: 10.3233/JAD-215448.
    >> Share

  1139. CAO H, Zhou X, Chen Y, Ip FCF, et al
    Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215311. doi: 10.3233/JAD-215311.
    >> Share

  1140. COLVERSON AJ, Trifilio E, Williamson JB
    Music, Mind, Mood, and Mingling in Alzheimer's Disease and Related Dementias: A Scoping Review.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215199. doi: 10.3233/JAD-215199.
    >> Share

  1141. PAYNE S, Shofer JB, Shutes-David A, Li G, et al
    Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer Coordinating Center.
    J Alzheimers Dis. 2022 Feb 23. pii: JAD215428. doi: 10.3233/JAD-215428.
    >> Share

  1142. CHOI H, Lee D, Mook-Jung I
    Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215235. doi: 10.3233/JAD-215235.
    >> Share

  1143. ALVAREZ-SANCHEZ L, Pena-Bautista C, Baquero M, Chafer-Pericas C, et al
    Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215093. doi: 10.3233/JAD-215093.
    >> Share

  1144. SCHINDLER SE
    Predicting Symptom Onset in Sporadic Alzheimer's Disease: "How Long Do I Have?"
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215722. doi: 10.3233/JAD-215722.
    >> Share

  1145. AKSNES M, Aass HCD, Tiiman A, Terenius L, et al
    Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215504. doi: 10.3233/JAD-215504.
    >> Share

  1146. TSAMOU M, Carpi D, Pistollato F, Roggen EL, et al
    Sporadic Alzheimer's Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215434. doi: 10.3233/JAD-215434.
    >> Share

  1147. JACOBS HIL, O'Donnell A, Satizabal CL, Lois C, et al
    Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215372. doi: 10.3233/JAD-215372.
    >> Share

  1148. LIU Z, Paek EJ, Yoon SO, Casenhiser D, et al
    Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215137. doi: 10.3233/JAD-215137.
    >> Share

  1149. HUA X, Church K, Walker W, L'Hostis P, et al
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.
    J Alzheimers Dis. 2022 Feb 18. pii: JAD215511. doi: 10.3233/JAD-215511.
    >> Share

  1150. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215536. doi: 10.3233/JAD-215536.
    >> Share

  1151. HANG Z, Cai S, Lei T, Zhang X, et al
    Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215495. doi: 10.3233/JAD-215495.
    >> Share

  1152. GALLUCCI M, Cenesi L, White C, Antuono P, et al
    Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer's Disease Framework.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215432. doi: 10.3233/JAD-215432.
    >> Share

  1153. SUAREZ-MENDEZ I, Bruna R, Lopez-Sanz D, Montejo P, et al
    Cognitive Training Modulates Brain Hypersynchrony in a Population at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215406. doi: 10.3233/JAD-215406.
    >> Share

  1154. BIJU K, Oh E, Rosenberg P, Xue QL, et al
    Vestibular Function Predicts Balance and Fall Risk in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215366. doi: 10.3233/JAD-215366.
    >> Share

  1155. ATAYDE AL, Fischer CE, Schweizer TA, Munoz DG, et al
    Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215276. doi: 10.3233/JAD-215276.
    >> Share

  1156. WANG J, Ma SF, Yun Q, Liu WJ, et al
    FOXG1 as a Potential Therapeutic Target for Alzheimer's Disease with a Particular Focus on Cell Cycle Regulation.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215144. doi: 10.3233/JAD-215144.
    >> Share

  1157. KELBERMAN MA, Anderson CR, Chlan E, Rorabaugh JM, et al
    Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215546. doi: 10.3233/JAD-215546.
    >> Share

  1158. TICINESI A, Mancabelli L, Carnevali L, Nouvenne A, et al
    Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215493. doi: 10.3233/JAD-215493.
    >> Share

  1159. GALASKO DR, Grill JD, Lingler JH, Heidebrink JL, et al
    A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215490. doi: 10.3233/JAD-215490.
    >> Share

  1160. PARRA MA
    Barriers to Effective Memory Assessments for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215445. doi: 10.3233/JAD-215445.
    >> Share

  1161. DE PAULA FRANCA RESENDE E, Ketelle R, Karydas A, Allen I, et al
    Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215369. doi: 10.3233/JAD-215369.
    >> Share

  1162. XU A, Kouznetsova VL, Tsigelny IF
    Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.
    J Alzheimers Dis. 2022 Feb 5. pii: JAD215502. doi: 10.3233/JAD-215502.
    >> Share

  1163. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Stage-Dependent Cerebral Blood Flow and Leukoaraiosis Couplings in Subcortical Ischemic Vascular Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 3. pii: JAD215405. doi: 10.3233/JAD-215405.
    >> Share

  1164. JANSSON D, Wang M, Thomas R, Erickson MA, et al
    Markers of Cerebrovascular Injury, Inflammation, and Plasma Lipids Are Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Cognitively Normal Persons.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215400. doi: 10.3233/JAD-215400.
    >> Share

  1165. ASSOGNA M, Motta C, Bonni S, Borghi I, et al
    Isolated Amyloid-beta Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215218. doi: 10.3233/JAD-215218.
    >> Share

  1166. THOMPSON RE, Tuchman AJ, Alkon DL
    Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1.
    J Alzheimers Dis. 2022 Feb 1. pii: JAD215545. doi: 10.3233/JAD-215545.
    >> Share

    January 2022
  1167. GEORGE DR, Whitehouse PJ
    How Not to Study a Disease: The Story of Alzheimer's by Karl Herrup, The MIT Press, 2021, 245 pp.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD220035. doi: 10.3233/JAD-220035.
    >> Share

  1168. JUTTEN RJ, Thompson L, Sikkes SAM, Maruff P, et al
    A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD215098. doi: 10.3233/JAD-215098.
    >> Share

  1169. UM YH, Wang SM, Kang DW, Kim NY, et al
    Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.
    J Alzheimers Dis. 2022 Jan 21. pii: JAD215460. doi: 10.3233/JAD-215460.
    >> Share

  1170. MESA-HERRERA F, Marin R, Torrealba E, Diaz M, et al
    Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215437. doi: 10.3233/JAD-215437.
    >> Share

  1171. ZHANG W, Zhang M, Wu Q, Shi JS, et al
    Dendrobium nobile Lindl. Alkaloids Ameliorate Abeta25-35-Induced Synaptic Deficits by Targeting Wnt/beta-Catenin Pathway in Alzheimer's Disease Models.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215433. doi: 10.3233/JAD-215433.
    >> Share

  1172. TEIXEIRA AL, Salem H, Martins LB, Gonzales MM, et al
    Factors Associated with Apathy in Alzheimer's Disease: A Cross-Sectional Analysis of the Texas Alzheimer's Research and Care Consortium (TARCC) Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215314. doi: 10.3233/JAD-215314.
    >> Share

  1173. PEDERSEN FN, Stokholm L, Pouwer F, Hass Rubin K, et al
    Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215313. doi: 10.3233/JAD-215313.
    >> Share

  1174. RICHTER N, David LS, Grothe MJ, Teipel S, et al
    Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD210261. doi: 10.3233/JAD-210261.
    >> Share

  1175. MCNERNEY MW, Heath A, Narayanan S, Yesavage J, et al
    Repetitive Transcranial Magnetic Stimulation Improves Brain-Derived Neurotrophic Factor and Cholinergic Signaling in the 3xTgAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215361. doi: 10.3233/JAD-215361.
    >> Share

  1176. KUKSA PP, Liu CL, Fu W, Qu L, et al
    Alzheimer's Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215055. doi: 10.3233/JAD-215055.
    >> Share

  1177. MIRON J, Picard C, Labonte A, Auld D, et al
    MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215410. doi: 10.3233/JAD-215410.
    >> Share

  1178. EASTMAN G, Sharlow ER, Lazo JS, Bloom GS, et al
    Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215357. doi: 10.3233/JAD-215357.
    >> Share

  1179. STEPLER KE, Gillyard TR, Reed CB, Avery TM, et al
    ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215306. doi: 10.3233/JAD-215306.
    >> Share

  1180. SCHAFFERT J, LoBue C, Hynan LS, Hart J, et al
    Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215200. doi: 10.3233/JAD-215200.
    >> Share

  1181. PARK M, Baik K, Lee YG, Kang SW, et al
    Erratum to: Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2022 Jan 11. pii: JAD219020. doi: 10.3233/JAD-219020.
    >> Share

  1182. BIAN Z, Liu X, Feng T, Yu H, et al
    Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Jan 5. pii: JAD215318. doi: 10.3233/JAD-215318.
    >> Share

  1183. DALY T, Mastroleo I, Henry V, Bourdenx M, et al
    An Argument for Simple Tests of Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215492. doi: 10.3233/JAD-215492.
    >> Share

  1184. BENCA R, Herring WJ, Khandker R, Qureshi Z, et al
    Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215324. doi: 10.3233/JAD-215324.
    >> Share

  1185. CONTARINO VE, Siggillino S, Arighi A, Scola E, et al
    Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia.
    J Alzheimers Dis. 2022;85:431-442.
    >> Share

  1186. WILKINS HM, Troutwine BR, Menta BW, Manley SJ, et al
    Mitochondrial Membrane Potential Influences Amyloid-beta Protein Precursor Localization and Amyloid-beta Secretion.
    J Alzheimers Dis. 2022;85:381-394.
    >> Share

  1187. YAN XD, Qu XS, Yin J, Qiao J, et al
    Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
    J Alzheimers Dis. 2022;85:343-357.
    >> Share

  1188. SCHWARZ CG, Knopman DS, Ramanan VK, Lowe VJ, et al
    Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.
    J Alzheimers Dis. 2022;85:59-64.
    >> Share

  1189. SONG Y, Du Z, Chen X, Zhang W, et al
    Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-beta142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
    J Alzheimers Dis. 2022;85:167-178.
    >> Share

  1190. JUNG KH, Park KI, Lee WJ, Son H, et al
    Association of Plasma Oligomerized Amyloid-beta and Cerebral White Matter Lesions in a Health Screening Population.
    J Alzheimers Dis. 2022;85:1835-1844.
    >> Share

  1191. STREIT WJ, Rotter J, Winter K, Muller W, et al
    Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation.
    J Alzheimers Dis. 2022;85:1701-1720.
    >> Share

  1192. KURANO M, Tsukamoto K, Sakai E, Hara M, et al
    Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells.
    J Alzheimers Dis. 2022;85:1529-1544.
    >> Share

  1193. SUN Y, Wang M, Zhao Y, Hu K, et al
    A Pathway-Specific Polygenic Risk Score Is Associated with Tau Pathology and Cognitive Decline.
    J Alzheimers Dis. 2022;85:1745-1754.
    >> Share

  1194. KHAN N, Alimova Y, Clark SJ, Vekaria HJ, et al
    Human APOE varepsilon3 and APOE varepsilon4 Alleles Have Differential Effects on Mouse Olfactory Epithelium.
    J Alzheimers Dis. 2022;85:1481-1494.
    >> Share

  1195. KHORANI M, Bobe G, Matthews DG, Magana AA, et al
    The Impact of the hAPP695SW Transgene and Associated Amyloid-beta Accumulation on Murine Hippocampal Biochemical Pathways.
    J Alzheimers Dis. 2022;85:1601-1619.
    >> Share

  1196. CHENG J, Fairchild JK, McNerney MW, Noda A, et al
    Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities.
    J Alzheimers Dis. 2022;85:1593-1600.
    >> Share

  1197. GAO Z, Zhang R, Jiang L, Zhou H, et al
    Administration of miR-195 Inhibitor Enhances Memory Function Through Improving Synaptic Degradation and Mitochondrial Dysfunction of the Hippocampal Neurons in SAMP8 Mice.
    J Alzheimers Dis. 2022;85:1495-1509.
    >> Share

  1198. WANG G, Zhou W, Kong D, Qu Z, et al
    Studying APOE varepsilon4 Allele Dose Effects with a Univariate Morphometry Biomarker.
    J Alzheimers Dis. 2022;85:1233-1250.
    >> Share

  1199. ZHOU AL, Sharda N, Sarma VV, Ahlschwede KM, et al
    Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-beta Peptides and Insulin.
    J Alzheimers Dis. 2022;85:1031-1044.
    >> Share

  1200. ZHANG XX, Ma YH, Hu HY, Ma LZ, et al
    Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: The CABLE Study.
    J Alzheimers Dis. 2022;85:877-887.
    >> Share

  1201. BAO J, Liang Z, Gong X, Yu J, et al
    High Fat Diet Mediates Amyloid-beta Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;85:863-876.
    >> Share

  1202. KHAJEHPIRI B, Moghaddam HA, Forouzanfar M, Lashgari R, et al
    Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression.
    J Alzheimers Dis. 2022;85:837-850.
    >> Share

  1203. SHANG X, Hill E, Zhu Z, Liu J, et al
    Macronutrient Intake and Risk of Dementia in Community-Dwelling Older Adults: A Nine-Year Follow-Up Cohort Study.
    J Alzheimers Dis. 2022;85:791-804.
    >> Share

  1204. SIL A, Erfani A, Lamb N, Copland R, et al
    Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.
    J Alzheimers Dis. 2022;85:755-778.
    >> Share

  1205. TALAN J
    Obituary for John Q. Trojanowski, leading Alzheimer's Disease Researcher.
    J Alzheimers Dis. 2022;86:1-3.
    >> Share

  1206. SHAFIR A, Ritchie CS, Garrett SB, Bernstein Sideman A, et al
    "Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic.
    J Alzheimers Dis. 2022;86:787-800.
    >> Share

  1207. KUNDU P, Zimmerman B, Quinn JF, Kaye J, et al
    Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.
    J Alzheimers Dis. 2022;86:1471-1481.
    >> Share

  1208. WEINSTEIN G, O'Donnell A, Davis-Plourde K, Zelber-Sagi S, et al
    Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-beta and Tau Pathology in Middle-Aged Adults: The Framingham Study.
    J Alzheimers Dis. 2022;86:1371-1383.
    >> Share

  1209. CHAN CK, Pettigrew C, Soldan A, Zhu Y, et al
    Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
    J Alzheimers Dis. 2022;86:1415-1426.
    >> Share

  1210. OWENS L, Bracewell J, Benedetto A, Dawson N, et al
    BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-beta Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAbetaPPalpha.
    J Alzheimers Dis. 2022;86:1201-1220.
    >> Share

  1211. TANAKA T, Gyanwali B, Villaraza SG, Saridin FN, et al
    The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study.
    J Alzheimers Dis. 2022;86:1093-1105.
    >> Share

  1212. SAJI N, Murotani K, Sato N, Tsuduki T, et al
    Relationship Between Plasma Neurofilament Light Chain, Gut Microbiota, and Dementia: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;86:1323-1335.
    >> Share

  1213. TIAN Q, Bilgel M, Moghekar AR, Ferrucci L, et al
    Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2022;86:1275-1285.
    >> Share

  1214. O'BRYANT SE, Zhang F, Petersen M, Hall JR, et al
    Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.
    J Alzheimers Dis. 2022;86:1243-1254.
    >> Share

  1215. DORAISWAMY PM, Goldberg TE, Qian M, Linares AR, et al
    Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:1131-1136.
    >> Share

  1216. RICE M, Davalos D, Thomas ML
    A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders.
    J Alzheimers Dis. 2022;86:1001-1024.
    >> Share

  1217. ZHU Z, Zeng Q, Zhang R, Luo X, et al
    White Matter Free Water Outperforms Cerebral Small Vessel Disease Total Score in Predicting Cognitive Decline in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:741-751.
    >> Share

  1218. CEYZERIAT K, Tournier BB, Millet P, Dipasquale G, et al
    Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.
    J Alzheimers Dis. 2022;86:641-653.
    >> Share

  1219. CHEN WT, Chi NF, Cheng HM, Ko YT, et al
    Associations Between Cerebral Vasoreactivity and Cognitive Function in the Middle-Aged Non-Demented Population.
    J Alzheimers Dis. 2022;86:679-690.
    >> Share

  1220. HSU YH, Huang SM, Lin SY, Yang JJ, et al
    Prospective Memory and Default Mode Network Functional Connectivity in Normal and Pathological Aging.
    J Alzheimers Dis. 2022;86:753-762.
    >> Share

  1221. CARDOSO S, Silva D, Alves L, Guerreiro M, et al
    The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:629-640.
    >> Share

  1222. YANG Z, Sheng X, Qin R, Chen H, et al
    Cognitive Improvement via Left Angular Gyrus-Navigated Repetitive Transcranial Magnetic Stimulation Inducing the Neuroplasticity of Thalamic System in Amnesic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2022;86:537-551.
    >> Share

  1223. JOSEPHS KA, Pham NTT, Graff-Radford J, Machulda MM, et al
    Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
    J Alzheimers Dis. 2022;86:491-498.
    >> Share

  1224. LEVY B, Priest A, Delaney T, Hogan J, et al
    Toward Pre-Diagnostic Detection of Dementia in Primary Care.
    J Alzheimers Dis. 2022;86:479-490.
    >> Share

  1225. SOHN BK, Byun MS, Yi D, Jeon SY, et al
    Late-Life Physical Activities Moderate the Relationship of Amyloid-beta Pathology with Neurodegeneration in Individuals Without Dementia.
    J Alzheimers Dis. 2022;86:441-450.
    >> Share

  1226. LIU M, Guo S, Huang D, Hu D, et al
    Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice.
    J Alzheimers Dis. 2022;86:315-331.
    >> Share

  1227. ZHANG LN, Li MJ, Shang YH, Liu YR, et al
    Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3beta Activation.
    J Alzheimers Dis. 2022;86:191-204.
    >> Share

  1228. DENNISON JL, Volmar CH, Ke D, Wang J, et al
    JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2022;86:173-190.
    >> Share

  1229. LERCH O, Laczo M, Vyhnalek M, Nedelska Z, et al
    APOEvarepsilon4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia.
    J Alzheimers Dis. 2022;86:155-171.
    >> Share

  1230. ZHANG Q, Zhang M, Chen Y, Cao Y, et al
    Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011-2014).
    J Alzheimers Dis. 2022;86:125-134.
    >> Share

  1231. HENDERSON C, Knapp M, Martyr A, Gamble LD, et al
    The Use and Costs of Paid and Unpaid Care for People with Dementia: Longitudinal Findings from the IDEAL Cohort.
    J Alzheimers Dis. 2022;86:135-153.
    >> Share

  1232. O'BRYANT SE, Petersen M, Hall J, Johnson L, et al
    Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.
    J Alzheimers Dis. 2022;86:1745-1750.
    >> Share

  1233. HU H, Fu JT, Bi YL, Ma YH, et al
    Tau Pathologies Mediate the Association of Cigarette Smoking with Cognitive Impairment in Older Adults Without Dementia: The CABLE Study.
    J Alzheimers Dis. 2022;86:1849-1859.
    >> Share

  1234. ZHANG L, Fu Y, Zhao Z, Cong Z, et al
    Analysis of Hippocampus Evolution Patterns and Prediction of Conversion in Mild Cognitive Impairment Using Multivariate Morphometry Statistics.
    J Alzheimers Dis. 2022;86:1695-1710.
    >> Share

  1235. PARKER AF, Ohlhauser L, Scarapicchia V, Smart CM, et al
    A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls.
    J Alzheimers Dis. 2022;86:1545-1567.
    >> Share

  1236. SANDBERG AA, Manning E, Wilkins HM, Mazzarino R, et al
    Mitochondrial Targeting of Amyloid-beta Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-beta.
    J Alzheimers Dis. 2022;86:1727-1744.
    >> Share

  1237. LI C, Liu M, Xia J, Mei L, et al
    Predicting Brain Amyloid-beta PET Grades with Graph Convolutional Networks Based on Functional MRI and Multi-Level Functional Connectivity.
    J Alzheimers Dis. 2022;86:1679-1693.
    >> Share

  1238. KONCZ R, Wen W, Makkar SR, Lam BCP, et al
    The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults.
    J Alzheimers Dis. 2022;86:1617-1628.
    >> Share

  1239. RAHMANI F, Wang Q, McKay NS, Keefe S, et al
    Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.
    J Alzheimers Dis. 2022;86:1831-1848.
    >> Share

  1240. ASHFORD JW, Schmitt FA, Bergeron MF, Bayley PJ, et al
    Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement.
    J Alzheimers Dis. 2022;87:305-315.
    >> Share

  1241. MORTON H, Basu T, Bose C, Reddy PH, et al
    Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study.
    J Alzheimers Dis. 2022;87:33-49.
    >> Share

  1242. CLEMENT A, Madsen MJ, Kastaniegaard K, Wiborg O, et al
    Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates.
    J Alzheimers Dis. 2022;87:259-272.
    >> Share

  1243. SOO SA, Zailan FZ, Tan JY, Sandhu GK, et al
    Safety and Usefulness of Lumbar Puncture for the Diagnosis and Management of Young-Onset Cognitive Disorders.
    J Alzheimers Dis. 2022;87:479-488.
    >> Share

  1244. NING J, Huang SY, Chen SD, Zhang YR, et al
    Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022;87:211-222.
    >> Share

  1245. KUCIKIENE D, Costa AS, Banning LCP, van Gils V, et al
    The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study.
    J Alzheimers Dis. 2022;87:185-195.
    >> Share

  1246. DHARMARAJ GL, Arigo FD, Young KA, Martins R, et al
    Novel Amylin Analogues Reduce Amyloid-beta Cross-Seeding Aggregation and Neurotoxicity.
    J Alzheimers Dis. 2022;87:373-390.
    >> Share

  1247. MARINO GAMMAZZA A, Restivo V, Baschi R, Caruso Bavisotto C, et al
    Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2022;87:161-172.
    >> Share

  1248. HOSSEINI AA, Brown T, Mannino L, Gran B, et al
    Clinical Utility of Cerebrospinal Fluid Abeta42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.
    J Alzheimers Dis. 2022;87:771-780.
    >> Share

  1249. ZHANG R, Jiang L, Li G, Wu J, et al
    Advanced Glycosylation End Products Induced Synaptic Deficits and Cognitive Decline Through ROS-JNK-p53/miR-34c/SYT1 Axis in Diabetic Encephalopathy.
    J Alzheimers Dis. 2022;87:843-861.
    >> Share

  1250. GIRTLER N, Chincarini A, Brugnolo A, Doglione E, et al
    The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort.
    J Alzheimers Dis. 2022;87:887-899.
    >> Share

  1251. LIU X, Yan J, Liu F, Zhou P, et al
    Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice.
    J Alzheimers Dis. 2022;87:873-886.
    >> Share

  1252. SOLOMON V, Hafez M, Xian H, Harrington MG, et al
    An Association Between Saturated Fatty Acid-Containing Phosphatidylcholine in Cerebrospinal Fluid with Tau Phosphorylation.
    J Alzheimers Dis. 2022;87:609-617.
    >> Share

  1253. MARTINEZ-HERRERA M, Figueroa-Gerstenmaier S, Lopez-Camacho PY, Millan-Pacheco C, et al
    Multiadducts of C60 Modulate Amyloid-beta Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies.
    J Alzheimers Dis. 2022;87:741-759.
    >> Share

  1254. GRANGEON L, Paquet C, Guey S, Zarea A, et al
    Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Abeta42, and Abeta40 in Probable Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;87:791-802.
    >> Share

  1255. SIVASARAVANAPARAN M, Olesen LO, Severino M, von Linstow CU, et al
    Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2022;87:685-699.
    >> Share

  1256. GE X, Qiao Y, Choi J, Raman R, et al
    Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms.
    J Alzheimers Dis. 2022;87:557-568.
    >> Share

  1257. ICHIMATA S, Yoshida K, Visanji NP, Lang AE, et al
    Patterns of Mixed Pathologies in Down Syndrome.
    J Alzheimers Dis. 2022;87:595-607.
    >> Share

  1258. WHITEHOUSE PJ, Saini V
    Making the Case for the Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:999-1001.
    >> Share

  1259. SCHWERTNER E, Pereira JB, Xu H, Secnik J, et al
    Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.
    J Alzheimers Dis. 2022;87:1307-1318.
    >> Share

  1260. HAN SH, Noh DH, Jo EJ, Kam KY, et al
    Effects of Apolipoprotein E varepsilon4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    J Alzheimers Dis. 2022;87:1181-1188.
    >> Share

  1261. RIPPON B, Palta P, Tahmi M, Sherwood G, et al
    Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    J Alzheimers Dis. 2022;87:1229-1238.
    >> Share

  1262. SHIMOSAKA M, Nishimoto H, Kinoshita A
    Analysis of the Clock-Reading Ability in Patients with Cognitive Impairment: Comparison of Analog Clocks and Digital Clocks.
    J Alzheimers Dis. 2022;87:1151-1165.
    >> Share

  1263. SHENG C, Yang K, He B, Li T, et al
    Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
    J Alzheimers Dis. 2022;87:1319-1333.
    >> Share

  1264. JEONG S, Huang LK, Tsai MJ, Liao YT, et al
    Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.
    J Alzheimers Dis. 2022;87:1115-1130.
    >> Share

  1265. WHITEHOUSE P, Gandy S, Saini V, George DR, et al
    Making the Case for Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:1003-1007.
    >> Share

  1266. SARTO J, Maya G, Molina-Porcel L, Balasa M, et al
    Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer's Disease Over a 25-Year Period in an Academic Brain Bank.
    J Alzheimers Dis. 2022;87:1659-1669.
    >> Share

  1267. MCCARTER SJ, Lesnick TG, Lowe VJ, Rabinstein AA, et al
    Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
    J Alzheimers Dis. 2022;87:1537-1547.
    >> Share

  1268. SHAW BC, Snider HC, Turner AK, Zajac DJ, et al
    An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain.
    J Alzheimers Dis. 2022;87:1647-1657.
    >> Share

  1269. ZHAO X, Du W, Jiang J, Han Y, et al
    Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study.
    J Alzheimers Dis. 2022;87:1581-1589.
    >> Share

  1270. CASTILLO-PASSI RI, Vergara RC, Rogers NK, Ponce DP, et al
    Cancer History Is Associated with Slower Speed of Cognitive Decline in Patients with Amnestic Cognitive Impairment.
    J Alzheimers Dis. 2022;87:1695-1711.
    >> Share

  1271. MCGRATH ER, Beiser AS, O'Donnell A, Yang Q, et al
    Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    J Alzheimers Dis. 2022;87:1517-1526.
    >> Share

  1272. BOMMARITO G, Garibotto V, Frisoni GB, Ribaldi F, et al
    The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging.
    J Alzheimers Dis. 2022;87:1483-1490.
    >> Share

  1273. LIBON DJ, Swenson R, Lamar M, Price CC, et al
    The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions.
    J Alzheimers Dis. 2022;87:1419-1432.
    >> Share

  1274. YEUNG MK, Lee TL, Chan AS
    Prefrontal Activation During Effortful Processing Differentiates Memory Abilities in Adults with Memory Complaints.
    J Alzheimers Dis. 2022;88:301-310.
    >> Share

  1275. ZHANG K, Ma X, Zhang R, Liu Z, et al
    Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population.
    J Alzheimers Dis. 2022;88:357-373.
    >> Share

  1276. RODDICK KM, Fertan E, Schellinck HM, Brown RE, et al
    A Signal Detection Analysis of Olfactory Learning in 12-Month-Old 5xFAD Mice.
    J Alzheimers Dis. 2022;88:37-44.
    >> Share

  1277. BLUJUS JK, Korthauer LE, Awe E, Frahmand M, et al
    BDNF and KIBRA Polymorphisms Are Related to Altered Resting State Network Connectivity in Middle Age.
    J Alzheimers Dis. 2022;88:323-334.
    >> Share

  1278. AGGER MP, Carstensen MS, Henney MA, Hansen LS, et al
    Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light.
    J Alzheimers Dis. 2022;88:335-344.
    >> Share

  1279. DROUIN SM, McFall GP, Potvin O, Bellec P, et al
    Data-Driven Analyses of Longitudinal Hippocampal Imaging Trajectories: Discrimination and Biomarker Prediction of Change Classes.
    J Alzheimers Dis. 2022;88:97-115.
    >> Share

  1280. HARPER JD, Fan KH, Aslam MM, Snitz BE, et al
    Genome-Wide Association Study of Incident Dementia in a Community-Based Sample of Older Subjects.
    J Alzheimers Dis. 2022;88:787-798.
    >> Share

  1281. HAEHNER A, Chen B, Espin M, Haussmann R, et al
    Training with Odors Impacts Hippocampal Thickness in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:743-755.
    >> Share

  1282. GARCIA-ROLDAN E, Arriola-Infante JE, Mendez-Barrio C, Montiel-Herrera F, et al
    Testing Visual Binding by the TMA-93 in People Aged 75 and Over.
    J Alzheimers Dis. 2022;88:503-512.
    >> Share

  1283. WANIGATUNGA AA, Liu F, Wang H, Urbanek JK, et al
    Daily Physical Activity Patterns as a Window on Cognitive Diagnosis in the Baltimore Longitudinal Study of Aging (BLSA).
    J Alzheimers Dis. 2022;88:459-469.
    >> Share

  1284. AGUILAR-CALVO P, Sevillano AM, Rasool S, Cao KJ, et al
    Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.
    J Alzheimers Dis. 2022;88:1137-1145.
    >> Share

  1285. NOVOTNY JS, Gonzalez-Rivas JP, Vassilaki M, Krell-Roesch J, et al
    Natural Pattern of Cognitive Aging.
    J Alzheimers Dis. 2022;88:1147-1155.
    >> Share

  1286. LORETO F, Fitzgerald A, Golemme M, Gunning S, et al
    Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.
    J Alzheimers Dis. 2022;88:1179-1187.
    >> Share

  1287. MABROUK R, Gotkiewicz M, Rauramaa T, Tanila H, et al
    DAPI (4',6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques.
    J Alzheimers Dis. 2022;88:949-955.
    >> Share

  1288. STOILJKOVIC M, Gutierrez KO, Kelley C, Horvath TL, et al
    TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-beta-Related Hippocampal Pathophysiology in Mice.
    J Alzheimers Dis. 2022;88:837-847.
    >> Share

  1289. BOUJELBANE MA, Trabelsi K, Boukhris O, Kacem FH, et al
    The Use of Digital Technology to Assess Cognitive Function in Tunisian Adults.
    J Alzheimers Dis. 2022;88:1545-1552.
    >> Share

  1290. ZHU MH, Jogdand AH, Jang J, Nagella SC, et al
    Evoked Cortical Depolarizations Before and After the Amyloid Plaque Accumulation: Voltage Imaging Study.
    J Alzheimers Dis. 2022;88:1443-1458.
    >> Share

  1291. ZHANG X, Cong R, Geng T, Zhang J, et al
    Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022;88:1435-1441.
    >> Share

  1292. TSUJIMOTO M, Suzuki K, Saji N, Sakurai T, et al
    Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1423-1433.
    >> Share

  1293. POLCHER A, Wolfsgruber S, Peters O, Frolich L, et al
    A Comparison of Operational Definitions for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1663-1678.
    >> Share

  1294. HE XY, Dobkin C, Brown WT, Yang SY, et al
    3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17beta-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    J Alzheimers Dis. 2022;88:1487-1497.
    >> Share

  1295. RUBIN-NOROWITZ M, Lipton RB, Petersen K, Ezzati A, et al
    Association of Depressive Symptoms and Cognition in Older Adults Without Dementia Across Different Biomarker Profiles.
    J Alzheimers Dis. 2022;88:1385-1395.
    >> Share

  1296. GOLDBERG SM, Zhao Y, Cheng Y, Weinstein AM, et al
    Clinical Progression of Baseline Risk States for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1377-1384.
    >> Share

  1297. VYHNALEK M, Jester DJ, Andel R, Horakova H, et al
    Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2022;88:1397-1409.
    >> Share

  1298. SAITO S, Yamashiro T, Yamauchi M, Yamamoto Y, et al
    Complement 3 Is a Potential Biomarker for Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:381-387.
    >> Share

  1299. ZHANG DD, Ou YN, Fu Y, Wang ZB, et al
    Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.
    J Alzheimers Dis. 2022;89:367-380.
    >> Share

  1300. WANG S, Gustafson S, Deckelman C, Sampene E, et al
    Dysphagia Profiles Among Inpatients with Dementia Referred for Swallow Evaluation.
    J Alzheimers Dis. 2022;89:351-358.
    >> Share

  1301. ZHANG Y, Yang Y, Hu Z, Zhu M, et al
    Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats.
    J Alzheimers Dis. 2022;89:335-350.
    >> Share

  1302. HUFFELS CFM, van Dijk RE, Karst H, Meye FJ, et al
    Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1.
    J Alzheimers Dis. 2022;89:283-297.
    >> Share

  1303. HEAL M, McFall GP, Vergote D, Jhamandas JH, et al
    Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories.
    J Alzheimers Dis. 2022;89:265-281.
    >> Share

  1304. KAMATH V, Senjem ML, Spychalla AJ, Chen H, et al
    The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;89:233-245.
    >> Share

  1305. CERAMI C, Perdixi E, Meli C, Marcone A, et al
    Early Identification of Different Behavioral Phenotypes in the Behavioral Variant of Frontotemporal Dementia with the Aid of the Mini-Frontal Behavioral Inventory (mini-FBI).
    J Alzheimers Dis. 2022;89:299-308.
    >> Share

  1306. MIOTTO EC, Brucki SMD, Cerqueira CT, Bazan PR, et al
    Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology.
    J Alzheimers Dis. 2022;89:181-192.
    >> Share

  1307. FAN Y, Liu W, Chen S, Li M, et al
    Association Between High Serum Tetrahydrofolate and Low Cognitive Functions in the United States: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;89:163-179.
    >> Share

  1308. SANDHU GK, Zailan FZ, Vipin A, Ann SS, et al
    Correlation Between Plasma Oligomeric Amyloid-beta and Performance on the Language Neutral Visual Cognitive Assessment Test in a Southeast Asian Population.
    J Alzheimers Dis. 2022;89:25-29.
    >> Share

  1309. ZHOU K, Wu P
    Osteoarthritis and APOE4 Interact to Influence Memory Decline in Non-Demented Older People.
    J Alzheimers Dis. 2022;89:79-86.
    >> Share

  1310. LI C, Li Y, Wu J, Wu M, et al
    Triple Network Model-Based Analysis on Abnormal Core Brain Functional Network Dynamics in Different Stage of Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;89:519-533.
    >> Share

  1311. WEIGAND AJ, Macomber AJ, Walker KS, Edwards L, et al
    Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition.
    J Alzheimers Dis. 2022;89:633-640.
    >> Share

  1312. CAO QL, Sun Y, Hu H, Wang ZT, et al
    Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study.
    J Alzheimers Dis. 2022;89:583-592.
    >> Share

  1313. RUSSO M, Santilli M, De Rosa MA, Calisi D, et al
    A Young Man with Cognitive Impairment and a Heart Condition.
    J Alzheimers Dis. 2022;89:405-410.
    >> Share

  1314. LIU S, Liu C, Hu W, Ji Y, et al
    Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;89:923-929.
    >> Share

  1315. DARTORA CM, de Moura LV, Koole M, Marques da Silva AM, et al
    Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features.
    J Alzheimers Dis. 2022;89:977-991.
    >> Share

  1316. ZHANG S, Wei D, Lv S, Wang L, et al
    Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:955-975.
    >> Share

  1317. KANG DW, Wang SM, Um YH, Kim NY, et al
    Associations Between Sub-Threshold Amyloid-beta Deposition, Cortical Volume, and Cognitive Function Modulated by APOE varepsilon4 Carrier Status in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2022;89:1003-1016.
    >> Share

  1318. VASSILAKI M, Crowson CS, Davis Iii JM, Duong SQ, et al
    Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2022;89:943-954.
    >> Share

  1319. DIAZ A, Martin-Jimenez C, Woo Y, Merino P, et al
    Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    J Alzheimers Dis. 2022;89:877-891.
    >> Share

  1320. WATTS A, Chalise P, Hu J, Hui D, et al
    A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.
    J Alzheimers Dis. 2022;89:913-922.
    >> Share

  1321. PICCARDUCCI R, Caselli MC, Zappelli E, Ulivi L, et al
    The Role of Amyloid-beta, Tau, and alpha-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:1039-1049.
    >> Share

  1322. MATSUZAKI TADA A, Hamezah HS, Pahrudin Arrozi A, Abu Bakar ZH, et al
    Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:835-848.
    >> Share

  1323. JUAREZ-CEDILLO T, Gonzelez-Figueroa E, Gutierez-Gutierez L, Aguilar-Navarro SG, et al
    Prevalence of Dementia and Main Subtypes in Mexico: The Study on Aging and Dementia in Mexico (SADEM).
    J Alzheimers Dis. 2022;89:931-941.
    >> Share

  1324. SANCHEZ-DE-LARA-SANCHEZ S, Sanchez-Perez AM
    Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review.
    J Alzheimers Dis. 2022;89:1173-1191.
    >> Share

  1325. MORROW CB, Chaney GS, Capuzzi D, Bakker A, et al
    Hyperorality in Frontotemporal Dementia: Cognitive and Psychiatric Symptom Profiles in Early-Stage Disease.
    J Alzheimers Dis. 2022;89:1203-1209.
    >> Share

  1326. NYHOLM E, Torkpoor R, Frolich K, Londos E, et al
    A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born?
    J Alzheimers Dis. 2022;89:1403-1412.
    >> Share

  1327. ZAWAR I, Mattos MK, Manning C, Quigg M, et al
    Sleep Disturbances, Cognitive Status, and Biomarkers of Dementia.
    J Alzheimers Dis. 2022;89:1367-1374.
    >> Share

  1328. WEIBLE AP, Wehr M
    Amyloid Pathology in the Central Auditory Pathway of 5XFAD Mice Appears First in Auditory Cortex.
    J Alzheimers Dis. 2022;89:1385-1402.
    >> Share

  1329. MICHOPOULOU S, Prosser A, Kipps C, Dickson J, et al
    Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-beta in a Heterogenous Clinical Cohort.
    J Alzheimers Dis. 2022;89:1303-1314.
    >> Share

  1330. GENTREAU M, Reynes C, Sabatier R, Maller JJ, et al
    Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia.
    J Alzheimers Dis. 2022;89:1293-1302.
    >> Share

  1331. KANAGASINGAM S, von Ruhland C, Welbury R, Singhrao SK, et al
    Antimicrobial, Polarizing Light, and Paired Helical Filament Properties of Fragmented Tau Peptides of Selected Putative Gingipains.
    J Alzheimers Dis. 2022;89:1279-1291.
    >> Share

  1332. BERDYNSKI M, Ludwiczak J, Barczak A, Barcikowska-Kotowicz M, et al
    TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
    J Alzheimers Dis. 2022;89:1211-1219.
    >> Share

  1333. MIAO Y, Cui L, Li J, Chen Y, et al
    Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE varepsilon4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.
    J Alzheimers Dis. 2022;89:1131-1142.
    >> Share

  1334. LACHNER C, Day GS, Camsari GB, Kouri N, et al
    Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.
    J Alzheimers Dis. 2022;90:405-417.
    >> Share

  1335. MATTIOLI P, Pardini M, Girtler N, Brugnolo A, et al
    Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy.
    J Alzheimers Dis. 2022;90:433-444.
    >> Share

  1336. LOEWENSTEIN DA, Curiel Cid RE, Kitaigorodsky M, Ortega A, et al
    Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults.
    J Alzheimers Dis. 2022;90:313-322.
    >> Share

  1337. THOMAS KR, Bangen KJ, Weigand AJ, Ortiz G, et al
    Cognitive Heterogeneity and Risk of Progression in Data-Driven Subtle Cognitive Decline Phenotypes.
    J Alzheimers Dis. 2022;90:323-331.
    >> Share

  1338. FU J, Zhu Y, Sun Y, Liu Q, et al
    Circulating Amyloid-beta and Methionine-Related Metabolites to Predict the Risk of Mild Cognitive Impairment: A Nested Case-Control Study.
    J Alzheimers Dis. 2022;90:389-404.
    >> Share

  1339. VAN HARTEN TW, Heijmans A, van Rooden S, Wermer MJH, et al
    Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;90:381-388.
    >> Share

  1340. BOLSEWIG K, Hok-A-Hin YS, Sepe FN, Boonkamp L, et al
    A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    J Alzheimers Dis. 2022;90:363-380.
    >> Share

  1341. WEI S, Dang L, Gao F, Wang J, et al
    Effects of Simvastatin on Plasma Amyloid-beta Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
    J Alzheimers Dis. 2022;90:349-362.
    >> Share

  1342. PENG Y, Zhang L, Zhou F, Wang Y, et al
    Scavenging Reactive Oxygen Species Decreases Amyloid-beta Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.
    J Alzheimers Dis. 2022;90:185-198.
    >> Share

  1343. VALLES-SALGADO M, Cabrera-Martin MN, Curiel-Cid RE, Delgado-Alvarez A, et al
    Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L.
    J Alzheimers Dis. 2022;90:823-840.
    >> Share

  1344. SHEPHERD-BANIGAN ME, Ford CB, Smith VA, Belanger E, et al
    Amyloid-beta PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.
    J Alzheimers Dis. 2022;90:775-782.
    >> Share

  1345. RABI R, Chow R, Paracha S, Hasher L, et al
    Time of Day Effects on Inhibitory Functioning: Cognitive and Neural Evidence of Sundowning in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;90:869-890.
    >> Share

  1346. BLIVET G, Relano-Gines A, Wachtel M, Touchon J, et al
    A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance.
    J Alzheimers Dis. 2022;90:811-822.
    >> Share

  1347. AERQIN Q, Jia SS, Shen XN, Li Q, et al
    Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;90:761-773.
    >> Share

  1348. YANG YH, Hsieh SW, Chang HW, Sung JL, et al
    Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-beta and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro.
    J Alzheimers Dis. 2022;90:917-928.
    >> Share

  1349. O'BRYANT SE, Petersen M, Hall J, Johnson LA, et al
    Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.
    J Alzheimers Dis. 2022;90:905-915.
    >> Share

  1350. ROVCANIN DRAGOVIC I, Popovic N, Zdralevic M, Radulovic L, et al
    Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro.
    J Alzheimers Dis. 2022;90:625-638.
    >> Share

  1351. WANG Z, Wang J, Liu N, Liu C, et al
    Learning Cognitive-Test-Based Interpretable Rules for Prediction and Early Diagnosis of Dementia Using Neural Networks.
    J Alzheimers Dis. 2022;90:609-624.
    >> Share

  1352. VIPIN A, Koh CL, Wong BYX, Zailan FZ, et al
    Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia.
    J Alzheimers Dis. 2022;90:543-551.
    >> Share

  1353. SONG Y, Quan M, Li T, Jia J, et al
    Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia.
    J Alzheimers Dis. 2022;90:681-691.
    >> Share

  1354. JOSHI MS, Galvin JE
    Cognitive Resilience in Brain Health and Dementia Research.
    J Alzheimers Dis. 2022;90:461-473.
    >> Share

  1355. WALTER S, Taylor A, Tyrone J, Langer S, et al
    Disclosing Individual Results in Dementia Research: A Proposed Study Participant's Bill of Rights.
    J Alzheimers Dis. 2022;90:945-952.
    >> Share

  1356. SHEN J, Li M, Long C, Yang L, et al
    Altered Odor-Evoked Electrophysiological Responses in the Anterior Piriform Cortex of Conscious APP/PS1 Mice.
    J Alzheimers Dis. 2022;90:1277-1289.
    >> Share

  1357. GAN J, Chen Z, Shi Z, Li X, et al
    Temporal Variation in Disease Onset and Clinical Features of Lewy Body Disease in China.
    J Alzheimers Dis. 2022;90:1263-1275.
    >> Share

  1358. HARRISON KL, Garrett SB, Halim M, Bernstein Sideman A, et al
    "I Didn't Sign Up for This": Perspectives from Persons Living with Dementia and Care Partners on Challenges, Supports, and Opportunities to Add Geriatric Neuropalliative Care to Dementia Specialty Care.
    J Alzheimers Dis. 2022;90:1301-1320.
    >> Share

  1359. SHI X, Zhou N, Sun B, Wu Y, et al
    Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
    J Alzheimers Dis. 2022;90:1329-1337.
    >> Share

  1360. WU S, Hu L, Lin J, Li K, et al
    Excretion of Amyloid-beta in the Gastrointestinal Tract and Regulation by the Gut Microbiota.
    J Alzheimers Dis. 2022;90:1153-1162.
    >> Share

  1361. ROSEN AC, Arias JJ, Ashford JW, Blacker D, et al
    The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All.
    J Alzheimers Dis. 2022;90:953-962.
    >> Share

  1362. WALTER S, Kim AB, Flores M, Ziolkowski J, et al
    Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?
    J Alzheimers Dis. 2022;90:1001-1009.
    >> Share

  1363. LERNER AJ
    Biomarkers and Mindfulness: A Way Forward.
    J Alzheimers Dis. 2022;90:993-996.
    >> Share

  1364. DALY T, Mastroleo I, Migliaccio R
    Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention.
    J Alzheimers Dis. 2022;90:989-992.
    >> Share

  1365. REN S, Hu J, Huang L, Li J, et al
    Graph Analysis of Functional Brain Topology Using Minimum Spanning Tree in Subjective Cognitive Decline.
    J Alzheimers Dis. 2022;90:1749-1759.
    >> Share

  1366. LIBARD S, Giedraitis V, Kilander L, Ingelsson M, et al
    Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation.
    J Alzheimers Dis. 2022;90:1601-1614.
    >> Share

    December 2021
  1367. DAY S, Roberts S, Launder NH, Goh AMY, et al
    Age of Symptom Onset and Longitudinal Course of Sporadic Alzheimer's Disease, Frontotemporal Dementia, and Vascular Dementia: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215360. doi: 10.3233/JAD-215360.
    >> Share

  1368. WANG J, Wang P, Jiang Y, Wang Z, et al
    Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215239. doi: 10.3233/JAD-215239.
    >> Share

  1369. GIANNAKOPOULOS P, Rodriguez C, Montandon ML, Garibotto V, et al
    Personality Impact on Alzheimer's Disease-Signature and Vascular Imaging Markers: A PET-MRI Study.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215062. doi: 10.3233/JAD-215062.
    >> Share

  1370. BLACK SAG, Stepanchuk AA, Templeton GW, Hernandez Y, et al
    Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215402. doi: 10.3233/JAD-215402.
    >> Share

  1371. LIU Q, Ling Z, Zhang J, Yu H, et al
    lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer's Disease Through NEDD4L Mediated PINK1 Degradation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215194. doi: 10.3233/JAD-215194.
    >> Share

  1372. BROBERG D, Wong D, Bellyou M, Montero-Odasso M, et al
    Effects of Memantine and High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following Vitamin D Deprivation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215188. doi: 10.3233/JAD-215188.
    >> Share

  1373. JANG H, Park YH, Choe YS, Kang SH, et al
    Amyloid Positive Hydrocephalus: A Hydrocephalic Variant of Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215110. doi: 10.3233/JAD-215110.
    >> Share

  1374. DUNK MM, Driscoll I
    Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215091. doi: 10.3233/JAD-215091.
    >> Share

  1375. AHN H, Yi D, Chu K, Joung H, et al
    Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215292. doi: 10.3233/JAD-215292.
    >> Share

  1376. DHAYNAUT M, Sprugnoli G, Cappon D, Macone J, et al
    Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215072. doi: 10.3233/JAD-215072.
    >> Share

  1377. DONG L, Mao C, Liu C, Li J, et al
    Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215067. doi: 10.3233/JAD-215067.
    >> Share

  1378. ZHAO Y, Bao J, Liu W, Gong X, et al
    Spatial Training Attenuates Long-Term Alzheimer's Disease-Related Pathogenic Processes in APP/PS1 Mice.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215016. doi: 10.3233/JAD-215016.
    >> Share

  1379. MASSETTI N, Russo M, Franciotti R, Nardini D, et al
    A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD210573. doi: 10.3233/JAD-210573.
    >> Share

  1380. GOLDSMITH HS
    Alzheimer's Disease: A Decreased Cerebral Blood Flow to Critical Intraneuronal Elements is the Cause.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215479. doi: 10.3233/JAD-215479.
    >> Share

  1381. ZHANG H, Lyu D, Jia J
    The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215456. doi: 10.3233/JAD-215456.
    >> Share

  1382. SUO WZ
    GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215379. doi: 10.3233/JAD-215379.
    >> Share

  1383. SCHAEFER SY, Malek-Ahmadi M, Hooyman A, King JB, et al
    Association Between Motor Task Performance and Hippocampal Atrophy Across Cognitively Unimpaired, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease Individuals.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD210665. doi: 10.3233/JAD-210665.
    >> Share

  1384. YUEN SC, Lee SM, Leung SW
    Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215349. doi: 10.3233/JAD-215349.
    >> Share

  1385. KWAK S, Oh DJ, Jeon YJ, Oh DY, et al
    Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215244. doi: 10.3233/JAD-215244.
    >> Share

  1386. TROPEA MR, Sanfilippo G, Giannino F, Davi V, et al
    Innate Preferences Affect Results of Object Recognition Task in Wild Type and Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215209. doi: 10.3233/JAD-215209.
    >> Share

  1387. RAMOS C, Villalba C, Garcia J, Lanata S, et al
    Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215169. doi: 10.3233/JAD-215169.
    >> Share

  1388. YANG L, Xuan C, Yu C, Zheng P, et al
    Diagnostic Model of Alzheimer's Disease in the Elderly Based on Protein and Metabolic Biomarkers.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215119. doi: 10.3233/JAD-215119.
    >> Share

  1389. SUN HL, Zhou FY, Chen DW, Tan CR, et al
    The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD210692. doi: 10.3233/JAD-210692.
    >> Share

  1390. SALAMI A, Adolfsson R, Andersson M, Blennow K, et al
    Association of APOE varepsilon4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210673. doi: 10.3233/JAD-210673.
    >> Share

  1391. VON LINSTOW CU, Waider J, Bergh MS, Anzalone M, et al
    The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210581. doi: 10.3233/JAD-210581.
    >> Share

  1392. FAN F, Liu H, Shi X, Ai Y, et al
    The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215423. doi: 10.3233/JAD-215423.
    >> Share

  1393. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215316. doi: 10.3233/JAD-215316.
    >> Share

  1394. TEIPEL SJ, Dyrba M, Ballarini T, Brosseron F, et al
    Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215196. doi: 10.3233/JAD-215196.
    >> Share

  1395. SMITH CA, Smith H, Roberts L, Coward L, et al
    Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer's Disease Produces Sex-Specific Effects on Cognitive Function.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD210464. doi: 10.3233/JAD-210464.
    >> Share

  1396. SUN X, Zhang H, Yao D, Xu Y, et al
    Integrated Bioinformatics Analysis Identifies Hub Genes Associated with Viral Infection and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215232. doi: 10.3233/JAD-215232.
    >> Share

  1397. WEN C, Bi YL, Hu H, Huang SY, et al
    Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215178. doi: 10.3233/JAD-215178.
    >> Share

  1398. SCHUBERT CR, Paulsen AJ, Pinto AA, Merten N, et al
    Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215096. doi: 10.3233/JAD-215096.
    >> Share

  1399. LI W, Zhao Z, Liu M, Yan S, et al
    Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    J Alzheimers Dis. 2021 Dec 10. pii: JAD215338. doi: 10.3233/JAD-215338.
    >> Share

  1400. TALAN J
    Reactive Astrocytes and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215436. doi: 10.3233/JAD-215436.
    >> Share

  1401. YOO TJ
    Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215270. doi: 10.3233/JAD-215270.
    >> Share

  1402. CUTULI D, Landolfo E, Petrosini L, Gelfo F, et al
    Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215193. doi: 10.3233/JAD-215193.
    >> Share

  1403. KOUKI MA, Pritchard AB, Alder JE, Crean S, et al
    Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215103. doi: 10.3233/JAD-215103.
    >> Share

  1404. BRITZ J, Ojo E, Dhukhwa A, Saito T, et al
    Assessing Sex-Specific Circadian, Metabolic, and Cognitive Phenotypes in the AbetaPP/PS1 and APPNL - F/NL - F Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210629. doi: 10.3233/JAD-210629.
    >> Share

  1405. SACCHI L, Carandini T, Fumagalli GG, Pietroboni AM, et al
    Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210593. doi: 10.3233/JAD-210593.
    >> Share

  1406. KOTHAPALLI SVVN, Benzinger TL, Aschenbrenner AJ, Perrin RJ, et al
    Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210503. doi: 10.3233/JAD-210503.
    >> Share

  1407. SAKR F, Dyrba M, Brauer AU, Teipel S, et al
    Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD201504. doi: 10.3233/JAD-201504.
    >> Share

  1408. SENEJANI AG, Maghsoudlou J, El-Zohiry D, Gaur G, et al
    Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.
    J Alzheimers Dis. 2021 Dec 5. pii: JAD215398. doi: 10.3233/JAD-215398.
    >> Share

  1409. KURODA T, Honma M, Mori Y, Futamura A, et al
    White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215187. doi: 10.3233/JAD-215187.
    >> Share

  1410. LIU XX, Wu PF, Liu YZ, Jiang YL, et al
    Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Populatio.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215104. doi: 10.3233/JAD-215104.
    >> Share

    November 2021
  1411. METSLA K, Kirss S, Laks K, Sildnik G, et al
    alpha-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 30. pii: JAD215026. doi: 10.3233/JAD-215026.
    >> Share

  1412. CHEN L, Shen Q, Xu S, Yu H, et al
    5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215217. doi: 10.3233/JAD-215217.
    >> Share

  1413. CRESTINI A, Santilli F, Martellucci S, Carbone E, et al
    Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215171. doi: 10.3233/JAD-215171.
    >> Share

  1414. SAPKOTA S, McFall GP, Masellis M, Dixon RA, et al
    Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215068. doi: 10.3233/JAD-215068.
    >> Share

  1415. HAOUDY S, Jonveaux T, Puisieux S, Epstein J, et al
    Epilepsy in Early Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210681. doi: 10.3233/JAD-210681.
    >> Share

  1416. NESHAN M, Malakouti SK, Kamalzadeh L, Makvand M, et al
    Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210480. doi: 10.3233/JAD-210480.
    >> Share

  1417. GE F, Dong L, Zhu D, Lin X, et al
    Comparison of Serum Triiodothyronine with Biomarkers for Alzheimer's Disease Continuum in Euthyroid Subjects.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215092. doi: 10.3233/JAD-215092.
    >> Share

  1418. ALTOMARI N, Bruno F, Lagana V, Smirne N, et al
    A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215061. doi: 10.3233/JAD-215061.
    >> Share

  1419. WANG L, Chen H, Tang J, Guo Z, et al
    Peptidylarginine Deiminase and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215302. doi: 10.3233/JAD-215302.
    >> Share

  1420. LARNER AJ, Marson AG
    Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215154. doi: 10.3233/JAD-215154.
    >> Share

  1421. BROD SA
    Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215125. doi: 10.3233/JAD-215125.
    >> Share

  1422. SUN X, Suo X, Xia X, Yu C, et al
    Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215074. doi: 10.3233/JAD-215074.
    >> Share

  1423. LYNN J, Park M, Ogunwale C, Acquaah-Mensah GK, et al
    A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD210612. doi: 10.3233/JAD-210612.
    >> Share

  1424. QIAO Y, Sun Y, Guo J, Chen Y, et al
    Disrupted White Matter Integrity and Cognitive Functions in Amyloid-beta Positive Alzheimer's Disease with Concomitant Lobar Cerebral Microbleeds.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD215251. doi: 10.3233/JAD-215251.
    >> Share

  1425. BERGAMINO M, Keeling EG, Baxter LC, Sisco NJ, et al
    Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD210406. doi: 10.3233/JAD-210406.
    >> Share

  1426. REALE M, Carrarini C, Russo M, Dono F, et al
    Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD215285. doi: 10.3233/JAD-215285.
    >> Share

  1427. BARTHELEMY NR, Toth B, Manser PT, Sanabria-Bohorquez S, et al
    Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210677. doi: 10.3233/JAD-210677.
    >> Share

  1428. HOY KE, Emonson MRL, Bailey NW, Humble G, et al
    Investigating Neurophysiological Markers of Symptom Severity in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210401. doi: 10.3233/JAD-210401.
    >> Share

  1429. NOGUCHI-SHINOHARA M, Yuki-Nozaki S, Abe C, Mori A, et al
    Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD Study.
    J Alzheimers Dis. 2021 Nov 15. pii: JAD215153. doi: 10.3233/JAD-215153.
    >> Share

  1430. CHUM PP, Hakim MA, Behringer EJ
    Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    J Alzheimers Dis. 2021 Nov 12. pii: JAD215223. doi: 10.3233/JAD-215223.
    >> Share

  1431. KUMARI S, Singh A, Singh AK, Yadav Y, et al
    Circulatory GSK-3beta: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215347. doi: 10.3233/JAD-215347.
    >> Share

  1432. MULLER EG, Edwin TH, Strand BH, Stokke C, et al
    Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215046. doi: 10.3233/JAD-215046.
    >> Share

  1433. NIHASHI T, Sakurai K, Kato T, Iwata K, et al
    Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215024. doi: 10.3233/JAD-215024.
    >> Share

  1434. TAN Y, Zhang J, Yang K, Xu Z, et al
    Anti-Stroke Chinese Herbal Medicines Inhibit Abnormal Amyloid-beta Protein Precursor Processing in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210652. doi: 10.3233/JAD-210652.
    >> Share

  1435. DIPROSPERO ND, Keator DB, Phelan M, van Erp TGM, et al
    Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210572. doi: 10.3233/JAD-210572.
    >> Share

  1436. FRANKLIN GL, Meira AT, Barbosa MT, Teive HAG, et al
    When My Child Has Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215234. doi: 10.3233/JAD-215234.
    >> Share

  1437. FATIMA SHAD K, Soubra W, Cordato DJ
    The Auditory Afferent Pathway as a Clinical Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215206. doi: 10.3233/JAD-215206.
    >> Share

  1438. CHEN KL, Li PX, Sun YM, Chen SF, et al
    Very Early-Onset Alzheimer's Disease in the Third Decade of Life with de novo PSEN1 Mutations.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215167. doi: 10.3233/JAD-215167.
    >> Share

  1439. WANG F, Xu J, Xu SJ, Guo JJ, et al
    Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215086. doi: 10.3233/JAD-215086.
    >> Share

  1440. PAVLIK VN, Burnham SC, Kass JS, Helmer C, et al
    Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD210525. doi: 10.3233/JAD-210525.
    >> Share

  1441. FU X, Liu Q, Sun X, Chang H, et al
    Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San.
    J Alzheimers Dis. 2021 Nov 7. pii: JAD210656. doi: 10.3233/JAD-210656.
    >> Share

    October 2021
  1442. MANDAL PK, Perry G
    SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD215354. doi: 10.3233/JAD-215354.
    >> Share

  1443. SAKURAI K, Iwase T, Kaneda D, Uchida Y, et al
    Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer's Disease and Argyrophilic Grain Disease.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210638. doi: 10.3233/JAD-210638.
    >> Share

  1444. MATTHIESEN ST, Rosenkjaer S, Ponten M, Jensen KB, et al
    Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210108. doi: 10.3233/JAD-210108.
    >> Share

  1445. BJORKLI C, Louet C, Flo TH, Hemler M, et al
    In Vivo Microdialysis in Mice Captures Changes in Alzheimer's Disease Cerebrospinal Fluid Biomarkers Consistent with Developing Pathology.
    J Alzheimers Dis. 2021 Oct 29. pii: JAD210715. doi: 10.3233/JAD-210715.
    >> Share

  1446. JEONG HJ, Lee YM, Park JM, Lee BD, et al
    Reduced Thickness of the Anterior Cingulate Cortex as a Predictor of Amnestic-Mild Cognitive Impairment Conversion to Alzheimer's Disease with Psychosis.
    J Alzheimers Dis. 2021 Oct 26. pii: JAD215005. doi: 10.3233/JAD-215005.
    >> Share

  1447. SCHULTZ B, Taday J, Menezes L, Cigerce A, et al
    Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215182. doi: 10.3233/JAD-215182.
    >> Share

  1448. TORRES AK, Jara C, Park-Kang HS, Polanco CM, et al
    Synaptic Mitochondria: An Early Target of Amyloid-beta and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215139. doi: 10.3233/JAD-215139.
    >> Share

  1449. RUSANEN M, Selander T, Karkkainen V, Koivisto A, et al
    The Positive Effects of Pet Ownership on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210557. doi: 10.3233/JAD-210557.
    >> Share

  1450. HIN N, Newman M, Pederson S, Lardelli M, et al
    Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210200. doi: 10.3233/JAD-210200.
    >> Share

  1451. SHOJAIE M, Tabarestani S, Cabrerizo M, DeKosky ST, et al
    PET Imaging of Tau Pathology and Amyloid-beta, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210064. doi: 10.3233/JAD-210064.
    >> Share

  1452. KARAMI V, Nittari G, Traini E, Amenta F, et al
    An Optimized Decision Tree with Genetic Algorithm Rule-Based Approach to Reveal the Brain's Changes During Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Oct 23. pii: JAD210626. doi: 10.3233/JAD-210626.
    >> Share

  1453. ZHANG Q, Schultz JL, Aldridge GM, Simmering JE, et al
    COVID-19 Case Fatality and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215161. doi: 10.3233/JAD-215161.
    >> Share

  1454. BRUUS AE, Waldemar G, Vogel A
    Impairment of Episodic-Specific Autobiographical Memory in Individuals with Subjective Cognitive Decline and in Patients with Prodromal or Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215113. doi: 10.3233/JAD-215113.
    >> Share

  1455. CLUTE-REINIG N, Jayadev S, Rhoads K, Ny AL, et al
    Alzheimer's Disease Diagnostics Must Be Globally Accessible.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD210663. doi: 10.3233/JAD-210663.
    >> Share

  1456. VRILLON A, Deramecourt V, Pasquier F, Magnin E, et al
    Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215226. doi: 10.3233/JAD-215226.
    >> Share

  1457. ISMAEL S, Mirzahosseini G, Ahmed HA, Yoo A, et al
    Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215051. doi: 10.3233/JAD-215051.
    >> Share

  1458. SWERDLOW NR, Kotz JE, Joshi YB, Talledo J, et al
    Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215029. doi: 10.3233/JAD-215029.
    >> Share

  1459. HAN F, Zhao J, Zhao G
    Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD210374. doi: 10.3233/JAD-210374.
    >> Share

  1460. HU D, Liu C, Xia K, Abramowitz A, et al
    Characterizing the Resilience Effect of Neurodegeneration for the Mechanistic Pathway of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD215160. doi: 10.3233/JAD-215160.
    >> Share

  1461. LIU H, Lutz M, Luo S
    Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD210700. doi: 10.3233/JAD-210700.
    >> Share

  1462. HOFMANN C, Sander A, Wang XX, Buerge M, et al
    Inhalational Anesthetics Do Not Deteriorate Amyloid-beta-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD201185. doi: 10.3233/JAD-201185.
    >> Share

  1463. KURKINEN M, Tran L
    Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215105. doi: 10.3233/JAD-215105.
    >> Share

  1464. ARANDELOVIC J, Santrac A, Batinic B, Todorovic L, et al
    Positive and Negative Selective Allosteric Modulators of alpha5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215079. doi: 10.3233/JAD-215079.
    >> Share

  1465. OH C
    Single-Task or Dual-Task? Gait Assessment as a Potential Diagnostic Tool for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210690. doi: 10.3233/JAD-210690.
    >> Share

  1466. SILHAN D, Pashkovska O, Bartos A
    Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210372. doi: 10.3233/JAD-210372.
    >> Share

  1467. SHUKLA D, Mandal PK, Mishra R, Punjabi K, et al
    Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215032. doi: 10.3233/JAD-215032.
    >> Share

  1468. WASHIDA K, Kitajima E, Tanaka T, Ikeda S, et al
    A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215006. doi: 10.3233/JAD-215006.
    >> Share

  1469. KIM H, Jun S, Kim BS, Kim IJ, et al
    Serum Adiponectin in Alzheimer's Disease (AD): Association with AD Biomarkers and Cognitive Outcome.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD210722. doi: 10.3233/JAD-210722.
    >> Share

  1470. PACHECO-HERRERO M, Soto-Rojas LO, Reyes-Sabater H, Garces-Ramirez L, et al
    Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD200863. doi: 10.3233/JAD-200863.
    >> Share

  1471. SHAFIEE N, Dadar M, Ducharme S, Collins DL, et al
    Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 1. pii: JAD210664. doi: 10.3233/JAD-210664.
    >> Share

    September 2021
  1472. PANDEY JP, Namboodiri AM, Nietert PJ, Barnes LL, et al
    Inhibitory Fcgamma Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215174. doi: 10.3233/JAD-215174.
    >> Share

  1473. ROBINSON AC, Davidson YS, Roncaroli F, Minshull J, et al
    Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer's Disease Pathology at Death.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215102. doi: 10.3233/JAD-215102.
    >> Share

  1474. LARGENT EA, Bhardwaj T, Abera M, Stites SD, et al
    Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
    J Alzheimers Dis. 2021 Sep 30. pii: JAD210675. doi: 10.3233/JAD-210675.
    >> Share

  1475. STANITSA E, Economou A, Beratis I, Kontaxopoulou D, et al
    Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210622. doi: 10.3233/JAD-210622.
    >> Share

  1476. SONG XJ, Zhou HY, Sun YY, Huang HC, et al
    Phosphorylation and Glycosylation of Amyloid-beta Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210337. doi: 10.3233/JAD-210337.
    >> Share

  1477. SONG J, Yang X, Zhang M, Wang C, et al
    Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210595. doi: 10.3233/JAD-210595.
    >> Share

  1478. HAO J, Qiao Y, Li T, Yang J, et al
    Investigating Changes in the Serum Inflammatory Factors in Alzheimer's Disease and Their Correlation with Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210552. doi: 10.3233/JAD-210552.
    >> Share

  1479. MATSUZONO K, Suzuki M, Miura K, Ozawa T, et al
    Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210490. doi: 10.3233/JAD-210490.
    >> Share

  1480. FUKUDA H, Ono R, Maeda M, Murata F, et al
    Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD201508. doi: 10.3233/JAD-201508.
    >> Share

  1481. LENNON MJ, Rigney G, Raymont V, Sachdev P, et al
    Genetic Therapies for Alzheimer's Disease: A Scoping Review.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD215145. doi: 10.3233/JAD-215145.
    >> Share

  1482. WANG Q, Dong X, Zhang R, Zhao C, et al
    Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210735. doi: 10.3233/JAD-210735.
    >> Share

  1483. NAN H, Kim YJ, Tsuchiya M, Fukao T, et al
    A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-beta Protein Precursor.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210706. doi: 10.3233/JAD-210706.
    >> Share

  1484. BLOCK ML, Kodavanti UP
    The Use of Standardized Diesel Exhaust Particles in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215201. doi: 10.3233/JAD-215201.
    >> Share

  1485. CULIBRK RA, Arabiyat AS, DeKalb CA, Hahn MS, et al
    Modeling Sympathetic Hyperactivity in Alzheimer's Related Bone Loss.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215007. doi: 10.3233/JAD-215007.
    >> Share

  1486. KATZ J, Gao H
    The Alzheimer-E. coli Axis: What Can We Learn from an Electronic Health Record Platform.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215004. doi: 10.3233/JAD-215004.
    >> Share

  1487. CHEN H, Chen F, Zhang M, Chen Y, et al
    A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210602. doi: 10.3233/JAD-210602.
    >> Share

  1488. KANG SH, Cho H, Shin J, Kim HR, et al
    Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210392. doi: 10.3233/JAD-210392.
    >> Share

  1489. GOLZARI-SORKHEH M, Brown C, Weaver DF, Reed M, et al
    The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210660. doi: 10.3233/JAD-210660.
    >> Share

  1490. MULAK A
    Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210608. doi: 10.3233/JAD-210608.
    >> Share

  1491. SEO SJ, Chang WS, Jeon JG, Choi Y, et al
    Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-beta Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210739. doi: 10.3233/JAD-210739.
    >> Share

  1492. BRUGULAT-SERRAT A, Canas A, Canals L, Marne P, et al
    Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210640. doi: 10.3233/JAD-210640.
    >> Share

  1493. TARAWNEH HY, Mulders WHAM, Sohrabi HR, Martins RN, et al
    Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210556. doi: 10.3233/JAD-210556.
    >> Share

  1494. CIANFLONE A, Coppola L, Mirabelli P, Salvatore M, et al
    Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-beta Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.
    J Alzheimers Dis. 2021 Sep 17. pii: JAD210496. doi: 10.3233/JAD-210496.
    >> Share

  1495. YAMADA Y, Shinkawa K, Kobayashi M, Caggiano V, et al
    Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Sep 16. pii: JAD210684. doi: 10.3233/JAD-210684.
    >> Share

  1496. ALLEN HB
    A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology.
    J Alzheimers Dis. 2021 Sep 14. pii: JAD210429. doi: 10.3233/JAD-210429.
    >> Share

  1497. KOLINKO Y, Marsalova L, Pena SP, Kralickova M, et al
    Stereological Changes in Microvascular Parameters in Hippocampus of a Transgenic Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210738. doi: 10.3233/JAD-210738.
    >> Share

  1498. SATO T, Hanyu H, Koyama Y, Horita H, et al
    Discrepancy Between the Degree of Cognitive Impairment and Brain Imaging Abnormalities in Alzheimer's Disease Patients Is Associated with Cognitive Reserve.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210728. doi: 10.3233/JAD-210728.
    >> Share

  1499. ABDULKADIR TS, Dawud FA, Isa AS, Ayo JO, et al
    Taurine and Camel Milk Modulate Neurobehavioral and Biochemical Changes in Aluminum Chloride-Induced Alzheimer's Disease in Rats.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210130. doi: 10.3233/JAD-210130.
    >> Share

  1500. SRIWICHAIIN S, Chattipakorn N, Chattipakorn SC
    Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210737. doi: 10.3233/JAD-210737.
    >> Share

  1501. COLATO E, Chiotis K, Ferreira D, Mazrina MS, et al
    Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210614. doi: 10.3233/JAD-210614.
    >> Share

  1502. WERBER T, Bata Z, Vaszine ES, Berente DB, et al
    The Association of Periodontitis and Alzheimer's Disease: How to Hit Two Birds with One Stone.
    J Alzheimers Dis. 2021 Sep 8. pii: JAD210491. doi: 10.3233/JAD-210491.
    >> Share

  1503. ZHANG XQ, Xu L, Yang SY, Hu LB, et al
    Reduced Synaptic and Intrinsic Excitability of a Subtype of Pyramidal Neurons in the Medial Prefrontal Cortex in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 2. pii: JAD210585. doi: 10.3233/JAD-210585.
    >> Share

  1504. CALDIERARO MA, Laufer-Silva T, Cassano P
    Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210586. doi: 10.3233/JAD-210586.
    >> Share

  1505. HE F, Zhang Y, Wu X, Li Y, et al
    Early Microstructure Changes of White Matter Fiber Bundles in Patients with Amnestic Mild Cognitive Impairment Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210495. doi: 10.3233/JAD-210495.
    >> Share

  1506. HADDAD M, Perrotte M, Ben Khedher MR, Madec E, et al
    Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210441. doi: 10.3233/JAD-210441.
    >> Share

    August 2021
  1507. FARACE P, Tamburin S
    Combining Low-Dose Radiation Therapy and Magnetic Resonance Guided Focused Ultrasound to Reduce Amyloid-beta Deposition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD215041. doi: 10.3233/JAD-215041.
    >> Share

  1508. KATZOUROU I, Leonenko G, Ivanov D, Meggy A, et al
    Cognitive Decline in Alzheimer's Disease Is Not Associated with APOE.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD210685. doi: 10.3233/JAD-210685.
    >> Share

  1509. PIEVANI M, Mega A, Quattrini G, Guidali G, et al
    Targeting Default Mode Network Dysfunction in Persons at Risk of Alzheimer's Disease with Transcranial Magnetic Stimulation (NEST4AD): Rationale and Study Design.
    J Alzheimers Dis. 2021 Aug 27. pii: JAD210659. doi: 10.3233/JAD-210659.
    >> Share

  1510. HANDY A, Lord J, Green R, Xu J, et al
    Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD210462. doi: 10.3233/JAD-210462.
    >> Share

  1511. LIU Z, Maiti T, Bender AR
    A Role for Prior Knowledge in Statistical Classification of the Transition from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD201398. doi: 10.3233/JAD-201398.
    >> Share

  1512. HAMBLIN MR, Salehpour F
    Photobiomodulation of the Brain: Shining Light on Alzheimer's and Other Neuropathological Diseases.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210743. doi: 10.3233/JAD-210743.
    >> Share

  1513. ZHANG Z, Wang M, Yuan S, Cai H, et al
    Genetically Predicted Coffee Consumption and Risk of Alzheimer's Disease and Stroke.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210678. doi: 10.3233/JAD-210678.
    >> Share

  1514. BOMMARITO G, Van De Ville D, Frisoni GB, Garibotto V, et al
    Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210534. doi: 10.3233/JAD-210534.
    >> Share

  1515. SYVERSTAD SKAARAAS GHE, Melbye C, Puchades MA, Yi Leung DS, et al
    Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer's Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor.
    J Alzheimers Dis. 2021 Aug 21. pii: JAD210571. doi: 10.3233/JAD-210571.
    >> Share

  1516. QURESHI ZP, Thiel E, Nelson J, Khandker R, et al
    Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210713. doi: 10.3233/JAD-210713.
    >> Share

  1517. TOK S, Ahnaou A, Drinkenburg W
    Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210397. doi: 10.3233/JAD-210397.
    >> Share

  1518. GE F, Zhu D, Tian M, Shi J, et al
    The Role of Thyroid Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210339. doi: 10.3233/JAD-210339.
    >> Share

  1519. TOFIQ A, Zetterberg H, Blennow K, Basun H, et al
    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210007. doi: 10.3233/JAD-210007.
    >> Share

  1520. ROBAKIS NK
    On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor1.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD215138. doi: 10.3233/JAD-215138.
    >> Share

  1521. CIOFFI F, Ibrahim Adam RH, Bansal R, Broersen K, et al
    A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD210497. doi: 10.3233/JAD-210497.
    >> Share

  1522. MOMMAERTS K, Willemse EAJ, Marchese M, Larue C, et al
    A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210741. doi: 10.3233/JAD-210741.
    >> Share

  1523. ZANGROSSI A, Montemurro S, Altoe G, Mondini S, et al
    Heterogeneity and Factorial Structure in Alzheimer's Disease: A Cognitive Perspective.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210719. doi: 10.3233/JAD-210719.
    >> Share

  1524. WANG H, Xu Y, Ren R, Yao F, et al
    Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210679. doi: 10.3233/JAD-210679.
    >> Share

  1525. YANG HJ, Lee S, Koh MJ, Lee HK, et al
    The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210494. doi: 10.3233/JAD-210494.
    >> Share

  1526. WIMO A, Belger M, Bon J, Jessen F, et al
    A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210303. doi: 10.3233/JAD-210303.
    >> Share

  1527. BARTHOLD D, Gibbons LE, Marcum ZA, Gray SL, et al
    Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.
    J Alzheimers Dis. 2021 Aug 14. pii: JAD210059. doi: 10.3233/JAD-210059.
    >> Share

  1528. SCARTH M, Rissanen I, Scholten RJPM, Geerlings MI, et al
    Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD210218. doi: 10.3233/JAD-210218.
    >> Share

  1529. SCHILD AK, Volk J, Scharfenberg D, Schuermann K, et al
    Social Cognition in Patients with Amnestic Mild Cognitive Impairment and Mild Dementia of the Alzheimer Type.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD201126. doi: 10.3233/JAD-201126.
    >> Share

  1530. REHAN S, Giroud N, Al-Yawer F, Wittich W, et al
    Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD201521. doi: 10.3233/JAD-201521.
    >> Share

  1531. FOTE G, Wu J, Mapstone M, Macciardi F, et al
    Plasma Sphingomyelins in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD200871. doi: 10.3233/JAD-200871.
    >> Share

  1532. YU Y, Gao Y, Winblad B, Tjernberg L, et al
    A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD215008. doi: 10.3233/JAD-215008.
    >> Share

  1533. PARK M, Baik K, Lee YG, Kang SW, et al
    Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210669. doi: 10.3233/JAD-210669.
    >> Share

  1534. PUDUMJEE SB, Lundt ES, Albertson SM, Machulda MM, et al
    A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210251. doi: 10.3233/JAD-210251.
    >> Share

  1535. KIM HR, Jang JH, Ham H, Choo SH, et al
    A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210650. doi: 10.3233/JAD-210650.
    >> Share

  1536. AGUERO P, Sainz MJ, Tellez R, Lorda I, et al
    De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210420. doi: 10.3233/JAD-210420.
    >> Share

  1537. LI Y, Wang R, Li Q, Wang YJ, et al
    Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210381. doi: 10.3233/JAD-210381.
    >> Share

  1538. RASMUSSEN ID, Boayue NM, Mittner M, Bystad M, et al
    High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210378. doi: 10.3233/JAD-210378.
    >> Share

  1539. TADOKORO K, Yamashita T, Kimura S, Nomura E, et al
    Retinal Amyloid Imaging for Screening Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210327. doi: 10.3233/JAD-210327.
    >> Share

  1540. HE H, Liu A, Zhang W, Yang H, et al
    Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210307. doi: 10.3233/JAD-210307.
    >> Share

  1541. VAN ZELLER M, Dias DM, Sebastiao AM, Valente CA, et al
    NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210268. doi: 10.3233/JAD-210268.
    >> Share

  1542. CAI HY, Yang D, Qiao J, Yang JT, et al
    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210256. doi: 10.3233/JAD-210256.
    >> Share

  1543. MUKHOPADHYAY S, Banerjee D
    A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD215065. doi: 10.3233/JAD-215065.
    >> Share

  1544. NOUS A, Wittens MMJ, Vermeiren Y, De Deyn PP, et al
    Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210562. doi: 10.3233/JAD-210562.
    >> Share

  1545. VAN DE MORTEL LA, Thomas RM, van Wingen GA
    Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210173. doi: 10.3233/JAD-210173.
    >> Share

  1546. CARCAMO J, Kociolek AJ, Fernandez KK, Gu Y, et al
    Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210019. doi: 10.3233/JAD-210019.
    >> Share

    July 2021
  1547. QIN W, Li W, Wang Q, Gong M, et al
    Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210549. doi: 10.3233/JAD-210549.
    >> Share

  1548. WATSON Y, Nelson B, Kluesner JH, Tanzy C, et al
    Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210492. doi: 10.3233/JAD-210492.
    >> Share

  1549. LIU P, Yang Q, Yu N, Cao Y, et al
    Phenylalanine Metabolism is Dysregulated in Human Hippocampus with Alzheimer's Disease Related Pathological Changes.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210461. doi: 10.3233/JAD-210461.
    >> Share

  1550. WITTENS MMJ, Sima DM, Houbrechts R, Ribbens A, et al
    Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210450. doi: 10.3233/JAD-210450.
    >> Share

  1551. LUCKEY AM, Robertson IH, Lawlor B, Mohan A, et al
    Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer's Disease in Females.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210404. doi: 10.3233/JAD-210404.
    >> Share

  1552. WALDEN LM, Hu S, Madabhushi A, Prescott JW, et al
    Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210308. doi: 10.3233/JAD-210308.
    >> Share

  1553. HLAVKA JP, Kinoshita AT, Fang S, Hunt A, et al
    Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210060. doi: 10.3233/JAD-210060.
    >> Share

  1554. SMAILOVIC U, Kareholt I, Koenig T, Ashton NJ, et al
    Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 25. pii: JAD201234. doi: 10.3233/JAD-201234.
    >> Share

  1555. CROSS DJ, Huber BR, Silverman MA, Cline MM, et al
    Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice.
    J Alzheimers Dis. 2021 Jul 23. pii: JAD210109. doi: 10.3233/JAD-210109.
    >> Share

  1556. WANG F, Xu CS, Chen WH, Duan SW, et al
    Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    J Alzheimers Dis. 2021 Jul 19. pii: JAD210540. doi: 10.3233/JAD-210540.
    >> Share

  1557. NARA PL, Sindelar D, Penn MS, Potempa J, et al
    Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 16. pii: JAD210448. doi: 10.3233/JAD-210448.
    >> Share

  1558. ALEXOPOULOS P, Skondra M, Kontogianni E, Vratsista A, et al
    Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
    J Alzheimers Dis. 2021 Jul 15. pii: JAD210477. doi: 10.3233/JAD-210477.
    >> Share

  1559. DE LA TORRE JC, Gonzalez-Lima F
    The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210736. doi: 10.3233/JAD-210736.
    >> Share

  1560. CHEN S, Song Y, Xu W, Hu G, et al
    Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210541. doi: 10.3233/JAD-210541.
    >> Share

  1561. SIBLE IJ, Bangen KJ, Blanken AE, Ho JK, et al
    Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 7. pii: JAD210435. doi: 10.3233/JAD-210435.
    >> Share

  1562. JOSEPH S, Patterson R, Wang W, Blumberger DM, et al
    Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210311. doi: 10.3233/JAD-210311.
    >> Share

  1563. BEARDMORE R, Hou R, Darekar A, Holmes C, et al
    The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210191. doi: 10.3233/JAD-210191.
    >> Share

  1564. SQUITTI R, Faller P, Hureau C, Granzotto A, et al
    Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD201556. doi: 10.3233/JAD-201556.
    >> Share

  1565. HOJJATI SH, Feiz F, Ozoria S, Razlighi QR, et al
    Topographical Overlapping of the Amyloid-beta and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210419. doi: 10.3233/JAD-210419.
    >> Share

  1566. KUWAR R, Rolfe A, Di L, Blevins H, et al
    A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210400. doi: 10.3233/JAD-210400.
    >> Share

    June 2021
  1567. GABRIEL A, Lehner CT, Hohler C, Schneider T, et al
    Anticipatory and Reactive Grip Force Control in Patients with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210387. doi: 10.3233/JAD-210387.
    >> Share

  1568. BAENA A, Bocanegra Y, Torres V, Vila-Castelar C, et al
    Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210185. doi: 10.3233/JAD-210185.
    >> Share

  1569. FRANK M, Hensel J, Baak L, Schramm S, et al
    Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210244. doi: 10.3233/JAD-210244.
    >> Share

  1570. MANCINI G, Dias C, Lourenco CF, Laranjinha J, et al
    A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210122. doi: 10.3233/JAD-210122.
    >> Share

  1571. YAO W, Chen H, Sheng X, Zhao H, et al
    Core-Centered Connection Abnormalities Associated with Pathological Features Mediate the Progress of Cognitive Impairments in Alzheimer's Disease Spectrum Patients.
    J Alzheimers Dis. 2021 Jun 22. pii: JAD210481. doi: 10.3233/JAD-210481.
    >> Share

  1572. CHAUDHARY S, Ashok A, McDonald D, Wise AS, et al
    Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2021 Jun 19. pii: JAD210221. doi: 10.3233/JAD-210221.
    >> Share

  1573. KANG S, Gim J, Lee J, Gunasekaran TI, et al
    Potential Novel Genes for Late-Onset Alzheimer's Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study.
    J Alzheimers Dis. 2021 Jun 18. pii: JAD210145. doi: 10.3233/JAD-210145.
    >> Share

  1574. XU LZ, Li FY, Li BQ, Cao SM, et al
    Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210516. doi: 10.3233/JAD-210516.
    >> Share

  1575. MITOLO M, Stanzani-Maserati M, Manners DN, Capellari S, et al
    The Combination of Metabolic Posterior Cingulate Cortical Abnormalities and Structural Asymmetries Improves the Differential Diagnosis Between Primary Progressive Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210211. doi: 10.3233/JAD-210211.
    >> Share

  1576. TARGUM SD, Fosdick L, Drake KE, Rosenberg PB, et al
    Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210530. doi: 10.3233/JAD-210530.
    >> Share

  1577. BAHAR B, Kanagasingam S, Tambuwala MM, Aljabali AAA, et al
    Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210465. doi: 10.3233/JAD-210465.
    >> Share

  1578. FRANCOIS M, Karpe A, Liu JW, Beale D, et al
    Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210283. doi: 10.3233/JAD-210283.
    >> Share

  1579. AKUSHEVICH I, Yashkin AP, Kravchenko J, Yashin AI, et al
    Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210273. doi: 10.3233/JAD-210273.
    >> Share

  1580. PAULO SL, Ribeiro-Rodrigues L, Rodrigues RS, Mateus JM, et al
    Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-beta-Induced Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201567. doi: 10.3233/JAD-201567.
    >> Share

  1581. FERNANDEZ G, Parra MA
    Oculomotor Behaviors and Integrative Memory Functions in the Alzheimer's Clinical Syndrome.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201189. doi: 10.3233/JAD-201189.
    >> Share

  1582. ESPAY AJ, Sturchio A, Schneider LS, Ezzat K, et al
    Soluble Amyloid-beta Consumption in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210415. doi: 10.3233/JAD-210415.
    >> Share

  1583. QU M, Shi H, Wang K, Wang X, et al
    The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210384. doi: 10.3233/JAD-210384.
    >> Share

  1584. LOURENCO MV, Ribeiro FC, Santos LE, Beckman D, et al
    Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210147. doi: 10.3233/JAD-210147.
    >> Share

  1585. WANG ZT, Li KY, Tan CC, Xu W, et al
    Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210140. doi: 10.3233/JAD-210140.
    >> Share

  1586. BABILONI C, Ferri R, Noce G, Lizio R, et al
    Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD201271. doi: 10.3233/JAD-201271.
    >> Share

  1587. CASTILLO-MENDIETA T, Arana-Lechuga Y, Campos-Pena V, Sosa AL, et al
    Plasma Levels of Amyloid-beta Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 11. pii: JAD200912. doi: 10.3233/JAD-200912.
    >> Share

  1588. SERRA L, D'Amelio M, Esposito S, Domenico CD, et al
    Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210171. doi: 10.3233/JAD-210171.
    >> Share

  1589. DARMANTHE N, Tabatabaei-Jafari H, Cherbuin N
    Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210092. doi: 10.3233/JAD-210092.
    >> Share

  1590. KVELLO-ALME M, Brathen G, White LR, Sando SB, et al
    Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210090. doi: 10.3233/JAD-210090.
    >> Share

  1591. SAMARA M, Levine SZ, Yoshida K, Goldberg Y, et al
    Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of D
    J Alzheimers Dis. 2021 Jun 9. pii: JAD201541. doi: 10.3233/JAD-201541.
    >> Share

  1592. RICHARD CHEN X, Shao Y, Sadowski MJ
    Segmented Linear Mixed Model Analysis Reveals Association of the APOEvarepsilon4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210434. doi: 10.3233/JAD-210434.
    >> Share

  1593. COVATTI MALCORRA BL, Mota NB, Weissheimer J, Schilling LP, et al
    Low Speech Connectedness in Alzheimer's Disease is Associated with Poorer Semantic Memory Performance.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210134. doi: 10.3233/JAD-210134.
    >> Share

  1594. VECCHIO F, Miraglia F, Alu F, Orticoni A, et al
    Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease versus Vascular Dementia Diagnosis.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210394. doi: 10.3233/JAD-210394.
    >> Share

  1595. SCHOEMAKER D, Velilla L, Zuluaga Y, Baena A, et al
    Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210313. doi: 10.3233/JAD-210313.
    >> Share

  1596. ZHAO X, Li C, Ding G, Heng Y, et al
    The Burden of Alzheimer's Disease Mortality in the United States, 1999-2018.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210225. doi: 10.3233/JAD-210225.
    >> Share

  1597. SPERA V, Sitnikova T, Ward MJ, Farzam P, et al
    Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210058. doi: 10.3233/JAD-210058.
    >> Share

  1598. BEN AYED I, Castor-Guyonvarch N, Amimour S, Naija S, et al
    Acute Exercise and Cognitive Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201317. doi: 10.3233/JAD-201317.
    >> Share

  1599. GRECO FA, McKee AC, Kowall NW, Hanlon EB, et al
    Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201021. doi: 10.3233/JAD-201021.
    >> Share

    May 2021
  1600. JIN N, Babiloni C, Drinkenburg WH, Hajos M, et al
    Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models.
    J Alzheimers Dis. 2021 May 29. pii: JAD210209. doi: 10.3233/JAD-210209.
    >> Share

  1601. DELAZER M, Zamarian L, Djamshidian A
    Handwriting in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 28. pii: JAD210279. doi: 10.3233/JAD-210279.
    >> Share

  1602. JEONG W, Joo JH, Kim H, Kim YK, et al
    Association Between the Use of Hypnotics and the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD201319. doi: 10.3233/JAD-201319.
    >> Share

  1603. BABIC LEKO M, Jurasovic J, Nikolac Perkovic M, Spanic E, et al
    The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD210158. doi: 10.3233/JAD-210158.
    >> Share

  1604. WEI W, Liu Y, Dai C, Baazaoui N, et al
    Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
    J Alzheimers Dis. 2021 May 27. pii: JAD201599. doi: 10.3233/JAD-201599.
    >> Share

  1605. THOMSEN BB, Madsen C, Krohn KT, Thygesen C, et al
    Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 26. pii: JAD210040. doi: 10.3233/JAD-210040.
    >> Share

  1606. KING-ROBSON J, Wilson H, Politis M
    Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 May 22. pii: JAD201457. doi: 10.3233/JAD-201457.
    >> Share

  1607. BARRIO JR, Whitehouse P, Alavi A, Hoilund-Carlsen PF, et al
    New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 May 20. pii: JAD210383. doi: 10.3233/JAD-210383.
    >> Share

  1608. LI X, Tian Y, Yang YX, Ma YH, et al
    Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 May 20. pii: JAD210345. doi: 10.3233/JAD-210345.
    >> Share

  1609. LAURIOLA M, D'Onofrio G, Ciccone F, Germano C, et al
    Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    J Alzheimers Dis. 2021 May 20. pii: JAD210166. doi: 10.3233/JAD-210166.
    >> Share

  1610. YANG H, Luo Y, Hu Q, Tian X, et al
    Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation.
    J Alzheimers Dis. 2021 May 20. pii: JAD201554. doi: 10.3233/JAD-201554.
    >> Share

  1611. BARTHELSON K, Dong Y, Newman M, Lardelli M, et al
    PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer's Disease or Familial Acne Inversa Differ in Their Effects on Genes Facilitating Energy Metabolism and Signal Transduction.
    J Alzheimers Dis. 2021 May 19. pii: JAD210128. doi: 10.3233/JAD-210128.
    >> Share

  1612. HAN H, Wang F, Chen J, Li X, et al
    Changes in Biothiol Levels Are Closely Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 19. pii: JAD210021. doi: 10.3233/JAD-210021.
    >> Share


  1613. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 May 18. pii: JAD219004. doi: 10.3233/JAD-219004.
    >> Share

  1614. FERNANDEZ-AGUILAR L, Lora Y, Satorres E, Ros L, et al
    Dimensional and Discrete Emotional Reactivity in Alzheimer's Disease: Film Clips as a Research Tool in Dementia.
    J Alzheimers Dis. 2021 May 18. pii: JAD210233. doi: 10.3233/JAD-210233.
    >> Share

  1615. RODRIGO-HERRERO S, Luque-Tirado A, Mendez-Barrio C, Garcia-Solis D, et al
    TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.
    J Alzheimers Dis. 2021 May 18. pii: JAD210115. doi: 10.3233/JAD-210115.
    >> Share

  1616. PISTONO A, Senoussi M, Guerrier L, Rafiq M, et al
    Language Network Connectivity Increases in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201584. doi: 10.3233/JAD-201584.
    >> Share

  1617. BERNSTEIN AS, Rapcsak SZ, Hornberger M, Saranathan M, et al
    Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201583. doi: 10.3233/JAD-201583.
    >> Share

  1618. MAO C, Sha L, Li J, Huang X, et al
    Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort.
    J Alzheimers Dis. 2021 May 16. pii: JAD210344. doi: 10.3233/JAD-210344.
    >> Share

  1619. DUAN W, Zhou GD, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    J Alzheimers Dis. 2021 May 16. pii: JAD210199. doi: 10.3233/JAD-210199.
    >> Share

  1620. JIMENEZ EC, Sierra-Marcos A, Romeo A, Hashemi A, et al
    Altered Vergence Eye Movements and Pupil Response of Patients with Alzheimer's Disease and Mild Cognitive Impairment During an Oddball Task.
    J Alzheimers Dis. 2021 May 16. pii: JAD201301. doi: 10.3233/JAD-201301.
    >> Share

  1621. ALVES SS, Silva-Junior RMPD, Servilha-Menezes G, Homolak J, et al
    Insulin Resistance as a Common Link Between Current Alzheimer's Disease Hypotheses.
    J Alzheimers Dis. 2021 May 15. pii: JAD210234. doi: 10.3233/JAD-210234.
    >> Share

  1622. YIN X, Xie Q, Huang L, Liu L, et al
    Assessment of the Psychological Burden Among Family Caregivers of People Living with Alzheimer's Disease Using the Zarit Burden Interview.
    J Alzheimers Dis. 2021 May 15. pii: JAD210025. doi: 10.3233/JAD-210025.
    >> Share

  1623. DU F, Yu Q, Yan SS
    PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2021 May 14. pii: JAD210095. doi: 10.3233/JAD-210095.
    >> Share

  1624. YE F, Wu A
    The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210132. doi: 10.3233/JAD-210132.
    >> Share

  1625. MASSETT HA, Mitchell AK, Alley L, Simoneau E, et al
    Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.
    J Alzheimers Dis. 2021 May 11. pii: JAD201463. doi: 10.3233/JAD-201463.
    >> Share

  1626. OU GY, Lin WW, Zhao WJ
    Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210068. doi: 10.3233/JAD-210068.
    >> Share

  1627. CAMARGO A, Wang Z
    Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    J Alzheimers Dis. 2021 May 5. pii: JAD210116. doi: 10.3233/JAD-210116.
    >> Share

  1628. DU Y, Dennis B, Liu J, Meyer K, et al
    A Conceptual Model to Improve Care for Individuals with Alzheimer's Disease and Related Dementias and Their Caregivers: Qualitative Findings in an Online Caregiver Forum.
    J Alzheimers Dis. 2021 May 3. pii: JAD210167. doi: 10.3233/JAD-210167.
    >> Share

  1629. HANNESTAD J, Duclos T, Chao W, Koborsi K, et al
    Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 May 3. pii: JAD210011. doi: 10.3233/JAD-210011.
    >> Share

    April 2021
  1630. SERPENTE M, Fenoglio C, Arighi A, Fumagalli GG, et al
    Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210249. doi: 10.3233/JAD-210249.
    >> Share

  1631. SOMAA F
    A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210157. doi: 10.3233/JAD-210157.
    >> Share

  1632. SMIRNI D, Oliveri M, Misuraca E, Catania A, et al
    Verbal Fluency in Mild Alzheimer's Disease: Transcranial Direct Current Stimulation over the Dorsolateral Prefrontal Cortex.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210003. doi: 10.3233/JAD-210003.
    >> Share

  1633. DE LA FUENTE M
    The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201587. doi: 10.3233/JAD-201587.
    >> Share

  1634. BERTRAND E, van Duinkerken E, Laks J, Dourado MCN, et al
    Structural Gray and White Matter Correlates of Awareness in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201246. doi: 10.3233/JAD-201246.
    >> Share

  1635. DE OLIVEIRA FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, et al
    Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210272. doi: 10.3233/JAD-210272.
    >> Share

  1636. PLACIDO J, Ferreira JV, Araujo J, de Oliveira Silva F, et al
    Beyond the Mini-Mental State Examination: The Use of Physical and Spatial Navigation Tests to Help to Screen for Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210106. doi: 10.3233/JAD-210106.
    >> Share

  1637. GUZMAN-MARTINEZ L, Farias GA, Tapia JP, Sanchez MP, et al
    Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10(R) in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201501. doi: 10.3233/JAD-201501.
    >> Share

  1638. ZUPANIC E, von Euler M, Winblad B, Xu H, et al
    Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201459. doi: 10.3233/JAD-201459.
    >> Share

  1639. LIN Y, Zeng Q, Hu M, Peng G, et al
    Temporal Dynamic Changes of Intrinsic Brain Activity Associated with Cognitive Reserve in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201244. doi: 10.3233/JAD-201244.
    >> Share

  1640. XU L, Li T, Xiong L, Wang X, et al
    Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD210098. doi: 10.3233/JAD-210098.
    >> Share

  1641. REN D, Lopez OL, Lingler JH, Conley Y, et al
    Association Between the APOEvarepsilon2/varepsilon4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD201613. doi: 10.3233/JAD-201613.
    >> Share

  1642. HAJ ME, Moustafa AA, Gallouj K
    Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD210190. doi: 10.3233/JAD-210190.
    >> Share

  1643. NERG O, Junkkari A, Hallikainen I, Rauramaa T, et al
    The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD201363. doi: 10.3233/JAD-201363.
    >> Share

  1644. SZEGECZKI V, Perenyi H, Horvath G, Hinnah B, et al
    Physical Training Inhibits the Fibrosis Formation in Alzheimer's Disease Kidney Influencing the TGFbeta Signaling Pathways.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD201206. doi: 10.3233/JAD-201206.
    >> Share

  1645. GOTTESMAN RT, Kociolek A, Fernandez K, Cosentino S, et al
    Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD200729. doi: 10.3233/JAD-200729.
    >> Share


  1646. Erratum Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD219318. doi: 10.3233/JAD-219318.
    >> Share

  1647. FELDMAN R
    Physicians Treating Alzheimer's Disease Patients Should Be Aware that Televised Direct-to-Consumer Advertising Links More Strongly to Drug Utilization in Older Patients.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210294. doi: 10.3233/JAD-210294.
    >> Share

  1648. LI J, Bur AM, Villwock MR, Shankar S, et al
    Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210175. doi: 10.3233/JAD-210175.
    >> Share

  1649. NORINS LC
    Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210080. doi: 10.3233/JAD-210080.
    >> Share

  1650. SAKURAI K, Kaneda D, Inui S, Uchida Y, et al
    Simple Quantitative Indices for the Differentiation of Advanced-Stage Alzheimer's Disease and Other Limbic Tauopathies.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210043. doi: 10.3233/JAD-210043.
    >> Share

  1651. MULLER L, Kirschstein T, Kohling R, Kuhla A, et al
    Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201540. doi: 10.3233/JAD-201540.
    >> Share

  1652. BEUCKMANN CT, Suzuki H, Musiek ES, Ueno T, et al
    Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201054. doi: 10.3233/JAD-201054.
    >> Share

  1653. EEZA MNH, Singer R, Hofling C, Matysik J, et al
    Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201575. doi: 10.3233/JAD-201575.
    >> Share

  1654. HALMINEN O, Vesikansa A, Mehtala J, Horhammer I, et al
    Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201502. doi: 10.3233/JAD-201502.
    >> Share

  1655. TSAMOU M, Pistollato F, Roggen EL
    A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201418. doi: 10.3233/JAD-201418.
    >> Share

  1656. HASHIMOTO M, Ho G, Sugama S, Takenouchi T, et al
    Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD210206. doi: 10.3233/JAD-210206.
    >> Share

  1657. MARRA C, Piccininni C, Iacobucci GM, Caprara A, et al
    Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD201452. doi: 10.3233/JAD-201452.
    >> Share

  1658. O'BRYANT S, Zhang F, Petersen M, Johnson L, et al
    A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201610. doi: 10.3233/JAD-201610.
    >> Share

  1659. BOSTROM G, Freyhult E, Virhammar J, Alcolea D, et al
    Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201565. doi: 10.3233/JAD-201565.
    >> Share

  1660. ZHOU Y, Wang Y, Quan M, Zhao H, et al
    Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201497. doi: 10.3233/JAD-201497.
    >> Share

  1661. ZHENG YM, Zhao YY, Zhang T, Hou XH, et al
    Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Normal Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201222. doi: 10.3233/JAD-201222.
    >> Share

  1662. AITKEN WW, Lombard J, Wang K, Toro M, et al
    Relationship of Neighborhood Greenness to Alzheimer's Disease and Non-Alzheimer's Dementia Among 249,405 U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201179. doi: 10.3233/JAD-201179.
    >> Share

    March 2021
  1663. QIU H, Zhao R, Fei G, Pan X, et al
    Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD210213. doi: 10.3233/JAD-210213.
    >> Share

  1664. PILLAI JA, Bena J, Bekris LM, Foldvary-Schaefer N, et al
    Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer's Disease with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201573. doi: 10.3233/JAD-201573.
    >> Share

  1665. LI LL, Ma YH, Bi YL, Sun FR, et al
    Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201192. doi: 10.3233/JAD-201192.
    >> Share

  1666. FENG LIU Q, Kanmani S, Lee J, Kim GW, et al
    Neoline Improves Memory Impairment and Reduces Amyloid-beta Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Mar 26. pii: JAD201614. doi: 10.3233/JAD-201614.
    >> Share

  1667. TEITSDOTTIR UD, Halldorsson S, Rolfsson O, Lund SH, et al
    Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    J Alzheimers Dis. 2021 Mar 25. pii: JAD200964. doi: 10.3233/JAD-200964.
    >> Share

  1668. IKEDA S, Mimura M, Ikeda M, Wada-Isoe K, et al
    Economic Burden of Alzheimer's Disease Dementia in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD210075. doi: 10.3233/JAD-210075.
    >> Share

  1669. MORRIS R, Luboff H, Jose RP, Eckhoff K, et al
    Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201551. doi: 10.3233/JAD-201551.
    >> Share

  1670. DOUROS A, Santella C, Dell'Aniello S, Azoulay L, et al
    Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201534. doi: 10.3233/JAD-201534.
    >> Share

  1671. ASHIZAWA T, Igarashi A, Sakata Y, Azuma M, et al
    Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201514. doi: 10.3233/JAD-201514.
    >> Share

  1672. KLEIMAN MJ, Barenholtz E, Galvin JE
    Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201377. doi: 10.3233/JAD-201377.
    >> Share

  1673. WONG D, Broberg DN, Doad J, Umoh JU, et al
    Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    J Alzheimers Dis. 2021 Mar 22. pii: JAD201137. doi: 10.3233/JAD-201137.
    >> Share

  1674. ASTROM DO, Adolfsson R, Segersson D, Forsberg B, et al
    Local Contrasts in Concentration of Ambient Particulate Air Pollution (PM2.5) and Incidence of Alzheimer's Disease and Dementia: Results from the Betula Cohort in Northern Sweden.
    J Alzheimers Dis. 2021 Mar 18. pii: JAD201538. doi: 10.3233/JAD-201538.
    >> Share


  1675. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD219002. doi: 10.3233/JAD-219002.
    >> Share

  1676. NI R, Rojdner J, Voytenko L, Dyrks T, et al
    In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201344. doi: 10.3233/JAD-201344.
    >> Share

  1677. FONSECA LM, Mattar GP, Haddad GG, Ekaterina B, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201009. doi: 10.3233/JAD-201009.
    >> Share

  1678. GAUDREAULT R, Herve V, van de Ven TGM, Mousseau N, et al
    Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201549. doi: 10.3233/JAD-201549.
    >> Share

  1679. MA YH, Wang YY, Tan L, Xu W, et al
    Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201426. doi: 10.3233/JAD-201426.
    >> Share

  1680. ARAYA J, Bello F, Shivashankar G, Neira D, et al
    Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer's Disease Are Linked with Neurotransmitter Alterations.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201195. doi: 10.3233/JAD-201195.
    >> Share

  1681. YANG J, Jia L, Li Y, Qiu Q, et al
    Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201068. doi: 10.3233/JAD-201068.
    >> Share

  1682. MIRANDA A, Montiel E, Ulrich H, Paz C, et al
    Selective Secretase Targeting for Alzheimer's Disease Therapy.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201027. doi: 10.3233/JAD-201027.
    >> Share

  1683. DIAS IHK, Griffiths HR
    Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210121. doi: 10.3233/JAD-210121.
    >> Share

  1684. TONG Q, Chen L
    Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210114. doi: 10.3233/JAD-210114.
    >> Share

  1685. VALOTASSIOU V, Sifakis N, Tzavara C, Lykou E, et al
    Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD201434. doi: 10.3233/JAD-201434.
    >> Share

  1686. DRAKE JD, Chambers AB, Ott BR, Daiello LA, et al
    Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD200759. doi: 10.3233/JAD-200759.
    >> Share

  1687. TASLIMA F, Jung CG, Zhou C, Abdelhamid M, et al
    Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD201055. doi: 10.3233/JAD-201055.
    >> Share

  1688. GUPTA HV, Beach TG, Mehta SH, Shill HA, et al
    Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD200323. doi: 10.3233/JAD-200323.
    >> Share

  1689. MOUSSAVI NIK SH, Porter T, Newman M, Bartlett B, et al
    Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Mar 7. pii: JAD201133. doi: 10.3233/JAD-201133.
    >> Share

  1690. ELVERMAN KH, Paitel ER, Figueroa CM, McKindles RJ, et al
    Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201559. doi: 10.3233/JAD-201559.
    >> Share

  1691. PEREZ-VALERO E, Lopez-Gordo MA, Morillas C, Pelayo F, et al
    A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201455. doi: 10.3233/JAD-201455.
    >> Share

  1692. JOUINI N, Saied Z, Ben Sassi S, Nebli F, et al
    Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201250. doi: 10.3233/JAD-201250.
    >> Share

  1693. DODICH A, Crespi C, Chiara Santi G, Luzzi S, et al
    Diagnostic Accuracy of Affective Social Tasks in the Clinical Classification Between the Behavioral Variant of Frontotemporal Dementia and Other Neurodegenerative Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201210. doi: 10.3233/JAD-201210.
    >> Share

  1694. WHITE B, Lyketsos CG, Rosenberg PB, Oh ES, et al
    Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201415. doi: 10.3233/JAD-201415.
    >> Share

  1695. VINUELA F, Barro A
    Assessment of a Potential Synergistic Effect of Souvenaid (R) in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201357. doi: 10.3233/JAD-201357.
    >> Share

  1696. ZHANG B, Lin L, Wu S
    A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer's Disease Heterogeneity Studies.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD201274. doi: 10.3233/JAD-201274.
    >> Share

  1697. DEVOUS MD, Fleisher AS, Pontecorvo MJ, Lu M, et al
    Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD200808. doi: 10.3233/JAD-200808.
    >> Share

    February 2021
  1698. AN N, Fu Y, Shi J, Guo HN, et al
    Synergistic Effects of APOE and CLU May Increase the Risk of Alzheimer's Disease: Acceleration of Atrophy in the Volumes and Shapes of the Hippocampus and Amygdala.
    J Alzheimers Dis. 2021 Feb 26. pii: JAD201162. doi: 10.3233/JAD-201162.
    >> Share

  1699. HINTEREGGER B, Loeffler T, Flunkert S, Neddens J, et al
    Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201204. doi: 10.3233/JAD-201204.
    >> Share

  1700. RYMAN SG, Yutsis M, Tian L, Henderson VW, et al
    Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201187. doi: 10.3233/JAD-201187.
    >> Share

  1701. LOPIS D, Pape TL, Manetta C, Conty L, et al
    Sensory Cueing of Autobiographical Memories in Normal Aging and Alzheimer's Disease: A Comparison Between Visual, Auditory, and Olfactory Information.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200841. doi: 10.3233/JAD-200841.
    >> Share

  1702. KIM S, Kim K, Nho K, Myung W, et al
    Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200671. doi: 10.3233/JAD-200671.
    >> Share

  1703. LIU X, Chen X, Zhou X, Shang Y, et al
    Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2021 Feb 24. pii: JAD200936. doi: 10.3233/JAD-200936.
    >> Share

  1704. MERIGHI S, Battistello E, Casetta I, Gragnaniello D, et al
    Upregulation of Cortical A2A Adenosine Receptors is Reflected in Platelets of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD201437. doi: 10.3233/JAD-201437.
    >> Share

  1705. CUTTLER JM, Abdellah E, Goldberg Y, Al-Shamaa S, et al
    Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD200620. doi: 10.3233/JAD-200620.
    >> Share

  1706. MONLLOR P, Giraldo E, Badia MC, de la Asuncion JG, et al
    Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201443. doi: 10.3233/JAD-201443.
    >> Share

  1707. NAGARAJ S, Duong TQ
    Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201438. doi: 10.3233/JAD-201438.
    >> Share

  1708. KLEIN J, Yan X, Johnson A, Tomljanovic Z, et al
    Olfactory Impairment is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201149. doi: 10.3233/JAD-201149.
    >> Share

  1709. CHUNG M, Chung WK
    Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD210042. doi: 10.3233/JAD-210042.
    >> Share

  1710. CIERI F, Yang Z, Cordes D, Jessica Caldwell ZK, et al
    Sex Differences of Brain Functional Topography Revealed in Normal Aging and Alzheimer's Disease Cohort.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201596. doi: 10.3233/JAD-201596.
    >> Share

  1711. JIN H, Wang R
    Alzheimer-Associated Neuronal Thread Protein: Research Course and Prospects for the Future.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201273. doi: 10.3233/JAD-201273.
    >> Share

  1712. LEYTON E, Matus D, Espinoza S, Benitez JM, et al
    DEF8 and Autophagy-Associated Genes are Altered in Mild Cognitive Impairment, Probable Alzheimer's Disease Patients and a Transgenic Model of the Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201264. doi: 10.3233/JAD-201264.
    >> Share

  1713. ZHANG G, Zhang Y, Shen Y, Wang Y, et al
    The Potential Role of Ferroptosis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201369. doi: 10.3233/JAD-201369.
    >> Share

  1714. KHODADADI H, Lopes Salles E, Jarrahi A, Costigliola V, et al
    Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD210026. doi: 10.3233/JAD-210026.
    >> Share

  1715. WANG YY, Huang ZT, Yuan MH, Jing F, et al
    Role of Hypoxia Inducible Factor-1alpha in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201448. doi: 10.3233/JAD-201448.
    >> Share

  1716. INDOREWALLA KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, et al
    Modifiable Barriers for Recruitment and Retention of Oldeult Participants from Underrepresented Minorities in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201081. doi: 10.3233/JAD-201081.
    >> Share

  1717. SHOUP TM, Griciuc A, Normandin MD, Quinti L, et al
    Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201419. doi: 10.3233/JAD-201419.
    >> Share

  1718. WANG YZ, Meng L, Zhuang QS, Shen L, et al
    Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201336. doi: 10.3233/JAD-201336.
    >> Share

  1719. LLADO A, Froelich L, Khandker RK, Roset M, et al
    Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201172. doi: 10.3233/JAD-201172.
    >> Share

  1720. SOOD A, Pavlik V, Darby E, Chan W, et al
    Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201124. doi: 10.3233/JAD-201124.
    >> Share

  1721. LIBARD S, Walter J, Alafuzoff I
    In vivo Characterization of Biochemical Variants of Amyloid-beta in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201469. doi: 10.3233/JAD-201469.
    >> Share

  1722. MA D, Yee E, Stocks JK, Jenkins LM, et al
    Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201591. doi: 10.3233/JAD-201591.
    >> Share

  1723. DANIELE S, Baldacci F, Piccarducci R, Palermo G, et al
    alpha-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201038. doi: 10.3233/JAD-201038.
    >> Share

  1724. SHEN LX, Yang YX, Kuo K, Li HQ, et al
    Social Isolation, Social Interaction, and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201442. doi: 10.3233/JAD-201442.
    >> Share

  1725. FUTAMURA A, Hieda S, Mori Y, Kasuga K, et al
    Toxic Amyloid-beta42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201407. doi: 10.3233/JAD-201407.
    >> Share

  1726. WANG J, Guo X, Lu W, Liu J, et al
    Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer's Disease: A Multicenter, Prospective Cohort Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201381. doi: 10.3233/JAD-201381.
    >> Share

  1727. YAO W, Chen H, Luo C, Sheng X, et al
    Hyperconnectivity of Self-Referential Network as a Predictive Biomarker of the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201376. doi: 10.3233/JAD-201376.
    >> Share

  1728. YU E, Liao Z, Fan W, Hu W, et al
    The Economic Burden of Alzheimer's Disease in Zhejiang Province.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201285. doi: 10.3233/JAD-201285.
    >> Share

  1729. ROSTAMZADEH A, Schwegler C, Gil-Navarro S, Rosende-Roca M, et al
    Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects. Study Protocol of the PreDADQoL Project.
    J Alzheimers Dis. 2021 Feb 4. pii: JAD200484. doi: 10.3233/JAD-200484.
    >> Share

  1730. CHALKIAS E, Topouzis F, Tegos T, Tsolaki M, et al
    The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201516. doi: 10.3233/JAD-201516.
    >> Share

  1731. KHALSA DS, Newberg A
    Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201433. doi: 10.3233/JAD-201433.
    >> Share

  1732. RIPHAGEN JM, Van Egroo M, Jacobs HIL
    Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201411. doi: 10.3233/JAD-201411.
    >> Share

  1733. KHATAMI SG, Domingo-Fernandez D, Mubeen S, Hoyt CT, et al
    A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201397. doi: 10.3233/JAD-201397.
    >> Share

  1734. PIUBELLI L, Murtas G, Rabattoni V, Pollegioni L, et al
    The Role of D-Amino Acids in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201217. doi: 10.3233/JAD-201217.
    >> Share

    January 2021
  1735. RIGBY T, Johnson DK, Taylor A, Galvin JE, et al
    Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201326. doi: 10.3233/JAD-201326.
    >> Share

  1736. LI M, Li R, Lyu JH, Chen JH, et al
    Relationship Between Alzheimer's Disease and Retinal Choroidal Thickness: A Cross-Sectional Study.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201142. doi: 10.3233/JAD-201142.
    >> Share

  1737. CHUANG YC, Chiu MJ, Chen TF, Chang YL, et al
    An Exploration of the Own-Age Effect on Facial Emotion Recognition in Normal Elderly People and Individuals with the Preclinical and Demented Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 27. pii: JAD200916. doi: 10.3233/JAD-200916.
    >> Share

  1738. YU F, Vock DM, Zhang L, Salisbury D, et al
    Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201100. doi: 10.3233/JAD-201100.
    >> Share

  1739. GUO M, Peng J, Huang X, Xiao L, et al
    Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201040. doi: 10.3233/JAD-201040.
    >> Share

  1740. MACEDO A, Gomez C, Rebelo MA, Poza J, et al
    Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD200963. doi: 10.3233/JAD-200963.
    >> Share

  1741. LLANO DA, Devanarayan V
    Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201420. doi: 10.3233/JAD-201420.
    >> Share

  1742. ZHUANG QS, Meng L, Wang Z, Shen L, et al
    Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201235. doi: 10.3233/JAD-201235.
    >> Share

  1743. JORGE L, Martins R, Canario N, Xavier C, et al
    Investigating the Spatial Associations Between Amyloid-beta Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD200840. doi: 10.3233/JAD-200840.
    >> Share

  1744. CHEN F, Zhang Y, Wang L, Wang T, et al
    PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer's Disease and Multiple Sclerosis.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201140. doi: 10.3233/JAD-201140.
    >> Share

  1745. GUZMAN-MARTINEZ L, Calfio C, Farias GA, Vilches C, et al
    New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201059. doi: 10.3233/JAD-201059.
    >> Share

  1746. CUERVO-ZANATTA D, Garcia-Mena J, Perez-Cruz C
    Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD201367. doi: 10.3233/JAD-201367.
    >> Share

  1747. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD200946. doi: 10.3233/JAD-200946.
    >> Share

  1748. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 18. pii: JAD201254. doi: 10.3233/JAD-201254.
    >> Share

  1749. MEHDER RH, Bennett BM, Andrew RD
    Age-Related Neuronal Deterioration Specifically Within the Dorsal CA1 Region of the Hippocampus in a Mouse Model of Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201024. doi: 10.3233/JAD-201024.
    >> Share

  1750. HAYASHI T, Shimonaka S, Elahi M, Matsumoto SE, et al
    Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer's Disease Brain Extract in Mouse Brains.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201002. doi: 10.3233/JAD-201002.
    >> Share

  1751. LEHINGUE E, Gueniat J, Jourdaa S, Hardouin JB, et al
    Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201088. doi: 10.3233/JAD-201088.
    >> Share

  1752. QIAN X, Zhang S, Duan L, Yang F, et al
    Periodontitis Deteriorates Cognitive Function and Impairs Neurons and Glia in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201007. doi: 10.3233/JAD-201007.
    >> Share

  1753. SHAFFER RM, Li G, Adar SD, Dirk Keene C, et al
    Fine Particulate Matter and Markers of Alzheimer's Disease Neuropathology at Autopsy in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201005. doi: 10.3233/JAD-201005.
    >> Share

  1754. LAO K, Zhang R, Luan J, Zhang Y, et al
    Therapeutic Strategies Targeting Amyloid-beta Receptors and Transporters in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD200851. doi: 10.3233/JAD-200851.
    >> Share

  1755. LY M, Raji CA, Yu GZ, Wang Q, et al
    Obesity and White Matter Neuroinflammation Related Edema in Alzheimer Disease Dementia Biomarker Negative Cognitively Normal Individuals.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201242. doi: 10.3233/JAD-201242.
    >> Share

  1756. LOEFFLER DA
    Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201182. doi: 10.3233/JAD-201182.
    >> Share

  1757. MERCERON-MARTINEZ D, Ibaceta-Gonzalez C, Salazar C, Almaguer-Melian W, et al
    Alzheimer's Disease, Neural Plasticity, and Functional Recovery.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201178. doi: 10.3233/JAD-201178.
    >> Share

  1758. FERINI-STRAMBI L, Hensley M, Salsone M
    Decoding Causal Links Between Sleep Apnea and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201066. doi: 10.3233/JAD-201066.
    >> Share

  1759. CHEN YS, Shu K, Kang HC
    Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201141. doi: 10.3233/JAD-201141.
    >> Share

  1760. PRAKASH M, Abdelaziz M, Zhang L, Strange BA, et al
    Quantitative Longitudinal Predictions of Alzheimer's Disease by Multi-Modal Predictive Learning.
    J Alzheimers Dis. 2021 Jan 12. pii: JAD200906. doi: 10.3233/JAD-200906.
    >> Share

  1761. BARIL AA, Beiser AS, Redline S, McGrath ER, et al
    Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD200545. doi: 10.3233/JAD-200545.
    >> Share

  1762. MAI Y, Yu Q, Zhu F, Luo Y, et al
    AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201033. doi: 10.3233/JAD-201033.
    >> Share

  1763. DELIC V, Ratliff WA, Citron BA
    Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201378. doi: 10.3233/JAD-201378.
    >> Share

  1764. CASTAGNA A, Fabbo A, Manzo C, Lacava R, et al
    A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201211. doi: 10.3233/JAD-201211.
    >> Share

  1765. DE LA TORRE JC
    Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201165. doi: 10.3233/JAD-201165.
    >> Share

  1766. DARST BF, Huo Z, Jonaitis EM, Koscik RL, et al
    Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200176. doi: 10.3233/JAD-200176.
    >> Share

  1767. PARK JH, Ah Lee S
    The Fragility of Temporal Memory in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200892. doi: 10.3233/JAD-200892.
    >> Share

  1768. WU R, Gu J, Zhou D, Tung YC, et al
    Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201290. doi: 10.3233/JAD-201290.
    >> Share

  1769. HYUN LEE Y, Jeon S, Soo Yoo H, Jong Chung S, et al
    Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201094. doi: 10.3233/JAD-201094.
    >> Share

  1770. JING J, Zhang F, Zhao L, Xie J, et al
    Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201335. doi: 10.3233/JAD-201335.
    >> Share

  1771. KHAN MJ, Desaire H, Lopez OL, Kamboh MI, et al
    Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201318. doi: 10.3233/JAD-201318.
    >> Share

  1772. YAN Y, Wu X, Wang X, Geng Z, et al
    The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD200971. doi: 10.3233/JAD-200971.
    >> Share

  1773. SOHRABI M, Pecoraro HL, Combs CK
    Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-beta Plaque Deposition in the AppNL - G - F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 3. pii: JAD201099. doi: 10.3233/JAD-201099.
    >> Share

  1774. RADHAKRISHNAN NS, Mufti M, Ortiz D, Maye ST, et al
    Implementing Delirium Prevention in the Era of COVID-19.
    J Alzheimers Dis. 2021;79:31-36.
    >> Share

  1775. CLARK IA, Vissel B
    Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
    J Alzheimers Dis. 2021;79:931-948.
    >> Share

  1776. CARCAVILLA N, Pozo AS, Gonzalez B, Moral-Cuesta D, et al
    Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.
    J Alzheimers Dis. 2021;80:533-537.
    >> Share

  1777. TAM MT, Dosso JA, Robillard JM
    The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.
    J Alzheimers Dis. 2021;80:865-875.
    >> Share


  1778. Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021;81:1343.
    >> Share

  1779. DAVOUDI A, Dion C, Amini S, Tighe PJ, et al
    Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.
    J Alzheimers Dis. 2021;82:47-57.
    >> Share

  1780. TONIOLO S, Scarioni M, Di Lorenzo F, Hort J, et al
    Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.
    J Alzheimers Dis. 2021;82:883-898.
    >> Share

  1781. SUH SW, Kim YJ, Kwak KP, Kim K, et al
    A 9-Year Comparison of Dementia Prevalence in Korea: Results of NaSDEK 2008 and 2017.
    J Alzheimers Dis. 2021;81:821-831.
    >> Share

  1782. LIU X, Chen KL, Wang Y, Huang YY, et al
    A Novel ITM2B Mutation Associated with Familial Chinese Dementia.
    J Alzheimers Dis. 2021;81:499-505.
    >> Share

  1783. SCHMIDT SL, Boechat YEM, Schmidt GJ, Nicaretta D, et al
    Clinical Utility of a Reaction-Time Attention Task in the Evaluation of Cognitive Impairment in Elderly with High Educational Disparity.
    J Alzheimers Dis. 2021;81:691-697.
    >> Share

  1784. MARTINEZ-FLOREZ JF, Osorio JD, Cediel JC, Rivas JC, et al
    Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
    J Alzheimers Dis. 2021;81:729-742.
    >> Share

  1785. KANATOME A, Ano Y, Shinagawa K, Ide Y, et al
    beta-Lactolin Enhances Neural Activity, Indicated by Event-Related P300 Amplitude, in Healthy Adults: A Randomized Controlled Trial.
    J Alzheimers Dis. 2021;81:787-796.
    >> Share

  1786. WANG X, Bui H, Vemuri P, Graff-Radford J, et al
    Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2021;81:533-543.
    >> Share

  1787. HALAAS NB, Zetterberg H, Idland AV, Knapskog AB, et al
    Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
    J Alzheimers Dis. 2021;81:667-677.
    >> Share

  1788. HIRAO K, Yamashita F, Tsugawa A, Haime R, et al
    Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;80:877-883.
    >> Share

  1789. QUINT WH, Matecko-Burmann I, Schilcher I, Loffler T, et al
    Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.
    J Alzheimers Dis. 2021;80:813-829.
    >> Share

  1790. YUAN L, Zhang J, Guo JH, Holscher C, et al
    DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    J Alzheimers Dis. 2021;80:695-713.
    >> Share

  1791. SAHU B, Mackos AR, Floden AM, Wold LE, et al
    Particulate Matter Exposure Exacerbates Amyloid-beta Plaque Deposition and Gliosis in APP/PS1 Mice.
    J Alzheimers Dis. 2021;80:761-774.
    >> Share

  1792. SATO K, Mano T, Iwata A, Toda T, et al
    Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
    J Alzheimers Dis. 2021;82:1333-1344.
    >> Share

  1793. UMEGAKI H, Suzuki Y, Komiya H, Watanabe K, et al
    Frequencies and Neuropsychological Characteristics of Errors in the Clock Drawing Test.
    J Alzheimers Dis. 2021;82:1291-1300.
    >> Share

  1794. GONZALEZ-ALCAIDE G, Fernandez-Rios M, Redolat R, Serra E, et al
    Research on Emotion Recognition and Dementias: Foundations and Prospects.
    J Alzheimers Dis. 2021;82:939-950.
    >> Share

  1795. EDLUND AK, Chen K, Lee W, Protas H, et al
    Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3/varepsilon4 Carriers.
    J Alzheimers Dis. 2021;81:339-354.
    >> Share

  1796. STONNINGTON CM, Wu J, Zhang J, Shi J, et al
    Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
    J Alzheimers Dis. 2021;81:209-220.
    >> Share

  1797. RHODES E, Insel PS, Butters MA, Morin R, et al
    The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
    J Alzheimers Dis. 2021;80:991-1002.
    >> Share

  1798. PEIRA E, Grazzini M, Bauckneht M, Sensi F, et al
    Probing the Role of a Regional Quantitative Assessment of Amyloid PET.
    J Alzheimers Dis. 2021;80:383-396.
    >> Share

  1799. LI X, Shen M, Jin Y, Jia S, et al
    Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
    J Alzheimers Dis. 2021;80:371-381.
    >> Share

  1800. COSTA AS, Pinho J, Kucikiene D, Reich A, et al
    Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    J Alzheimers Dis. 2021;79:1661-1672.
    >> Share

  1801. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    The Free and Cued Selective Reminding Test Predicts Braak Stage.
    J Alzheimers Dis. 2021;80:175-183.
    >> Share

  1802. DENNISON JL, Ricciardi NR, Lohse I, Volmar CH, et al
    Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
    J Alzheimers Dis. 2021;80:41-52.
    >> Share

  1803. GNANAPRAKASH M, Staniszewski A, Zhang H, Pitstick R, et al
    Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
    J Alzheimers Dis. 2021;79:1813-1829.
    >> Share

  1804. MARTINEZ-MALDONADO A, Ontiveros-Torres MA, Harrington CR, Montiel-Sosa JF, et al
    Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    J Alzheimers Dis. 2021;79:1517-1531.
    >> Share

  1805. BASCUNANA P, Brackhan M, Pahnke J
    Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-beta Deposits and Activated Microglia.
    J Alzheimers Dis. 2021;79:597-605.
    >> Share

  1806. BERGER M, Cooter M, Roesler AS, Chung S, et al
    APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.
    J Alzheimers Dis. 2021;79:511-530.
    >> Share

  1807. NIU J, Iqbal K, Liu F, Hu W, et al
    Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.
    J Alzheimers Dis. 2021;82:855-869.
    >> Share

  1808. KORPIOJA A, Kruger J, Koivuluoma S, Pylkas K, et al
    Novel Rare SORL1 Variants in Early-Onset Dementia.
    J Alzheimers Dis. 2021;82:761-770.
    >> Share

  1809. SHINOHARA M, Suzuki K, Bu G, Sato N, et al
    Interaction Between APOE Genotype and Diabetes in Longevity.
    J Alzheimers Dis. 2021;82:719-726.
    >> Share

  1810. SVENSSON J, Blomqvist M, Kettunen P, Eckerstrom C, et al
    Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2021;82:781-790.
    >> Share

  1811. ZILLI EM, O'Donnell A, Salinas J, Aparicio HJ, et al
    Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study.
    J Alzheimers Dis. 2021;82:593-605.
    >> Share

  1812. YERSTEIN O, Parand L, Liang LJ, Isaac A, et al
    Benson's Disease or Posterior Cortical Atrophy, Revisited.
    J Alzheimers Dis. 2021;82:493-502.
    >> Share

  1813. KARANTH SD, Schmitt FA, Nelson PT, Katsumata Y, et al
    Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies.
    J Alzheimers Dis. 2021;82:647-659.
    >> Share

  1814. XIAO T, Wijnant SRA, Licher S, Terzikhan N, et al
    Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.
    J Alzheimers Dis. 2021;82:621-630.
    >> Share

  1815. RIEGEROVA P, Brejcha J, Bezdekova D, Chum T, et al
    Expression and Localization of AbetaPP in SH-SY5Y Cells Depends on Differentiation State.
    J Alzheimers Dis. 2021;82:485-491.
    >> Share

  1816. CHAPARRO D, Flores-Gaspar A, Ali-Torres J
    Computational Design of Copper Ligands with Controlled Metal Chelating, Pharmacokinetics, and Redox Properties for Alzheimer's Disease.
    J Alzheimers Dis. 2021;82.
    >> Share

  1817. SHENG C, Lin L, Lin H, Wang X, et al
    Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    J Alzheimers Dis. 2021;82:513-526.
    >> Share

  1818. WOODWORTH DC, Scambray KA, Corrada MM, Kawas CH, et al
    Neuroimaging in the Oldest-Old: A Review of the Literature.
    J Alzheimers Dis. 2021;82:129-147.
    >> Share

  1819. NG KP, Cheng GH, Yatawara C, Rosa-Neto P, et al
    Baseline Neurodegeneration Influences the Longitudinal Effects of Tau on Cognition.
    J Alzheimers Dis. 2021;82:159-167.
    >> Share

  1820. ALMKVIST O, Bruggen K, Nordberg A
    Subcortical and Cortical Regions of Amyloid-beta Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients.
    J Alzheimers Dis. 2021;81:1613-1624.
    >> Share

  1821. ZHANG H, D'Agostino C, Forman HJ, Cacciottolo M, et al
    Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.
    J Alzheimers Dis. 2021;82:307-316.
    >> Share

  1822. WANG YY, Ge YJ, Tan CC, Cao XP, et al
    The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.
    J Alzheimers Dis. 2021;81:1331-1339.
    >> Share

  1823. SIMONSEN AH, Musaeus CS, Christensen GL, Hasselbalch SG, et al
    Upwards Drift of Cerebrospinal Fluid Amyloid-beta 42 Over Twelve Years in a Consecutive Clinical Cohort.
    J Alzheimers Dis. 2021;81:1369-1373.
    >> Share

  1824. PAIS M, Loureiro J, do Vale V, Radanovic M, et al
    Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study.
    J Alzheimers Dis. 2021;81:949-962.
    >> Share

  1825. BEISHON LC, Panerai RB, Budgeon C, Subramaniam H, et al
    The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow.
    J Alzheimers Dis. 2021;80:1567-1581.
    >> Share

  1826. LUKKARINEN H, Tesseur I, Pemberton D, Van Der Ark P, et al
    Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2021;80:1629-1642.
    >> Share

  1827. TANNER JJ, Hanchate S, Price CC, Garvan C, et al
    Relationships Between Chronic Pain Stage, Cognition, Temporal Lobe Cortex, and Sociodemographic Variables.
    J Alzheimers Dis. 2021;80:1539-1551.
    >> Share

  1828. DING XL, Tuo QZ, Lei P
    An Introduction to Ultrasensitive Assays for Plasma Tau Detection.
    J Alzheimers Dis. 2021;80:1353-1362.
    >> Share

  1829. JARDEL A, Hopes L, Malaplate C, Roch V, et al
    Prognostic Impact of 18-F-Florbetaben Amyloid PET Imaging in Patients with Isolated Increases in Cerebrospinal Fluid Phospho-Tau Biomarkers: A Longitudinal Study.
    J Alzheimers Dis. 2021;80:1389-1394.
    >> Share

  1830. CLARK AL, Weigand AJ, Thomas KR, Solders SK, et al
    Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;80:1451-1463.
    >> Share

  1831. GJORA L, Strand BH, Bergh S, Borza T, et al
    Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.
    J Alzheimers Dis. 2021;79:1213-1226.
    >> Share

  1832. GRUTERS AAA, Ramakers IHGB, Stiekema APM, Verhey FRJ, et al
    An Exploratory Study of the Development and Pilot Testing of an Interactive Visual Tool of Neuropsychological Test Results in Memory Clinics.
    J Alzheimers Dis. 2021;79:1157-1170.
    >> Share

  1833. KUMON H, Yoshino Y, Funahashi Y, Mori H, et al
    PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.
    J Alzheimers Dis. 2021;79:1055-1062.
    >> Share

  1834. BASTA M, Zaganas I, Simos P, Koutentaki E, et al
    Apolipoprotein E varepsilon4 (APOE varepsilon4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    J Alzheimers Dis. 2021;79:763-771.
    >> Share

  1835. BALEA-FERNANDEZ FJ, Martinez-Vega B, Ortega S, Fabelo H, et al
    Analysis of Risk Factors in Dementia Through Machine Learning.
    J Alzheimers Dis. 2021;79:845-861.
    >> Share

  1836. OVIEDO DC, Perez-Lao AR, Flores-Cuadra JA, Villarreal AE, et al
    Apolipoprotein varepsilon4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics.
    J Alzheimers Dis. 2021;82.
    >> Share

  1837. STOJAKOVIC A, Chang SY, Nesbitt J, Pichurin NP, et al
    Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.
    J Alzheimers Dis. 2021;79:335-353.
    >> Share

  1838. SUN L, Li W, Yue L, Xiao S, et al
    Blood TDP-43 Combined with Demographics Information Predicts Dementia Occurrence in Community Non-Dementia Elderly.
    J Alzheimers Dis. 2021;79:301-309.
    >> Share

  1839. SOARES JZ, Pettersen R, Benth JS, Persson K, et al
    Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms.
    J Alzheimers Dis. 2021;79:311-321.
    >> Share

  1840. VITTAL RAO H, Bihaqi SW, Iannucci J, Sen A, et al
    Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.
    J Alzheimers Dis. 2021;79:211-224.
    >> Share

  1841. TUENA C, Mancuso V, Stramba-Badiale C, Pedroli E, et al
    Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review.
    J Alzheimers Dis. 2021;79:95-116.
    >> Share

  1842. RODRIGUEZ-SALGADO AM, Llibre-Guerra JJ, Tsoy E, Penalver-Guia AI, et al
    A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.
    J Alzheimers Dis. 2021;79:85-94.
    >> Share

  1843. TRAN L, Jung J, Carlin C, Lee S, et al
    Use of Direct-Acting Antiviral Agents and Survival Among Medicare Beneficiaries with Dementia and Chronic Hepatitis C.
    J Alzheimers Dis. 2021;79:71-83.
    >> Share

  1844. YLA-HERTTUALA S, Hakulinen M, Poutiainen P, Laitinen TM, et al
    Severe Obstructive Sleep Apnea and Increased Cortical Amyloid-beta Deposition.
    J Alzheimers Dis. 2021;79:153-161.
    >> Share

  1845. ZHU M, Jia L, Jia J
    Inhibition of miR-96-5p May Reduce Abeta42/Abeta40 Ratio via Regulating ATP-binding cassette transporter A1.
    J Alzheimers Dis. 2021;83:367-377.
    >> Share

  1846. TAKAO H, Amemiya S, Abe O
    Reproducibility of Brain Volume Changes in Longitudinal Voxel-Based Morphometry Between Non-Accelerated and Accelerated Magnetic Resonance Imaging.
    J Alzheimers Dis. 2021;83:281-290.
    >> Share

  1847. VAN DER LEE SJ, van Steenoven I, van de Beek M, Tesi N, et al
    Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021;83:269-279.
    >> Share

  1848. KAWAMURA K, Miyajima M, Nakajima M, Kanai M, et al
    Cerebrospinal Fluid Amyloid-beta Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2021;83:179-190.
    >> Share

  1849. IBANEZ A, Fittipaldi S, Trujillo C, Jaramillo T, et al
    Predicting and Characterizing Neurodegenerative Subtypes with Multimodal Neurocognitive Signatures of Social and Cognitive Processes.
    J Alzheimers Dis. 2021;83:227-248.
    >> Share

  1850. JONES E, Aigbogun MS, Pike J, Berry M, et al
    Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System.
    J Alzheimers Dis. 2021;83:89-101.
    >> Share

  1851. PARK J, Galvin JE
    Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021;82:1847-1859.
    >> Share

  1852. QUATTRINI G, Marizzoni M, Pizzini FB, Galazzo IB, et al
    Convergent and Discriminant Validity of Default Mode Network and Limbic Network Perfusion in Amnestic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2021;82:1797-1808.
    >> Share

  1853. MORI H, Funahashi Y, Yoshino Y, Kumon H, et al
    Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases.
    J Alzheimers Dis. 2021;82:1737-1744.
    >> Share

  1854. WANG WZ, Li MW, Chen Y, Liu LY, et al
    3xTg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-beta Production and Tau Hyperphosphorylation.
    J Alzheimers Dis. 2021;82:1635-1649.
    >> Share

  1855. ELMALEH DR, Downey MA, Kundakovic L, Wilkinson JE, et al
    New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease.
    J Alzheimers Dis. 2021;82:1373-1401.
    >> Share

  1856. BARRETT T, Stangis KA, Saito T, Saido T, et al
    Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.
    J Alzheimers Dis. 2021;82:1683-1702.
    >> Share

  1857. SAKAKIBARA Y, Hirota Y, Ibaraki K, Takei K, et al
    Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-beta Amyloidosis.
    J Alzheimers Dis. 2021;82:1513-1530.
    >> Share

  1858. LI W, Wang S, Zhang H, Li B, et al
    Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming.
    J Alzheimers Dis. 2021;82:1475-1485.
    >> Share

  1859. LAZAROVA MI, Tsekova DS, Tancheva LP, Kirilov KT, et al
    New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity.
    J Alzheimers Dis. 2021;83:1211-1220.
    >> Share

  1860. SAKURAI K, Kaneda D, Uchida Y, Inui S, et al
    Can Medial Temporal Impairment Be an Imaging Red Flag for Neurodegeneration in Disproportionately Enlarged Subarachnoid Space Hydrocephalus?
    J Alzheimers Dis. 2021;83:1199-1209.
    >> Share

  1861. FELISBERTI FM
    Hedonic Preferences to Audio and Visual Stimulation in Seniors with Cognitive Impairments.
    J Alzheimers Dis. 2021;83:1353-1366.
    >> Share

  1862. SCHENNING KJ, Holden S, Davis BA, Mulford A, et al
    Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.
    J Alzheimers Dis. 2021;83:1251-1268.
    >> Share

  1863. SIERRA-FONSECA JA, Rodriguez M, Themann A, Lira O, et al
    Autophagy Induction and Accumulation of Phosphorylated Tau in the Hippocampus and Prefrontal Cortex of Adult C57BL/6 Mice Subjected to Adolescent Fluoxetine Treatment.
    J Alzheimers Dis. 2021;83:1691-1702.
    >> Share

  1864. MORRIS R, Umeukeje G, Bu K, Cheng F, et al
    The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021;83:1061-1071.
    >> Share

  1865. JORDA A, Aldasoro M, Aldasoro C, Valles SL, et al
    Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice.
    J Alzheimers Dis. 2021;83:1051-1060.
    >> Share

  1866. GOUILLY D, Tisserand C, Nogueira L, Saint-Lary L, et al
    Taking the A Train? Limited Consistency of Abeta42 and the Abeta42/40 Ratio in the AT(N) Classification.
    J Alzheimers Dis. 2021;83:1033-1038.
    >> Share

  1867. SIQUEIRA LD, Celes APM, Santos HD, Ferreira ST, et al
    A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-beta Oligomers in Mice.
    J Alzheimers Dis. 2021;83:1113-1124.
    >> Share

  1868. POPE CA, Wilkins HM, Swerdlow RH, Wolfe MS, et al
    Mutations in the Amyloid-beta Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-beta Peptide.
    J Alzheimers Dis. 2021;83:1039-1049.
    >> Share

  1869. SUBRAMANIAM S, Blake DT, Constantinidis C
    Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders.
    J Alzheimers Dis. 2021;83:491-503.
    >> Share

  1870. DHANA K, James BD, Agarwal P, Aggarwal NT, et al
    MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2021;83:683-692.
    >> Share

  1871. YANG L, Wu C, Tucker L, Dong Y, et al
    Photobiomodulation Therapy Attenuates Anxious-Depressive-Like Behavior in the TgF344 Rat Model.
    J Alzheimers Dis. 2021;83:1415-1429.
    >> Share

  1872. ASO Y, Kimura N, Matsubara E
    Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition.
    J Alzheimers Dis. 2021;84:905-914.
    >> Share

  1873. YIN X, Zhou Z, Qiu Y, Fan X, et al
    SIRT1 Regulates Tau Expression and Tau Synaptic Pathology.
    J Alzheimers Dis. 2021;84:895-904.
    >> Share

  1874. DAI S, Zhou F, Sun J, Li Y, et al
    NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-beta42 by Inhibiting GSK3beta Activation in N2a/APP695swe Cells.
    J Alzheimers Dis. 2021;84:869-881.
    >> Share

  1875. FINK A, Doblhammer G, Tamguney G
    Recurring Gastrointestinal Infections Increase the Risk of Dementia.
    J Alzheimers Dis. 2021;84:797-806.
    >> Share

  1876. LAZAROVA M, Tancheva L, Alexandrova A, Tsvetanova E, et al
    Effects of New Galantamine Derivatives in a Scopolamine Model of Dementia in Mice.
    J Alzheimers Dis. 2021;84:671-690.
    >> Share

  1877. KITANI-MORII F, Friedland RP, Yoshida H, Mizuno T, et al
    Drosophila as a Model for Microbiota Studies of Neurodegeneration.
    J Alzheimers Dis. 2021;84:479-490.
    >> Share

  1878. LAZRIS D, Perkins MM, Bay AA, Hackney ME, et al
    Qualitative Evaluation Informs Understanding of Motor Cognition and Therapies in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;84:691-703.
    >> Share

  1879. WEI S, Shang S, Dang L, Gao F, et al
    Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-beta Transport: A Population-Based Cross-Sectional Study.
    J Alzheimers Dis. 2021;84:303-314.
    >> Share

  1880. XIA L, Pang Y, Li J, Wu B, et al
    Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
    J Alzheimers Dis. 2021;84:239-248.
    >> Share

  1881. DEFEIS B, Ying G, Kurasz AM, De Wit L, et al
    Latent Factor Structure of Outcome Measures Used in the HABIT(R) Mild Cognitive Impairment Intervention Programs.
    J Alzheimers Dis. 2021;84:193-205.
    >> Share

  1882. GAN J, Liu S, Wang XD, Hu W, et al
    The Association Between Hyperhidrosis and Dementia: A Community-Based Research.
    J Alzheimers Dis. 2021;84:1657-1667.
    >> Share

  1883. UPITE J, Bruning T, Mohle L, Brackhan M, et al
    A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-beta Compounds.
    J Alzheimers Dis. 2021;84:1677-1690.
    >> Share

  1884. GALVIN JE, Chrisphonte S, Chang LC
    Medical and Social Determinants of Brain Health and Dementia in a Multicultural Community Cohort of Older Adults.
    J Alzheimers Dis. 2021;84:1563-1576.
    >> Share

  1885. FOUCARD C, Palisson J, Belin C, Bereaux C, et al
    The Diagnostic Value of a Short Memory Test: The TNI-93.
    J Alzheimers Dis. 2021;84:1461-1471.
    >> Share

  1886. HOILUND-CARLSEN PF, Alavi A
    Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data.
    J Alzheimers Dis. 2021;84:1457-1460.
    >> Share

  1887. NAKAHATA N, Nakamura T, Kawarabayashi T, Seino Y, et al
    Age-Related Cognitive Decline and Prevalence of Mild Cognitive Impairment in the Iwaki Health Promotion Project.
    J Alzheimers Dis. 2021;84:1233-1245.
    >> Share

  1888. TIAN T, Qin X, Wang Y, Shi Y, et al
    40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice.
    J Alzheimers Dis. 2021;84:983-993.
    >> Share

  1889. FILIPPONE A, Li JG, Pratico D
    VPS35 Downregulation Alters Degradation Pathways in Neuronal Cells.
    J Alzheimers Dis. 2021;84:1079-1089.
    >> Share

    December 2020
  1890. SOLDEVILA-DOMENECH N, Forcano L, Boronat A, Lorenzo T, et al
    Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 31. pii: JAD201408. doi: 10.3233/JAD-201408.
    >> Share

  1891. GONZALEZ C, Tommasi NS, Briggs D, Properzi MJ, et al
    Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201122. doi: 10.3233/JAD-201122.
    >> Share

  1892. FU Z, Zhao M, Wang X, He Y, et al
    Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201116. doi: 10.3233/JAD-201116.
    >> Share

  1893. BARTHELSON K, Pederson SM, Newman M, Lardelli M, et al
    Brain Transcriptome Analysis of a Protein-Truncating Mutation in Sortilin-Related Receptor 1 Associated With Early-Onset Familial Alzheimer's Disease Indicates Early Effects on Mitochondrial and Ribosome Function.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201383. doi: 10.3233/JAD-201383.
    >> Share

  1894. TRUMBORE CN
    Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer's and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201025. doi: 10.3233/JAD-201025.
    >> Share

  1895. RYAN M, Tan VTY, Thompson N, Guevremont D, et al
    Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD200757. doi: 10.3233/JAD-200757.
    >> Share

  1896. BABULAL GM, Johnson A, Fagan AM, Morris JC, et al
    Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201294. doi: 10.3233/JAD-201294.
    >> Share

  1897. STREIT WJ, Khoshbouei H, Bechmann I
    The Role of Microglia in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201248. doi: 10.3233/JAD-201248.
    >> Share

  1898. FUTAMURA A, Hieda S, Mori Y, Sugimoto A, et al
    Cingulate Island Sign in Single Photon Emission Computed Tomography: Clinical Biomarker Correlations in Lewy Body Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201145. doi: 10.3233/JAD-201145.
    >> Share

  1899. HOANG MT, Kareholt I, von Euler M, von Koch L, et al
    Satisfaction with Stroke Care Among Patients with Alzheimer's and Other Dementias: A Swedish Register-Based Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200976. doi: 10.3233/JAD-200976.
    >> Share

  1900. BAO YW, Chau ACM, Chiu PK, Shea YF, et al
    Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200890. doi: 10.3233/JAD-200890.
    >> Share

  1901. TROMP K, Smedinga M, Richard E, Perry M, et al
    Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200884. doi: 10.3233/JAD-200884.
    >> Share

  1902. YUAN J, Maserejian N, Liu Y, Devine S, et al
    Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    J Alzheimers Dis. 2020 Dec 20. pii: JAD200786. doi: 10.3233/JAD-200786.
    >> Share

  1903. MINTA K, Brinkmalm G, Portelius E, Johansson P, et al
    Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD201039. doi: 10.3233/JAD-201039.
    >> Share

  1904. WU W, Lee I, Spratt H, Fang X, et al
    tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD200917. doi: 10.3233/JAD-200917.
    >> Share

  1905. PETERSEN ME, Rafii MS, Zhang F, Hall J, et al
    Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD201167. doi: 10.3233/JAD-201167.
    >> Share

  1906. ORJUELA A, Lakey-Beitia J, Mojica-Flores R, Hegde ML, et al
    Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-beta Monomers and Fibrils: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD200941. doi: 10.3233/JAD-200941.
    >> Share

  1907. MOZERSKY J, Hartz S, Linnenbringer E, Levin L, et al
    Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200993. doi: 10.3233/JAD-200993.
    >> Share

  1908. FANET H, Tournissac M, Leclerc M, Caron V, et al
    Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-beta and Tau Pathologies.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200637. doi: 10.3233/JAD-200637.
    >> Share

  1909. MURCHISON CF, Kennedy RE, McConathy JE, Roberson ED, et al
    Racial Differences in Alzheimer's Disease Specialist Encounters are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
    J Alzheimers Dis. 2020 Dec 14. pii: JAD200796. doi: 10.3233/JAD-200796.
    >> Share

  1910. ROMANO RR, Carter MA, Dietrich MS, Cowan RL, et al
    Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201293. doi: 10.3233/JAD-201293.
    >> Share

  1911. TEIPEL SJ, Marie Temp AG, Levin F, Dyrba M, et al
    Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201032. doi: 10.3233/JAD-201032.
    >> Share

  1912. IBI D, Hirashima K, Kojima Y, Sumiya K, et al
    Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD200972. doi: 10.3233/JAD-200972.
    >> Share

  1913. WANG Q, Chen B, Zhong X, Zhou H, et al
    Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201168. doi: 10.3233/JAD-201168.
    >> Share

  1914. ETTCHETO M, Busquets O, Cano A, Sanchez-Lopez E, et al
    Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 2. pii: JAD201106. doi: 10.3233/JAD-201106.
    >> Share

  1915. BEACH TG, Malek-Ahmadi M
    Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD201213. doi: 10.3233/JAD-201213.
    >> Share

  1916. FLAX J, Wilkins HM, Miller R, Griffith S, et al
    OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200996. doi: 10.3233/JAD-200996.
    >> Share

  1917. BIRKENBIHL C, Westwood S, Shi L, Nevado-Holgado A, et al
    ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200948. doi: 10.3233/JAD-200948.
    >> Share

  1918. JAYATUNGA DPW, Hone E, Bharadwaj P, Garg M, et al
    Targeting Mitophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD191258. doi: 10.3233/JAD-191258.
    >> Share

    November 2020
  1919. DENIZ K, Ho CCG, Malphrus KG, Reddy JS, et al
    Plasma Biomarkers of Alzheimer's Disease in African Americans.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200828. doi: 10.3233/JAD-200828.
    >> Share

  1920. BASTRUP J, Hansen KH, Poulsen TBG, Kastaniegaard K, et al
    Anti-Abeta Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200715. doi: 10.3233/JAD-200715.
    >> Share

  1921. KOYCHEV I, Jansen K, Dette A, Shi L, et al
    Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2020 Nov 24. pii: JAD200900. doi: 10.3233/JAD-200900.
    >> Share

  1922. SOTO-MERCADO V, Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C, et al
    Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.
    J Alzheimers Dis. 2020 Nov 23. pii: JAD201045. doi: 10.3233/JAD-201045.
    >> Share

  1923. GIL R, Arroyo-Anllo EM
    Alzheimer's Disease and Face Masks in Times of COVID-19.
    J Alzheimers Dis. 2020 Nov 22. pii: JAD201233. doi: 10.3233/JAD-201233.
    >> Share

  1924. YEE E, Ma D, Popuri K, Wang L, et al
    Construction of MRI-Based Alzheimer's Disease Score Based on Efficient 3D Convolutional Neural Network: Comprehensive Validation on 7,902 Images from a Multi-Center Dataset.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200830. doi: 10.3233/JAD-200830.
    >> Share

  1925. SERGOTT RC, Raji A, Kost J, Sur C, et al
    Retinal Optical Coherence Tomography Metrics are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200735. doi: 10.3233/JAD-200735.
    >> Share

  1926. VAN WAALWIJK VAN DOORN LJC, Ghafoorian M, van Leijsen EMC, Claassen JAHR, et al
    White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200496. doi: 10.3233/JAD-200496.
    >> Share

  1927. FLORES-CUADRA JA, Madrid A, Fernandez PL, Perez-Lao AR, et al
    Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    J Alzheimers Dis. 2020 Nov 20. pii: JAD200870. doi: 10.3233/JAD-200870.
    >> Share

  1928. BUSQUETS O, Parcerisas A, Verdaguer E, Ettcheto M, et al
    c-Jun N-Terminal Kinases in Alzheimer's Disease: A Possible Target for the Modulation of the Earliest Alterations.
    J Alzheimers Dis. 2020 Nov 18. pii: JAD201053. doi: 10.3233/JAD-201053.
    >> Share

  1929. RADESTIG MA, Skoog J, Zetterberg H, Kern J, et al
    Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200751. doi: 10.3233/JAD-200751.
    >> Share

  1930. YANG B, Yang S, Zhang Y, Liu W, et al
    Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P).
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200652. doi: 10.3233/JAD-200652.
    >> Share

  1931. FEMMINELLA GD, Harold D, Scott J, Williams J, et al
    The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200578. doi: 10.3233/JAD-200578.
    >> Share

  1932. BECKER S, Boettinger O, Sulzer P, Hobert MA, et al
    Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200256. doi: 10.3233/JAD-200256.
    >> Share

  1933. MADERNA E, Visona S, Bolcato V, Redaelli V, et al
    Neuropathological Alzheimer's Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes.
    J Alzheimers Dis. 2020 Nov 13. pii: JAD201085. doi: 10.3233/JAD-201085.
    >> Share

  1934. BARKER W, Quinonez C, Greig MT, Behar R, et al
    Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    J Alzheimers Dis. 2020 Nov 13. pii: JAD200901. doi: 10.3233/JAD-200901.
    >> Share

  1935. GUARNIERI B, Maestri M, Cucchiara F, Lo Gerfo A, et al
    Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences.
    J Alzheimers Dis. 2020 Nov 11. pii: JAD200632. doi: 10.3233/JAD-200632.
    >> Share

  1936. SINGH A, Allen D, Fracassi A, Tumurbaatar B, et al
    Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology is Associated with Absence of Synaptic Tau Oligomers.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200716. doi: 10.3233/JAD-200716.
    >> Share

  1937. WALKER JD, Spiro G, Loewen K, Jacklin K, et al
    Alzheimer's Disease and Related Dementia in Indigenous Populations: A Systematic Review of Risk Factors.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200704. doi: 10.3233/JAD-200704.
    >> Share

  1938. HONG T, Hirano S, Sakurai T, Nakano Y, et al
    The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200676. doi: 10.3233/JAD-200676.
    >> Share

  1939. LI X, Xuan W, Chen D, Gao H, et al
    Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200770. doi: 10.3233/JAD-200770.
    >> Share

  1940. DE LA FUENTE GARCIA S, Ritchie C, Luz S
    Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200888. doi: 10.3233/JAD-200888.
    >> Share

  1941. YANG YX, Ku K, Li HQ, Shen XN, et al
    Investigating Causal Relations Between Risk Tolerance, Risky Behaviors, and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200773. doi: 10.3233/JAD-200773.
    >> Share

  1942. ARMSTRONG TD, Suwannasual U, Kennedy CL, Thasma A, et al
    Exposure to Traffic-Generated Pollutants Exacerbates the Expression of Factors Associated with the Pathophysiology of Alzheimer's Disease in Aged C57BL/6 Wild-Type Mice.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200929. doi: 10.3233/JAD-200929.
    >> Share

  1943. RICHTER N, Bischof G, Dronse J, Nellessen N, et al
    Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200835. doi: 10.3233/JAD-200835.
    >> Share

    October 2020
  1944. POPLE CB, Meng Y, Li DZ, Bigioni L, et al
    Neuromodulation in the Treatment of Alzheimer's Disease: Current and Emerging Approaches.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200913. doi: 10.3233/JAD-200913.
    >> Share

  1945. YILMAZ A, Ustun I, Ugur Z, Akyol S, et al
    A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200305. doi: 10.3233/JAD-200305.
    >> Share

  1946. BARTELS C, Kogel A, Schweda M, Wiltfang J, et al
    Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200794. doi: 10.3233/JAD-200794.
    >> Share

  1947. LIU KY, Costello H, Reeves S, Howard R, et al
    The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200516. doi: 10.3233/JAD-200516.
    >> Share

  1948. FIELDS TN, Mueller KD, Koscik RL, Johnson SC, et al
    Self-Reported Hearing Loss and Longitudinal Cognitive Function in a Cohort Enriched with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 17. pii: JAD200701. doi: 10.3233/JAD-200701.
    >> Share

  1949. GIBSON GE, Luchsinger JA, Cirio R, Chen H, et al
    Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200896. doi: 10.3233/JAD-200896.
    >> Share

  1950. RESCHKE-HERNANDEZ AE, Belfi AM, Guzman-Velez E, Tranel D, et al
    Hooked on a Feeling: Influence of Brief Exposure to Familiar Music on Feelings of Emotion in Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200889. doi: 10.3233/JAD-200889.
    >> Share

  1951. CROCCO E, Curiel-Cid RE, Kitaigorodsky M, Gonzalez-Jimenez CJ, et al
    A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200790. doi: 10.3233/JAD-200790.
    >> Share

  1952. MENNE F, Schipke CG, Klostermann A, Fuentes-Casan M, et al
    Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200710. doi: 10.3233/JAD-200710.
    >> Share

  1953. KRITIKOS M, Gandy S, Meliker JR, Luft BJ, et al
    Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200679. doi: 10.3233/JAD-200679.
    >> Share

  1954. MARIZZONI M, Cattaneo A, Mirabelli P, Festari C, et al
    Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 14. pii: JAD200306. doi: 10.3233/JAD-200306.
    >> Share

  1955. KHALSA DS
    The End of Alzheimer's Protocol: The First Protocol to Enhance Cognition and Reverse Decline at Any Age by Dale Bredesen, Avery, 2020, 352 pp.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD201157. doi: 10.3233/JAD-201157.
    >> Share

  1956. ITZHAKI RF
    Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200986. doi: 10.3233/JAD-200986.
    >> Share

  1957. MATIAS-GUIU JA, Pytel V, Matias-Guiu J
    Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200940. doi: 10.3233/JAD-200940.
    >> Share

  1958. DUGGAN MR, Torkzaban B, Ahooyi TM, Khalili K, et al
    Potential Role for Herpesviruses in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200814. doi: 10.3233/JAD-200814.
    >> Share

  1959. GABERE M, Thu Pham NT, Graff-Radford J, Machulda MM, et al
    Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200625. doi: 10.3233/JAD-200625.
    >> Share

  1960. LOUPY KM, Lee T, Zambrano CA, Elsayed AI, et al
    Alzheimer's Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200568. doi: 10.3233/JAD-200568.
    >> Share

  1961. ZHANG T, Han X, Zhang X, Chen Z, et al
    Dietary Fatty Acid Factors in Alzheimer's Disease: A Mini-Review.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200558. doi: 10.3233/JAD-200558.
    >> Share

  1962. RUITER M, Herstel LJ, Wierenga CJ
    Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200527. doi: 10.3233/JAD-200527.
    >> Share

  1963. ROSIN ER, Blasco D, Pilozzi AR, Yang LH, et al
    A Narrative Review of Alzheimer's Disease Stigma.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200932. doi: 10.3233/JAD-200932.
    >> Share

  1964. HUTTENRAUCH M, Lopez-Noguerola JS, Castro-Obregon S
    Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200743. doi: 10.3233/JAD-200743.
    >> Share

  1965. RAVONA-SPRINGER R, Sharvit-Ginon I, Ganmore I, Greenbaum L, et al
    The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200623. doi: 10.3233/JAD-200623.
    >> Share

  1966. CHANG KH, Huang CC, Chen CM, Wu HC, et al
    Differences in Clinical Presentation of Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease According to Sex and Education Level.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200507. doi: 10.3233/JAD-200507.
    >> Share

  1967. STONNINGTON CM, Velgos SN, Chen Y, Syed S, et al
    Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200132. doi: 10.3233/JAD-200132.
    >> Share

  1968. LEE JH, Byun MS, Yi D, Ko K, et al
    Long-Term Exposure to PM10 and in vivo Alzheimer's Disease Pathologies.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200694. doi: 10.3233/JAD-200694.
    >> Share

  1969. GAVRIEL Y, Rabinovich-Nikitin I, Ezra A, Barbiro B, et al
    Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200506. doi: 10.3233/JAD-200506.
    >> Share

  1970. GAO L, Wang J, Jiang Y, Wei S, et al
    Relationship Between Peripheral Transport Proteins and Plasma Amyloid-beta in Patients with Alzheimer's Disease were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD191320. doi: 10.3233/JAD-191320.
    >> Share

    September 2020
  1971. POSADA-DUQUE RA, Cardona-Gomez GP
    CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200730. doi: 10.3233/JAD-200730.
    >> Share

  1972. SI Z, Wang X
    The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200720. doi: 10.3233/JAD-200720.
    >> Share

  1973. GEERTS H, Spiros A
    Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200688. doi: 10.3233/JAD-200688.
    >> Share

  1974. DUARTE-GUTERMAN P, Albert AY, Inkster AM, Barha CK, et al
    Inflammation in Alzheimer's Disease: Do Sex and APOE Matter?
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200982. doi: 10.3233/JAD-200982.
    >> Share

  1975. TORRES-ACOSTA N, O'Keefe JH, O'Keefe EL, Isaacson R, et al
    Therapeutic Potential of TNF-alpha Inhibition for Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200711. doi: 10.3233/JAD-200711.
    >> Share

  1976. TALAN J
    A Life Committed to Changing the Face of Alzheimer's.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD201108. doi: 10.3233/JAD-201108.
    >> Share

  1977. LI D, Liu Y, Zeng X, Xiong Z, et al
    Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200843. doi: 10.3233/JAD-200843.
    >> Share

  1978. YUAN X, Wang L, Tendon N, Sun H, et al
    Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200594. doi: 10.3233/JAD-200594.
    >> Share

  1979. CARDOSO R, Lemos C, Oliveiros B, Rosario Almeida M, et al
    APOEvarepsilon4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200556. doi: 10.3233/JAD-200556.
    >> Share

  1980. ABDELNOUR C, Esteban de Antonio E, Perez-Cordon A, Lafuente A, et al
    Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundacio ACE in Barcelona, Spain.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200750. doi: 10.3233/JAD-200750.
    >> Share

  1981. MOREIRA NCDS, Lima JEBF, Chierrito TPC, Carvalho I, et al
    Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200425. doi: 10.3233/JAD-200425.
    >> Share

  1982. KATHERINE BLUJUS J, Elizabeth Korthauer L, Awe E, Frahmand M, et al
    Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    J Alzheimers Dis. 2020 Sep 20. pii: JAD200444. doi: 10.3233/JAD-200444.
    >> Share

  1983. XIA Y, Yassi N, Raniga P, Bourgeat P, et al
    Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200419. doi: 10.3233/JAD-200419.
    >> Share

  1984. LI Y, Li S, Xu S, Yu H, et al
    Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200233. doi: 10.3233/JAD-200233.
    >> Share

    February 2020
  1985. ARNALDI D, Donniaquio A, Mattioli P, Massa F, et al
    Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191315. doi: 10.3233/JAD-191315.
    >> Share

    January 2020
  1986. FALGAS N, Balasa M, Bargallo N, Borrego-Ecija S, et al
    Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191167. doi: 10.3233/JAD-191167.
    >> Share

  1987. HAMILTON RKB, Phelan CH, Chin NA, Wyman MF, et al
    The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research.
    J Alzheimers Dis. 2020;73:431-442.
    >> Share

  1988. WANG YL, Chen W, Cai WJ, Hu H, et al
    Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    J Alzheimers Dis. 2020;73:759-768.
    >> Share

  1989. ECKERSTROM C, Eckerstrom M, Gothlin M, Molinder A, et al
    Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia.
    J Alzheimers Dis. 2020;73:597-607.
    >> Share

  1990. REIMAND J, Groot C, Teunissen CE, Windhorst AD, et al
    Why Is Amyloid-beta PET Requested After Performing CSF Biomarkers?
    J Alzheimers Dis. 2020;73:559-569.
    >> Share

  1991. ROBINSON AC, Chew-Graham S, Davidson YS, Horan MA, et al
    A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
    J Alzheimers Dis. 2020;73:619-632.
    >> Share

  1992. KLINEDINST BS, Le ST, Larsen B, Pappas C, et al
    Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study.
    J Alzheimers Dis. 2020;78:1245-1257.
    >> Share

  1993. ZHANG Y, Hao Y, Li L, Xia K, et al
    A Novel Computational Proxy for Characterizing Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2020;78:1217-1228.
    >> Share

  1994. SRIVASTAVA A, Das B, Yao AY, Yan R, et al
    Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
    J Alzheimers Dis. 2020;78:1345-1361.
    >> Share

  1995. LIU N, Sun J, Wang X, Zhao M, et al
    The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020;78:1775-1782.
    >> Share

  1996. KRESGE HA, Liu D, Gupta DK, Moore EE, et al
    Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
    J Alzheimers Dis. 2020;74:965-974.
    >> Share

  1997. WATT G, Shang K, Zieba J, Olaya J, et al
    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Abeta40 Levels in 12-Month-Old Male AbetaPPswe/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2020;74:937-950.
    >> Share

  1998. GRONTVEDT GR, Lauridsen C, Berge G, White LR, et al
    The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.
    J Alzheimers Dis. 2020;74:829-837.
    >> Share

  1999. RICHARDSON K, Wharton SB, Grossi CM, Matthews FE, et al
    Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.
    J Alzheimers Dis. 2020;74:999-1009.
    >> Share

  2000. ZHANG J, Hua XF, Gu J, Chen F, et al
    High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2020;74:851-864.
    >> Share

  2001. SUNDSTROM A, Sorman DE, Hansson P, Ljungberg JK, et al
    Mental Demands at Work and Risk of Dementia.
    J Alzheimers Dis. 2020;74:735-740.
    >> Share

  2002. BREWER GJ, Herrera RA, Philipp S, Sosna J, et al
    Age-Related Intraneuronal Aggregation of Amyloid-beta in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
    J Alzheimers Dis. 2020;73:229-246.
    >> Share

  2003. VERGOUW LJM, Bosman B, van de Beek M, Salome M, et al
    Family History is Associated with Phenotype in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2020;73:269-275.
    >> Share

  2004. ARFANAKIS K, Evia AM, Leurgans SE, Cardoso LFC, et al
    Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    J Alzheimers Dis. 2020;73:333-345.
    >> Share

  2005. TSUNODA K, Yamashita T, Osakada Y, Sasaki R, et al
    Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020;73:209-215.
    >> Share

  2006. DAVIDOWITZ EJ, Krishnamurthy PK, Lopez P, Jimenez H, et al
    In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.
    J Alzheimers Dis. 2020;73:147-161.
    >> Share

  2007. PARVAND M, Rankin CH
    Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease?
    J Alzheimers Dis. 2020;73:1-21.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016